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Introduction in DNA repair
The genetic information that takes care of the proper functioning of all cell types 
that makes up an organism is organized in DNA. This so-called blue print of life is 
continuously attacked by a variety of genotoxic agents and environmental stresses that 
can damage the DNA (Figure ). For instance, ultraviolet radiation (UV) causes helix-
distorting lesions, cis-syn-cyclobutane pyrimidine dimers (CPDs) and pyrimidine-(,)-
pyrimidone products (-PPs) (Sancar, ). On the other hand, ionizing radiation (IR) 
can cause formation of single strand breaks (SSBs) and double strand breaks (DSBs) (van 
Gent et al., 00). The organism’s own metabolism generates reactive oxygen species 
(ROS) (including superoxide anions, hydrogen peroxide and hydroxyl radicals and 
their numerous subsequent reaction products) lipid peroxidation products, oestrogen 
metabolites, reactive carbonyl species, endogenous alkylating agents, spontaneous 
hydrolysis and deamination products (De Bont and van Larebeke, 00). These result 
in DNA damages like oxidative DNA lesions, including -oxo-’-deoxyguanosine (-
oxodG), thymine glycols, cyclopurines and SSBs and DSBs (Hoeijmakers, 00). Finally, 
spontaneous modifications of nucleotides such as hydrolysis leading to abasic sites are 
common in cells. In total this adds up to 0-0 lesions per cell per day (Lindahl, ). 
The consequences of DNA damage can be severe and may lead to cellular malfunctioning 
caused by hampered transcription and replication, and may result in permanent cell 
cycle arrest (senescence) or cell death (apoptosis). If the cells don’t get replaced, and the 
tissue or organismal homeostasis gets lost, it can result in (premature) ageing (Mitchell 
et al., 00). However, when these DNA damages result in irreversible mutations or 
chromosomal aberrations, and therefore replication errors, these mutations can lead 
to carcinogenesis (Mitchell et al., 00). A complex network of DNA repair pathways 
(first found in bacteria and yeast), each selective for a specific subset of DNA lesions has 
evolved to overcome early onset of cancer or ageing. However, the more complex the 
system, the more sensitive it is to errors and deficiencies. 
Repair pathways
In mammals, multiple partially overlapping DNA repair mechanism exist, each with 
their own damage specificity (Essers et al., 00). Base excision repair (BER), nucleotide 
excision repair (NER), mismatch repair (MMR), and double strand break repair are the 
four main DNA repair pathways. Each of these repair pathways uses different modes of 
damage recognition, which in most cases depends on the damage appearance on the 
DNA in terms of helix distortions, obstruction of DNA probing, or blockage of DNA 
transcription or replication (Hanawalt, 00; Hoeijmakers, 00; Jackson, 00). Lesions 
that are recognised and repaired by BER or NER only affect one strand of the double helix. 
BER repairs non-bulky lesions produced by the alkylation, oxidation or deamination of 
bases, and single strand DNA breaks. A DNA glycosylase enzyme, followed by excision 
of the resulting sugar phosphate, removes the altered base in BER. The small gap left in 
the DNA helix is filled in by the sequential action of DNA polymerase and DNA ligase 
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(Parikh et al., ). NER can recognise a large range of structurally very different DNA 
damages. The recognition of DNA damage in NER is less specific than in BER and this 
process can thus repair a wider range of damage types. There are two modes of NER, 
global genome repair (GG-NER), which removes damage throughout the whole genome 
and transcription-coupled repair (TC-NER), which specifically repairs the transcribed 
strand of active genes from lesions that actually block transcription (de Laat et al., ; 
Hanawalt, 00). A more extensive explanation into the mechanism or NER will follow 
in the next subsection. Double strand breaks (DSBs) are very problematic, because both 
strands are affected; therefore at least two major pathways have developed to cope with 
this problem. First, homologous recombination (HR), which occurs in S and G phase 
cells when an intact second copy of the sequence (sister chromatid) is available. A joint 
molecule between the homologous damaged and undamaged duplex is formed, followed 
by DNA synthesis, ligation and resolution of recombination intermediates (van Gent et 
al., 00). Second, the less-accurate non-homologous end joining (NHEJ) is most relevant 
in the G phase of the cell cycle when a second copy of the sequence is not available. This 
pathway uses very limited or no sequence homology and is mediated by direct end-joining 
(Jackson, 00). Finally, there is also a repair pathway that recognises and repairs the 
erroneous insertion, deletion and miss-incorporation of bases that can arise during DNA 
replication and recombination, as-well as repairing some forms of DNA damage. After 
recognition of the damage the MMR pathway in E. coli (bacteria) distinguishes between 
the correct (unmutated) and the ‘wrong’ strand (mutated strand), using the strand-specific 
methylation fingerprint. Excising the wrongly incorporated base and replacing it with 
the correct nucleotide to repair the damage (Fleck and Nielsen, 00). Of all the repair 
systems, NER is the most all-round in terms of lesion recognition.
Figure 1.
The top row show DNA damaging agents, the middle row depict examples of DNA lesions induced by these agents, 
and the bottom row are the most relevant DNA repair mechanism responsible for the removal of the lesions. 
Abbreviations: cis-Pt and MMC, cisplatin and mitomycin C, respectively (both DNA-crosslinking agents); (−)PP 
and CPD, − photoproduct and cyclobutane pyrimidine dimer, respectively (both induced by UV light); BER and 
NER, base- and nucleotide-excision repair, respectively; HR, homologous recombination; EJ, end joining. This 
figure was adapted from Hoeijmakers (00).
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Nucleotide excision repair
Nucleotide excision repair (NER) removes a wide variety of DNA helix-distorting injuries 
of both exogenous and endogenous origin. It is a multistep pathway that is responsible 
for the removal of damage such as induced by UV irradiation. UV radiation contained in 
the solar light can be divided into three wavelengths: UVA (-00 nm), UVB (0- 
nm) and UVC (00-0 nm). Shorter wavelengths (that are more highly absorbed by the 
ozone layer) are more effective in causing DNA damage than the higher wavelengths 
(Setlow, ). UVB and UVC can produce photolesions in the DNA like CPDs and -PPs, 
which are recognised and repaired by NER. NER also removes bulky chemical adducts, 
intrastrand cross-links and several forms of oxidative lesions such as cyclopurines 
induced by reactive chemicals, ROS or cigarette smoke (Hoeijmakers, 00; Smith and 
Pereira-Smith, ). There are two subpathways of NER, GG-NER and TC-NER. GG-NER 
has its focus of repair on the entire genome, whereas TC-NER only repairs lesions on 
actively transcribed parts of the DNA that arrest transcription. CPDs are mostly removed 
by TC-NER, and are therefore preferentially removed from transcriptionally active genes 
(Bohr et al., ), while (-)PP lesions, which distort the DNA more than CPDs,  are 
more rapidly removed by GG-NER (Mullenders and Berneburg, 00). In NER about 0 
proteins are involved, most function in GG-NER as well as in TC-NER (Christmann et 
al., 00). However they have different modes of damage recognition and therefore 
different proteins that recognize the damage. NER is a complex process in which at 
least the five following enzymatic steps can be distinguished: I) recognition of the DNA 
distortion; II) DNA unwinding around the damage; III) ‘bubble’ formation and multi 
protein complex stabilization; IV) incision on both sides of the damaged DNA; V) DNA 
repair synthesis and ligation of the newly synthesized strand (Figure ). 
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Figure 2.
NER and the proteins involved, divided in GG-NER and TC-NER. Steps I to V show the different proteins in action 
following UV damage. Step I: damage recognition (the blue C stands for XPC, and the brown E stands for XPE), step 
II: DNA unwinding (G (green), stands for XPG), step III: bubble formation (A (red), stands for XPA), step IV: incision 
(F (beige), stands for the ERCC-XPF complex), step V: de novo synthesis. For further description see text. This figure 
is taken from de Laat et al. ().
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Recognition
The first step in DNA repair is the recognition of the damage, this is also the step where 
GG-NER and TC-NER differ. GG-NER uses the XPC-hHRB protein complex as the 
primary recognition factor (Hanawalt, 00; Sugasawa et al., ; Volker et al., 00). 
XPC-hHRB has a high affinity to DNA damaged by UV. It recognises the damage and 
binds it, thereby locally distorting the DNA double helix and recruiting other factors 
of the NER pathway (de Laat et al., ; Gillet and Scharer, 00; Trego and Turchi, 
00). Recently it has become clear that, for certain types of lesions, different proteins 
are responsible for the initial recognition. XPE (or DDB) bound to DDB can recognise 
CPD lesions. The XPE-DDB complex recruits the XPC-hHB complex to the lesion, 
where it gets exchanged by the XPC-hHB complex and repair takes place (Kulaksiz 
et al., 00). TC-NER lesion recognition occurs in a different manner compared to GG-
NER recognition. In this case, the XPC-hHRB protein complex is redundant since 
there already is ‘bubble’ formation at the location where RNA polymerase II (RNApolII) 
is stalled by a lesion (Hanawalt and Mellon, ; Thoma and Vasquez, 00). Earlier 
it was believed that arrested transcription by RNApolII resulted in the recruitment of 
a large protein complex. This complex included the CSA and CSB proteins and some 
MMR proteins (Friedberg, 00). However, more recent research suggests that CSA and 
CSB function in different protein complexes from each other. CSA is associated with 
RNApolII, and CSB is found in a different complex together with RNApolII. They both 
assist RNApolII, either blocking it, in the case of UV damage, or assisting the polymerase 
to progress in case of transcription blocks due to secondary DNA structure (Lehmann, 
00; van Gool et al., ). After recognition, CSB assembles the other NER proteins for 
the damage repair to take place. 
DNA unwinding and bubble formation
In GG-NER the DNA lesion is recognised by XPC-hHRB. Next, this complex attracts the 
rest of the NER proteins to further open up the DNA. XPC-hHRB together with the 
multi-subunit transcription factor IIH (TFIIH) is responsible for the initial opening of the 
first 0 nucleotides. TFIIH consists of ten subunits, including XPB and XPD. XPB and XPD 
are ATP-dependent ’-’ and ’-’directed helicases respectively, and play a key role in 
opening up the DNA around the damage (Evans et al., ), and transcription initiation 
of RNApolII at the promoter (Holstege et al., ). On the other hand, in TC-NER the 
stalled RNApolII has to be removed first before excision repair can proceed. CSA and CSB 
together with TFIIH and XPG can displace the stalled polymerase II, so the rest of the NER 
reaction can take place (de Laat et al., ). XPA and replication protein A (RPA) when 
bound together dislocate XPC-hHRB from the damaged site since this protein complex 
is no longer needed (Fousteri et al., 00). The full opening of about  nucleotides is also 
obtained with the help of XPA and RPA while XPG is there to stabilize the whole complex. 
This process is the same for GG-NER and TC-NER. The proteins have binding sites for the 
TFIIH complex, which is recruited in both types of NER.
H1.indd   17 20-04-2009   13:23:52

chapter  chapter 
Dual incision
After DNA is unwound, an oligonucleotide of  to  nucleotides containing the lesion 
is finally excised by ERCC-XPF and XPG. ERCC-XPF makes the incision at the ’ end of 
the lesion and XPG at the ’ end of the lesion. RPA interacts with both XPG and ERCC by 
ERCC at its ’- oriented side and XPG at its ’-oriented side. While bound to the undamaged 
strand, RPA coordinates strand specificity to ERCC-XPF by strongly stimulating incisions 
in the damaged strand and therefore inhibiting cuts in the undamaged strand (de Laat 
et al., ). On the ’ incision site, RPA together with TFIIH positions XPG on the right 
strand (Evans et al., ; Iyer et al., ). Evans et al. () suggested that XPB has an 
additional function in facilitating ERCC-XPF in making the ’ incision. A patient missing 
only the C-terminus of XPB did not have a defect in open complex formation, but ’-
incisions were prevented (Evans et al., ). After the lesion has been removed, RPA stays 
associated with the excised DNA, initiating the assembly of resynthesis factors (Riedl et 
al., 00).
Synthesis and ligation
The final step is synthesis of DNA for the excised patch, and to this end the intact strand is 
used as a template to fill in the gap. DNA polymerase δ, ε and the lately found κ, replication 
factor C (RFC), proliferating cell nuclear antigen (PCNA), and RPA are all necessary for 
efficient repair synthesis (Lehmann et al., 00; Shivji et al., ). The ligation of the 
newly synthesized DNA, that is probably done by DNA ligase I, is the final step of the NER 
reaction (Barnes et al., ). 
Nucleotide excision repair deficiency syndromes
Any imaginable deficiency in one of the repair proteins can lead to serious disorders. 
Analysis of these disorders helped us to understand the mechanisms of DNA repair and 
highlighted their importance. For NER, there are three known deficiency syndromes: 
xeroderma pigmentosum (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD). 
The three NER deficiency syndromes XP, CS and TTD are the result of mutations in 
the NER system. The genetics involved in the diseases contributed to unravel the NER 
pathway. Seven complementation groups have been identified in XP (XP-A to XP-G), two 
in CS (CS-A and CS-B), and three in TTD (XP-B, XP-D, and TTD-A) There is also a fourth 
syndrome, which is a combination of XP and CS, XPCS which will also be discussed in 
this section, and was identified in  complementation groups (XP-B, XP-D, XP-G and XP-
F) (Broughton et al., 00; Giglia-Mari et al., 00; Hoeijmakers, 00)
H1.indd   18 20-04-2009   13:23:52
chapter 

chapter 
Xeroderma pigmentosum
XP is a group of rare autosomal-recessive inherited disorders characterized by a parchment 
skin (xeroderma) that is extremely sensitivity to ultraviolet (UV) light, abnormal skin 
pigmentation (pigmentosum), and high frequency of skin cancers, especially on sun-
exposed areas. The mean age of onset of these symptoms is  years (Kraemer, ). 
Early clinical signs are erythema and blistering after exposure to sunlight followed by 
atrophy, scabbing and scarring of the skin, and degenerative alterations of the eyes 
(Weeda et al., ). Xeroderma pigmentosum (XP) was first described in  by Hebra 
and Kaposi, and eight years later Kaposi coined the term xeroderma pigmentosum for 
the condition, referring to its characteristics (Norgauer et al., 00). In , Cleaver 
discovered that fibroblasts taken from the skin of XP patients carry out less UV-induced 
DNA synthesis than normal fibroblasts. He hypothesised that this was due to reduced 
capacity for repair of UV-DNA lesions (Cleaver, ). De Weerd-Kastelein et al. (), 
discovered that fusing cells from different XP patients could correct the repair defect. 
They discovered that there were different complementation groups for XP patients. 
More complementation studies showed the involvement of  genes in XP (XP-A to XP-
G) (Bootsma et al., ). While XPC and XPE are specifically deficient in the GG-NER 
pathway (Venema et al., ), the other five complementation groups have a defect 
in both subpathways. The generally mild XP features (except for cancer risk) in XPC 
and XPE patients can therefore be explained by the fact that TC-NER is still functional. 
Moreover, many XP mutations do not cause complete inactivation of the protein, and 
therefore have residual repair capacity, which can explain the milder forms of XP. XP 
patients develop normally, but die of neoplasia at an average age of 0 years unless when 
exquisitely protected from sunlight (Kraemer et al., ). Neurological abnormalities are 
reported in about % of XP patients, likely caused by enhanced neuronal degeneration. 
Neurological symptoms only occur in XP patients belonging to complementation groups 
A and D (and C only when they become older), that have a severe loss of repair capacity 
(Rapin et al., 000). The most severe early onset neurologic subtype of XP (mostly caused 
by mutations in XPA) is De Sanctis-Cacchione Syndrome (XP-DSC). In addition to the 
neurological symptoms described above, this disease involves dwarfing, hypogonadism 
and a 0-0 fold increase in frequency of several types of internal cancers (Kraemer et 
al., ).                                                 
The first mouse model successfully made was for XPA in  (de Vries et al., ; 
Miyauchi-Hashimoto et al., ). Later, an XPC mouse model was made (Sands et al., 
), these mice are fertile and mimic the XP patients’ response to UV exposure, 
being highly susceptible to developing skin cancer at the UV exposed areas of their 
skin. Mouse models for other XP complementation groups quickly followed, like XPG 
and XPF; both mice showed a growth retardation and premature death (Harada et al., 
; Tian et al., 00). Attempts of making fully XPD-deficient mice have failed. This 
emphasizes the essential function of the XPD protein and is consistent with the notion 
that only subtle XPD mutations are found in XP, XPCS, and TTD patients (Andressoo et 
al., 00a; de Boer et al., ).
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Cockayne syndrome
Cockayne, in , reported two siblings with dwarfism, microcephaly, mental 
retardation, deafness, a photosensitive dermatitis and a peculiar form of retinal 
pigmentation. Similar to XP, CS is an autosomal recessive disease, characterised by 
cutaneous photosensitivity. However, CS differs from XP by the occurrence of profound 
postnatal growth failure (cachexia), progressive neurological dysfunction and no UV-
induced skin cancer predisposition (Rapin et al., 000). However, skin fibroblasts from 
affected patients show sensitivity to sunlight. This low cancer predisposition is probably 
associated with functional GG-NER in CS cells and an increased apoptosis rate, which 
likely removes premutagenic cells (Ljungman and Lane, 00). Also the mean age at 
death (. years) (Nance and Berry, ), and the fact that the disease is noted very 
early in life could allow adequate protection. CS is a disease with clinical features that 
could range from mild to severe and are diverse. Therefore, patients are divided in 
differential clinical groups according to severity and onset of the disease: mild CS, 
classical CS (CS), and severe CS (CSII) (Lowry, ), reviewed by (Rapin et al., 000). 
In general, CS patients display skeletal abnormalities like kyphosis, bird-like face and 
early onset of osteoporosis, and also impaired sexual development, caries, cachexia, and 
mental retardation. Other symptoms found in CS patients are pigmentary retinopathy, 
thin hair and cataracts, and many of these symptoms classify CS as progeriod disease. 
The most common cause of death is pneumonia, resulting from an overall poor condition 
of patients and due to the severe neurological degeneration (Nance and Berry, ). 
Molecular research of CS patients showed that mutations in two genes, CSA, CSB, could 
cause the CS phenotype. 
In  CSB-deficient mice were generated, the mice display all off the CS repair 
characteristics: UV sensitivity, inactivation of  TC-NER, unaffected GG-NER, and an inability 
to resume RNA synthesis after UV exposure. Growth failure and neurological dysfunction 
are present in a mild form. In contrast to the human syndrome, CSB-deficient mice show 
a slight increased susceptibility to skin cancer after UV exposure, but a normal lifespan 
(van der Horst et al., ). In 00 CSA-deficient mice were generated, showing the same 
phenotype as the CSB-deficient mice (van der Horst et al., 00). In 0% of reported CS 
cases, the disease is caused by mutations in XPD, XPB or XPG gene, which leads to the 
combined phenotype of XP and CS. In contrast to classical CS, these patients are more 
cancer-prone. 
Trichothiodystrophy
The term trichothiodystrophy (TTD) was first introduced in 0 by Price et al. for 
sulfur-deficient brittle hair. Patients with trichothiodystrophy have brittle hair and nails 
(because of reduced content of cysteine-rich matrix proteins), ichthyotic skin, physical 
and mental retardation, short stature and decreased fertility (Price et al., 0). Other 
prominent features are an aged appearance, shortened lifespan, skeletal abnormalities 
(osteopenia, osteoporosis, kyphosis) (McCuaig et al., ). Brittle hair and nails are a 
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unique symptom in TTD patients, whereas other features are strikingly similar to CS, 
including the absense of cancer predisposition. Cell fusion experiments demonstrated 
that in all but  trichothiodystrophy (TTD) cell strains examined until , the repair 
deficiency was in the same complementation group as is the defect in xeroderma 
pigmentosum group D (Stefanini et al., ). Later two other complementation groups 
were found for TTD, namely a mutation in the XPB gene found in siblings who were 
diagnosed with TTD at the age of three (Weeda et al., b), and a third complementation 
group which is called TTD-A. The protein that is mutated in this latter complementation 
group is part of the TFIIH protein complex, like XPB and XPD (Giglia-Mari et al., 00; 
Vermeulen et al., 000). 
To study the complex clinical symptoms and the paradoxical absence of skin cancer 
in NER-deficient TTD patients, a mouse model was generated with the same point 
mutation in the XPD gene as found in  patients. TTD mice reflect the pleiotropic features 
of the human disorder, including growth delay, reduced fertility shortened life span, 
cutaneous abnormalities, mild UV sensitivity of cultured fibroblasts and the remarkable 
brittle hair phenotype (de Boer et al., ). Recent studies with TTD mice have shown 
accelerated aging symptoms, likely due to accumulation of endogenously generated 
DNA damage and reduced transcription leading to cell death. Further the mice show 
signs of calorie restriction (CR) although their food intake is normal (Wijnhoven et al., 
00). 
Genetically, XPB and XPD are not only involved in NER but also in transcription (as 
part of TFIIH), and mutations that causes TTD are all found in components of the TFIIH 
complex. Therefore, the assumption is made that the TTD phenotype is a combination 
of repair deficiency (UV-sensitivity, accelerated ageing) together with a transcription 
deficiency (brittle hair due to instable TFIIH) (Bootsma and Hoeijmakers, ). 
Interestingly, TTD is the third disease associated with XPB and XPD, clearly showing 
that specific mutations in these proteins can cause different diseases. 
Xeroderma pigmentosum combined with Cockayne syndrome
Usually, XP and CS are clinically and genetically distinct. However, in rare cases, CS 
patients have been shown to have mutations in genes that were previously linked to 
the development of XP and show combined (XPCS) pathology (Lindenbaum et al., 00). 
In total very few cases have been reported of XPCS patients. Rapin et al. reviewed XPCS 
in 000, when there were only  cases known. The patients had mutations in XPB, XPD 
or XPG. Recently a XPCS mouse has been generated in our lab by copying a specific XPD 
point mutation of a patient. The XPCS mice had a shorter mean life span, a phenotype 
likely at least in part related to an earlier onset of spontaneous cancers, and this mouse 
displayed an extreme UV-induced cancer predisposition as in the human XPD patient. 
Thus, the patient-based XPD point mutation recapitulated in mice many elements of 
both the XP and CS components of the combined disorder (Andressoo et al., 00b).
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Compound heterozygosity
Compound heterozygotes are individuals carrying two different mutant alleles of the 
same gene in the absence of a dominant WT allele. Genetic interactions between the two 
differently mutated alleles could result in a wide variety of disease outcomes that are 
sometimes hard to dissect from the effects of differences in environment and/or genetic 
background. Because different mutations in XPD can give rise to different diseases, XPD 
is a good example of a gene where evidence of potential genetic interactions between 
two different recessive alleles can be found. For example, certain patients that are 
called compound heterozygous in their XPD gene have a mutation on one allele that 
in homozygous state gives an XPCS phenotype, and on the other allele is a certain 
presumed ‘null allele’. This ‘null allele’ is named on the basis of their failure to support 
viability in a yeast complementation assay. The combination of this ‘null allele’ in 
which the XPCS allele gave milder disease symptoms, than what is seen for patients 
who are hemizygous for the XPCS mutation (only having one XPD-XPCS gene and no 
other) (Andressoo et al., 00a; Broughton et al., 00). With a lifespan that is ten times 
as long as the hemizyous XPCS patients, this presumed ‘null allele’ has a substantial 
impact on the disease outcome. Two patients with a combined TTD and XP phenotype 
are also thought to have phenotypic contributions from both alleles. These patients 
have one TTD allele, and the other XPD allele is interpreted as a ‘null allele’ although 
it partially rescues the typical hair phenotype seen in TTD patients (Andressoo et al., 
00a; Broughton et al., 00). 
To dissect the environmental and background effects from the effect of the two 
mutated alleles itself, Andressoo et al. (00) crossed the TTD mouse model with 
XPCS and XP alleles generated in our lab that fail to support viability on their own 
in the homozygous state. These inviable alleles partially rescued the TTD-associated 
premature segmental ageing, cutaneous features, cellular DNA repair capacity, and UV 
survival when present in a compound heterozygote state together with the TTD allele 
(Andressoo et al., 00a). Later crossings were made with a viable version of a XPCS 
allele and this allele even rescued the TTD phenotypes to a further extent (see also 
Chapter  of this thesis).  
More NER discoveries  
Many mice that are partially NER-deficient (TTD, ERCC) or only deficient in TC-(NE)R 
like CSA and CSB mice, display ageing symptoms, while mice fully defective in NER 
(XPA) or only in GG-NER, like XPC mice, don’t show this progeriod phenotype. An even 
more accelerated ageing phenotype originated when TTD mice where crossed with mice      
that have two XPA null alleles. These double mutant TTD|XPA mice were born normally 
but soon after birth displayed a severe accelerated ageing phenotype which resulted 
in growth failure, disproportionally big head and limbs, kyphosis, ataxia, spasticity, 
balance problems, disturbed gait, severe cachexia and death around  to  weeks of age 
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(de Boer et al., 00). The same features were found when the double mutant XPCS|XPA, 
CSB|XPA, CSB|XPC or CSA|XPC were generated (Andressoo et al., 00b; Murai et al., 
00; van der Pluijm et al., 00). This is in contrast with XPC|XPA, CSB|CSA and XPC|TTD 
animals which are viable and appear to be quite normal. These findings suggest that a 
complete NER deficiency in combination with CSA, CSB or XPD is necessary to induce 
this severe premature ageing phenotype. ERCC, XPF and XPG mutants also live only 
 weeks and have a similar, but not always identical phenotype (Harada et al., ; 
Tian et al., 00; Weeda et al., a). Compound heterozygous mice for XPD in an 
XPA background (TTD/XPCS|XPA, hereafter mentioned as CH|XPA) survive the stressful 
weaning period and show a partial rescue of the severe premature ageing phenotype 
as would be expected, due to phenotypic contributions of both alleles (see compound 
heterozygosity section above, and Chapter ) (van de Ven et al., 00).
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Scope of this thesis
In Chapter  we extend this introduction with a review of our findings on longevity-
associated and dietary-restricted (DR) characteristics, like lowering of the growth 
hormone (GH) and insulin-like growth factor (IGF-) axis, in short–lived progeriod (NER) 
mouse models as a result of an adaptive stress/survival response. In Chapter  we show 
further phenotypic rescue of progeria in CH|XPA background and identify that also this 
genotype together with XPCS|XPA overlap with dietary restriction (DR), and the long-
lived dwarfism phenotype in terms of repression of the GH and IGF- axis. In addition 
we looked at the acute oxidative stress resistance after DR by ischemia reperfusion 
injury and found that reduced signalling through insulin and IGF- caused by DR induces 
resistance to ischemia reperfusion injury (IRI) in mice (Chapter ). In Chapter  we test if 
the adaptive stress response found in NER mice also protects against the acute oxidative 
stress by ischemia reperfusion injury. CSA and CSB mice were found to have an organ 
specific protection from acute oxidative stress. Later we looked at the different effects of 
XPD mutations on cancer and ageing and found out that in CH animals the accelerated 
aging and calorie restricted-like phenotypes are rescued to near completion. However, 
this is not the case for repair of UV lesions in various cell-based and in vivo assays. We 
therefore can say that defective repair of UV lesions is not the (only) relevant cause in 
the origin of the segmental progeria or calorie restricted-like phenotype (Chapter ). 
Finally, we address a total different field where we test if the NER proteins are in fact 
required for DNA demethylation in a GADD-dependent reaction and conclude that 
the TC-NER pathway this is necessary for recognizing the substrate. However, we find 
that different Xpd mutations behave differently in this activity (Chapter ).
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Abstract
�emantic distinctions between “normal” aging, “pathological” aging (or age-related disease) 
and “premature” aging (otherwise known as segmental progeria) potentially confound 
important insights into the nature of each of the complex processes. Here we review a 
recent, unexpected discovery: the presence of longevity-associated characteristics typical 
of long-lived endocrine-mutant and dietary-restricted animals in short-lived progeroid 
mice. These data suggest that a subset of symptoms observed in premature aging, and 
possibly normal aging as well, may be indirect manifestations of a beneficial adaptive 
stress response to endogenous oxidative damage, rather than a detrimental result of the 
damage itself. 
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Definitions of aging: current focus on lifespan.
Most definitions of aging attempt to capture the irreversible, degenerative nature of the 
process by focusing on quite apparent symptoms like wrinkled skin and gray hair that 
affect different people in different ways as they age. A more general definition of aging 
avoids such individual variation and focuses on the one constant, the time-dependent 
increase in the probability of dying. The problem with this latter definition is that lifespan 
is only one component of aging and says nothing about a potentially more important 
aspect, the quality of life up until the point of death. 
In the so-called “premature aging” disorders, or segmental progerias, lifespan is 
shortened and a number of characteristics, or “segments”, of aging (in addition to a 
number of disease-specific pathologies) appear early or in exacerbated form (Martin 
and Oshima, 2000). The relation between progeria and “normal” aging is controversial, 
largely because there are so many ways to shorten lifespan that have nothing to do with 
the normal aging process (Miller, 2004). Also poorly defined is the connection between 
“normal” and “pathological” aging. Cancer or Alzheimer’s both increase with age, but 
some people become very old without either and still die of “old age”. 
On the opposite side of premature or pathological aging, the connection between 
lifespan extension and “normal” aging is most often taken for granted. But perhaps it 
should not be. An increase in maximum lifespan can be achieved by slowing the rate 
of aging or merely by delaying its onset, with different implications for the underlying 
mechanism (Barger et al., 2003). Restricting the diet by reducing the total amount of 
food eaten (Weindruch and Walford, 1988) achieves both. �enetic models of lifespan 
extension, however, may simply delay the onset of ageing-related pathologies, some of 
which otherwise would limit lifespan (Barger et al., 2003). 
What then is aging, and does broadening its definition beyond lifespan reveal anything 
useful about its nature? We gained an unexpected insight into this problem by performing 
detailed phenotypic analyses of segmental progeroid mice engineered with various defects 
in DNA damage repair.
Progeroid NER syndrome: longevity-associated traits in short-lived mice
Nucleotide excision repair (NER) is an evolutionarily conserved mechanism for the removal 
of bulky, helix-distorting lesions from DNA such as UV-induced damage. It functions 
by a “cut-and-patch” mechanism in which the damage is recognized, the DNA helix 
unwound, the damaged strand excised, and the remaining single-stranded region patched 
(Hoeijmakers, 2001). In humans, congenital defects in NER-associated components are 
uniformly associated with UV (sun) hypersensitivity. �pecific defects in a subset of these 
components can also lead to the segmental progeroid disorders Cockayne syndrome and 
trichothiodystrophy (Bootsma et al., 2002). These recessive disorders display postnatal 
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onset of progressive neurodevelopmental pathology with overlapping progeroid features 
including reduced subcutaneous fat and small size (together known as cachectic dwarfism), 
sensorineural deafness, retinal degeneration, white matter hypomyelination and CN� 
calcification sometimes accompanied with premature appearance of neurofibrillary 
tangles (Itin et al., 2001; Nance and Berry, 1992; Rapin et al., 2000).
Mouse models of these diseases (Table 1 and references therein) display an overlapping 
set of progressive symptoms including cachectic dwarfism, reduced bone mineral density 
resembling osteoporosis, curvature of the spine (lordokyphosis) and failure to thrive. 
Cerebellar ataxia, a disease-specific pathology not associated with normal aging in mice, 
is sometimes accompanied by the loss of Purkinje neurons late in disease progression. 
Death usually occurs before weaning at about three weeks of age. 
Recently we reported a surprising finding in Xpd/Xpa double homozygous mutant mice 
(van de Ven et al., 2006). In addition to the progeroid features listed above, these mice 
display characteristics usually associated with good health and extended lifespan, as in 
endocrine-deficient or dietary-restricted animals (Bartke and Brown-Borg, 2004). These 
characteristics, measured at two weeks of age when the pups are still nursing, include 
reduced weight, hypoglycemia, hypoinsulinemia, reduced serum insulin-like growth 
factor-1 (I�F-1) and reduced body temperature. In addition, a number of genes involved 
in the postnatal growth axis are downregulated in the livers of these animals, including 
growth hormone receptor. These features are observed in a variety of progeroid NER 
mice, including two different Xpd/Xpa (van de Ven et al., 2006) mutants, Csb/Xpa (van der 
Pluijm et al., 2006) and Ercc1 (Niedernhofer et al., 2006) and are likely to be common to all 
of the progeroid NER mutants. 
Adaptive response vs. constitutive defect
Constitutive defects in endocrine-mediated insulin signaling and dietary restriction can 
both extend longevity in a number of model organisms. In mice, both result in reduced size, 
hypoglycemia, hypoinsulinemia, reduced serum I�F-1 and reduced temperature (Bartke 
and Brown-Borg, 2004; Koubova and �uarente, 2003). One clear difference, however, is 
that these phenotypes are permanent in endocrine-deficient animals but reversible in 
dietary restricted animals. In short-lived progeroid NER mice, normal pituitaries (van der 
Pluijm et al., 2006) and normal growth hormone (Niedernhofer et al., 2006; van de Ven 
et al., 2006; van der Pluijm et al., 2006) are inconsistent with defects in hypothalamic 
or pituitary function. A more attractive hypothesis is that the alteration of energy 
metabolism via dampening of the growth hormone/I�F-1 axis in progeroid NER mice 
reflects an adaptive response in which reduction of mitochondrial RO�-derived oxidative 
DNA damage is the intended consequence. However, such a hypothesis is difficult to test 
in mice with an early onset, irreversible condition as in progeroid NER syndrome in which 
animals die within three weeks after birth. 
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Fortuitously, one particular combination of mutant alleles (XpdR722W/G602D/Xpa-/-, Table 
1) resulted in mice with each of the longevity-associated traits of dietary restriction in 
addition to all of the pathologies of progeroid NER syndrome, save one: instead of a three 
week lifespan, mutants survived past weaning with 80% penetrance. We hypothesize this 
to be due to complementation between the two different mutant Xpd alleles (Andressoo 
et al., 2006a). This allowed us to study these animals past early development and into 
adulthood. We noted additional phenotypes including normal to elevated food intake 
per gram body mass (like hypopituitary Ames dwarf mice (Bartke et al., 2001)) despite 
continuing dwarfism, time-dependent reduction in the mass of both white and brown 
adipose tissue deposits relative to total mass, progressive lordokyphosis, frequent loss of 
balance and a mean lifespan of approximately 5 months of age. 
Blood glucose and serum I�F-1 levels of adult mutants gave us an unexpected clue 
about the nature of the effect on growth and metabolism observed at the earlier age of 
2 weeks. By ten weeks of age, when control animals are past postnatal development and 
have reached sexual maturity, blood glucose and serum I�F-1 levels in the mutants are 
once again normal despite the remaining dwarfism (van de Ven et al., 2006).This is further 
evidence against any constitutive alteration of the growth hormone/I�F-1 axis or glucose 
homeostasis and strongly in favor of the interpretation that the downregulation of these 
components at two weeks of age reflects an adaptive response to stress. 
SIRT6 KO mice: similar adaptive response to a common DNA repair defect?
�IRT6 deficiency results in a phenotype strongly overlapping progeroid NER syndrome. 
Like progeroid NER mice, �IRT6 KO mice are born normally but display early postnatal 
onset of growth retardation followed by lordokyphosis, cachexia and failure to thrive, 
with a maximum lifespan of 24 days (Mostoslavsky et al., 2006). Beginning at postnatal 
day 12, animals become increasingly hypoglycemic despite evidence of normal eating 
(milk in the stomach) and a normal ability to absorb glucose (R. Mostoslavsky, personal 
communication). Like in the NER progeroid mice, reduced serum I�F-1 (Mostoslavsky et 
al., 2006) despite normal growth hormone levels (D. Lombard, personal communication), 
suggestive of growth hormone insensitivity, is also present. Furthermore, ablation of the 
DNA damage response protein p53 does not affect lifespan in �IRT6 deficient mice (D. 
Lombard, R. Mostoslavsky, personal communication) or progeroid NER Csb/Xpa mice (H. 
van �teeg, unpublished observation). 
Differences between �IRT6 deficiency and progeroid NER disorder also exist, but are 
minor compared to the overall similarities. These differences appear mainly in the end-of-
life pathology. �IRT6 KO mice lose splenocytes, thymocytes and peripheral lymphocytes 
as the result of a systemic, non-cell autonomous defect, which may be attributable in 
part to the sensitivity of these cells to hypoglycemia and low I�F-1 (Alves et al., 2006; 
Mostoslavsky et al., 2006). The loss of Purkinje neurons typical of progeroid NER mice 
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may be due to a cell-type specific hypersensitivity to oxidative DNA damage combined 
with the systemic effects of reduced I�F-1, a neuronal survival factor. Decreased serum 
I�F-1 levels are associated with cerebellar ataxias of various etiologies in both humans 
and experimental rodent models (Busiguina et al., 2000; Torres-Aleman et al., 1996), and 
Purkinje neurons are hypersensitive to oxidative stress accompanying ischemic injury 
although relatively resistant to other types of stress such as hypoglycemia (Mohseni, 
2001). Interestingly, different gene-specific pathologies also exist amongst progeroid 
NER disorders (Table 1). For example, liver- and kidney-specific pathologies exclusively in 
XPF- and ERCC1-deficient mice are probably due to the particular roles of these proteins 
outside of NER, such as interstrand crosslink repair or telomere maintenance; brittle 
hair is specific to the R722W-encoding mutation in Xpd, probably due to transcriptional 
deficiencies particular to this mutation (de Boer et al., 1999). Despite these differences, 
the overlapping phenotype of progeroid NER syndrome and �IRT6 deficiency is consistent 
with a common adaptive response to genotoxic stress during development.
Is there any evidence that this hypothetical shared adaptive response is triggered by a 
common genotoxic stress? �IRT6-deficient cells are hypersensitive to the effects of RO� 
generated by ionizing radiation or H2O2, and monoadducts by the alkylating agent MM�, 
but not to ultraviolet radiation, consistent with a defect in the base excision repair (BER) 
system (Mostoslavsky et al., 2006) or in other DNA damage response pathways. Although 
BER is functionally distinct from NER, there is recent genetic and biochemical evidence 
of a partial functional overlap between components previously thought to be specific to 
one system (NER components XP� and C�B) or the other (BER components O��-1 and 
PARP-1)(Dianov et al., 2000; Licht et al., 2003; Osterod et al., 2002; Thorslund et al., 2005; 
Tuo et al., 2002). Although much further evidence is required, it is tempting to speculate 
that such a shared DNA repair defect can elicit a common adaptive response. 
Adaptive stress response is not a general characteristic of genome instability
In addition to progeroid NER syndrome and �IRT6 deficiency, a number of genetically 
engineered mice have progeroid characteristics (reviewed in (Lombard et al., 2005)). At 
face value, these progeroid conditions appear to have much in common. The engineered 
mutations are mostly in genes involved in nucleic acid metabolism, for example, other 
types of DNA repair (Espejel et al., 2004), telomere maintenance (Lee et al., 1998), 
chromosome segregation (Baker et al., 2004), DNA methylation (�un et al., 2004), mito-
chondrial DNA replication fidelity (Trifunovic et al., 2004), and the DNA damage response 
(Maier et al., 2004; Tyner et al., 2002). Also, the progeroid phenotypes have an overlapping 
set of characteristics including cachectic dwarfism, reduced fertility, hair loss and graying, 
curvature of the spine, cancer predisposition and shortened lifespan. 
We asked whether other forms of genome instability in addition to excision repair 
defects could trigger a preservative organismal response through the postnatal growth/
energy metabolism axis. We chose KU80-deficient mice, with a defect in repairing DNA 
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double-strand breaks via the non-homologous endjoining pathway. These animals are 
cachectic dwarfs throughout their lives and display many characteristics of premature 
senescence on both the cellular and organismal levels (Vogel et al., 1999). In two-week-old 
animals, however, we found no difference in blood glucose, serum I�F-1, or gene expression 
from the postnatal growth axis in the liver as there is in progeroid NER syndrome (van 
de Ven et al., 2006). Together these data suggest that whatever the apparent similarities 
amongst genomically unstable progeroid mice, on both the molecular and organismal 
levels different mechanisms, or possibly similar mechanisms with very different kinetics, 
are at work. In support of this conclusion, a different form of genome instability related to 
short telomeres produces a related subset of progeroid symptoms including hair loss and 
graying, osteoporosis and fingernail atrophy in a variety of otherwise unrelated progerias 
(Hofer et al., 2005).
Evolution of the preservative stress response
An adaptive stress response involving downregulation of growth and alteration of energy 
metabolism in favor of conservation may have evolved to cope with periods of reduced 
food availability or life-threatening disease. It may be thus best defined as a preservative 
stress response rather than a longevity stress response, because its primary purpose is 
to help animals through a period of stress that could occur during any stage of life (and 
thus could be selected for) rather than to extend lifespan past the reproductive years. A 
developmental stage-specific version of this response is also conserved in the worm C. 
elegans. During early larval development, food inadequacy triggers an adaptive response 
known as dauer formation in which metabolism is altered via the insulin-signaling 
pathway in an attempt to survive until environmental conditions are once again favorable 
(Kenyon et al., 1993). 
The phenotypes of progeroid NER syndrome and �IRT6 deficiency suggest another 
way to trigger this response: a particular type of oxidative genotoxic stress during early 
development. The rapid postnatal onset suggests that birth stress, which involves an 
Table 1.
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increase in RO� levels (Randerath et al., 1997a; Randerath et al., 1997b) may trigger it 
and that rapid postnatal growth may further exacerbate it. Combined with the inability 
to repair certain endogenous lesions as in �IRT6 or NER deficiency, oxidative genotoxic 
stress may trigger an adaptive response intended to reduce generation of RO� through 
mitochondrial respiration and thus prevent further damage. 
This stress response may also not be limited to aging or aging-related pathology, but 
may also occur in response to acute stress. In support of this, we have data implicating 
downregulation of I�F-1 and growth hormone receptor on the mRNA level in response to 
the acute oxidative stress of renal ischemia reperfusion injury (J.R. Mitchell, see Chapter 
4). Furthermore, chronic exposure of mice to a peroxisome proliferator (resulting in 
elevated oxidative DNA damage (de Waard et al., 2004)) induces a similar response in the 
gene expression profile of livers of wild-type mice (van der Pluijm et al., 2006). A reduction 
of the growth hormone/I�F-1 may thus be a more general marker of both chronic and 
acute oxidative stress. However, as is clear from the shortened lifespan of progeroid NER 
and �IRT6 deficient mice, reduced I�F-1 on its own cannot ensure a beneficial outcome; 
the nature and duration of the stress must also be taken into consideration (Figure 1). 
Terminal senescent weight loss: an adaptive stress response to normal aging?
If the reaction to certain types of genome instability resembles a stress response, does the 
oxidative DNA damage that accumulates with age also trigger such a beneficial response? 
There is some evidence that normal aging evokes a similar response to stress. In the 
absence of age-related disease such as cancer or diabetes, people at advanced age often 
enter a period of weight loss culminating in death. This syndrome is known as geriatric 
failure to thrive (�arkisian and Lachs, 1996). The cause of the weight loss is currently 
unknown. Rats that live to advanced age also display a related phenomenon known as 
senescent terminal weight loss. Although originally believed to be caused by decreased 
food intake, new data indicate this not to be the case (Black et al., 2003). The growth 
hormone/I�F-1 axis is already greatly reduced by this age, and thermoregulation and 
blood glucose may also be altered in this terminal senescent period (Black et al., 2003; 
van de Ven et al., 2006). In light of the data reviewed here, perhaps its not surprising 
then that rats (Black et al., 2003) (and probably mice (Miller et al., 2005)) that experience 
this senescent terminal weight loss “syndrome” actually live significantly longer than 
those that do not. In other words, we propose that terminal senescent weight loss and 
geriatric failure to thrive, despite their foreboding names, are probably components of 
a beneficial, adaptive response triggered very late in life in response to the accumulated 
oxidative damage to macromolecules including DNA.
H2.indd   40 20-04-2009   13:25:14
chapter 2 chapter 2
41
Figure 1.
Correlations between serum I�F-1, genotoxic stress and lifespan. In dietary restricted and endocrine-deficient mice, 
reduced serum I�F-1 (black bars; y axis on the left) correlates with increased longevity. In progeroid NER and �IRT6 
knockout (excision repair deficient) mice, this correlation doesn’t hold. To explain this apparent paradox, we add 
the presumed cause of the reduced I�F-1 in excision repair deficient and dietary restricted animal: stress (red bars; 
y axis on the right). Different shadings indicate the different nature of the stressors (unrepaired endogenous DNA 
damage, dark red; reduced energy intake, light red; baseline stress in control and endocrine-deficient animals, 
empty). Constitutive unrepaired genotoxic stress may overrule the efficacy of reduced I�F-1 signalling in excision 
repair-deficient progeroid mice, while in dietary restriction or endocrine deficiency the stress is either of a different 
nature, or absent relative to controls as in constitutive endocrine deficiency. 
Conclusions
Everything changes with age, and few of them for the better. Most things, from our 
muscles to our short-term memory, deteriorate over time. Here we emphasize the 
potential importance of another component of the aging process: the body’s own response 
to deterioration. This adaptive response probably evolved to combat other stresses such 
as starvation early in life, but may be activated in cases of premature, pathological and 
natural aging. A more nuanced and useful definition of aging should thus include at least 
four basic components: underlying mechanisms including molecular oxidation (Harman, 
1988), genetic background (from progeroid to centenarian) defining susceptibility to 
such damage, time-dependent primary effects of stochastic oxidative macromolecular 
damage, and secondary adaptive organismal attempts to counterbalance these effects. In 
the future, a better understanding of these components and their interactions will tell us 
more, not just about how we age, but about how we function at all stages of our lives.
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Abstract
How congenital defects causing genome instability can result in the pleiotropic symptoms   
reminiscent of aging but in a segmental and accelerated fashion remains largely unknown. 
Most segmental progerias are associated with accelerated fibroblast senescence suggesting 
that cellular senescence is a likely contributing mechanism. Contrary to expectations, 
neither accelerated senescence nor acute oxidative stress hypersensitivity was detected 
in primary fibroblast or erythroblast cultures from multiple progeroid mouse models for     
defects in the nucleotide excision DNA repair  (NER) pathway, which share premature 
aging features including postnatal growth retardation, cerebellar ataxia and death before      
weaning. Instead, we report a prominent phenotypic overlap with long-lived dwarfism 
and calorie restriction during postnatal development (two weeks of age), including 
reduced size, reduced body temperature, hypoglycemia and perturbation of the growth 
hormone/insulin-like growth factor-1 (IGF-1) neuroendocrine axis. These symptoms were 
also present at two weeks of age in a novel progeroid NER mouse model (XPDG602D/R722W/
XPA-/-) that survived weaning with high penetrance. However, despite persistent cachectic 
dwarfism, blood glucose and serum IGF-1 levels returned to normal by ten weeks, with 
hypoglycemia reappearing near their premature death at five months of age. These data 
strongly suggest changes in energy metabolism as part of an adaptive response during the 
stressful period of postnatal growth. Interestingly, a similar perturbation of the postnatal 
growth axis was not detected in another progeroid mouse model, the double strand DNA 
break repair deficient Ku80-/- mouse. Specific (but not all) types of genome instability may 
thus engage a conserved response to stress that evolved to cope with environmental 
pressures such as food shortage. 
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Introduction
Congenital defects in genome stability-promoting mechanisms such as DNA repair often 
lead to elevated cancer predisposition and/or the accelerated appearance of some but not 
all characteristics (“segments”) observed in natural aging (Martin, 2005). Among these 
so-called segmental progerias, different defects lead to the acceleration or exaggeration 
of different segments of aging. Typical examples include Werner syndrome, in which 
diabetes, osteoporosis and increased cancer incidence are observed; and Cockayne 
syndrome, characterized by neurological dysfunction and cachectic dwarfism. While 
the causative genetic defects of many progerias are known, the molecular mechanisms 
underlying pleiotropic disease symptoms remain elusive and their relevance to normal 
aging controversial (Miller, 2004). However, because cultured fibroblasts from almost all 
reported mouse models of segmental progeria (as well as many of the corresponding 
human progerias) exhibit limited proliferative capacity (Lombard et al., 2005), cell-based 
mechanisms including premature senescence and enhanced apoptosis have emerged as 
strong candidates underlying pleiotropic disease symptoms (Hasty et al., 2003; Mitchell 
et al., 2003).
The evolutionarily conserved nucleotide excision repair (NER) pathway removes helix-
distorting DNA damage (such as UV lesions) in a complex ‘cut and patch” mechanism. 
Inborn NER defects can lead to the skin cancer syndrome xeroderma pigmentosum 
(XP) or the segmental progerias Cockayne syndrome (CS) and trichothiodystrophy (TTD) 
(Bootsma et al., 2002). An increase in the mutation rate caused by defects in one of at 
least 7 different NER proteins (XPA-G) explains the cancer predisposition in XP (Cleaver, 
2000); each of these proteins participates in lesion removal anywhere in the genome 
(global genome NER). In contrast, how alterations in any of 5 NER-associated proteins 
(XPB, XPD, XPG, CSA, CSB) can cause progeria remains largely obscure. Current genetic 
evidence points to a link with defective transcription-coupled repair (TCR) (Andressoo 
and Hoeijmakers, 2005; Andressoo et al., 2006b; de Boer et al., 1998; Spivak and Hanawalt, 
2005), a subpathway of NER that specifically removes lesions on the transcribed strand 
of active genes that interfere with transcription thus promoting cellular survival from 
DNA damage (Hanawalt, 2002; Svejstrup, 2003).
The XPD gene, encoding a helicase subunit of the transcription/NER-associated TFIIH 
complex, is unique amongst NER genes in that different point mutations are associated 
with cancer (XP), progeria (TTD) or a combination (XP combined with Cockayne 
syndrome [XPCS] ot trichothiodystrophy [XPTTD]) (Andressoo and Hoeijmakers, 2005; 
Kraemer, 2004; Lehmann, 2001). Although the hallmark feature of TTD, brittle hair, is 
not observed in CS or XPCS, the neurodevelopmental features of the disease are similar 
(Itin et al., 2001; Nance and Berry, 1992). In most cases these features include (i) normal 
in utero development followed by postnatal growth failure in the first year (including 
reduced postnatal brain growth (Rapin et al., 2000)), (ii) progressive gait abnormalities 
caused by a combination of cerebellar ataxia, joint contractures, spasticity and frequent 
kyphosis, (iii) sensorineural hearing loss, (iv) progressive loss of subcutaneous fat 
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(cachexia) yielding an “aged” appearance and (v) the conspicuous lack of (skin) cancer 
predisposition despite sun sensitivity due to a cellular UV repair defect (Itin et al., 2001; 
Nance and Berry, 1992).  
We mimicked point mutations found in human TTD (XpdTTD) (de Boer et al., 1998) 
and XPCS (XpdXPCS) patients (Andressoo et al., 2006b) in the mouse and reported 
phenotypic overlap between homozygous mutant animals and the corresponding 
human syndromes. Crossing mutant Xpd animals allowed us to address the effects of 
compound heterozygosity, or the presence of two different mutant alleles of the same 
gene, on disease symptoms. Compound heterozygosity between XpdTTD and XpdXPCS alleles 
surprisingly ameliorated developmental delay and age-related premature cachexia 
and kyphosis associated with each homozygous mutant mouse model as well as the 
cutaneous abnormalities specific to the TTD model (Andressoo et al., 2006a).
Exacerbation of the repair defect by Xpa ablation, on the other hand, results in a much 
more severe phenotype including dramatic postnatal growth retardation, progressive 
cerebellar ataxia, lack of subcutaneous fat and death around weaning in several of these 
mouse models (e.g. XPCS/XPA, TTD/XPA and CSB/XPA) (Andressoo et al., 2006b; de Boer 
et al., 2002; Murai et al., 2001). We refer to the above segmental progeroid phenotypes         
as “progeroid NER syndrome”. Here, we tested the ability of compound heterozygosity        
at the Xpd locus in an XPA-deficient background (XpdTTD/XPCS/Xpa-/-) to ameliorate the 
severe symptoms of progeroid NER syndrome associated with the corresponding double 
homozygous (XpdTTD/TTD/Xpa-/- and XpdXPCS/XPCS/Xpa-/-) animals. 
Table 1
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Results 
XPD compound heterozygotes in an XPA-deficient background
A comparison amongst the subset of single and combined NER defects resulting in a severe 
segmental progeroid phenotype is presented in Table 1. Intercrossing of Xpd+/TTD/Xpa-/- and 
Xpd+/ XPCS/Xpa-/- animals resulted in double homozygous XpdTTD/TTD/Xpa-/- and XpdXPCS/ XPCS/Xpa-
/- mutant mice (subsequently referred to as TTD/XPA and XPCS/XPA animals, respectively) 
as well as compound heterozygous XpdXPCS/TTD/Xpa-/- (CH/XPA) mice. Expected at a Mendelian 
frequency of 25%, XPCS/XPA and TTD/XPA mice were instead observed at 15% and 5%, 
respectively, upon genotyping at postnatal day 9-10. CH/XPA animals were present at 20%, 
closer to the expected ratio of 25%. Xpdwt/XPCS or TTD/Xpa-/- (subsequently referred to as XPA) 
were used as controls in subsequent experiments since XPA deficiency on its own has no or 
relatively minor effects on growth, development or fecundity (de Vries et al., 1995; Nakane 
et al., 1995). 
Although indistinguishable from control littermates after birth indicative of normal in 
utero development, CH/XPA mice were visibly smaller than XPA littermates by two weeks 
of age (Fig. 1A and data not shown), similar to XPCS/XPA and TTD/XPA mice (Andressoo 
et al., 2006b; de Boer et al., 2002). CH/XPA mice also displayed abnormal gait and tremors         
(data not shown) consistent with cerebellar ataxia as previously observed in several other 
progeroid NER-deficient mouse models (Table 1). However, unlike XPCS/XPA and TTD/
XPA, CH/XPA mice survived the stressful weaning period with high penetrance (~80%), 
reaching an average body weight about half that of littermate controls (Fig. 1A). 
Despite their small size, we consistently noted unusual daytime feeding behavior in   
CH/XPA mice, prompting an investigation into their average daily food intake. At 6 weeks 
of age, mutant mice consumed 23% more food per gram of body weight than littermate 
controls (p=0.001; Fig. 1B). In a repeat experiment with 7 week-old mice from a different 
litter, CH/XPA animals ate 12% more than littermate controls (p=0.09). In both cases, food 
consumption per gram of body weight was similar between CH/XPA mice and younger 
(3-5 week old) control mice having similar weights but growing faster (Fig 1B and data not 
shown). We conclude that food consumption corrected for body weight in CH/XPA mice 
was equal to or greater than littermate controls, and thus does not explain their smaller 
size. Furthermore at ten weeks of age, CH/XPA weighed on average 71% of littermate XPA 
controls and had a cachectic appearance. Corrected for body weight, white adipose tissue 
deposits were on average 48% of controls (perigonadal 41%, mesenteric 52%, adrenal 37%, 
subcutaneous 57%; overall p=0.01). Interestingly, however, interscapular brown adipose 
tissue deposits corrected for body weight were similar between CH/XPA and littermate 
controls at ten weeks of age. Together these data suggest that CH/XPA mice differ from 
control mice in either the extraction or use of energy from their food. 
Between four and six months of age, we observed a rapid and general decline in the 
overall condition of CH/XPA mice. Prior to sacrifice due to poor health status, mice were 
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Figure 1.  Compound heterozygosity at the Xpd locus partially rescues severe progeroid NER syndrome.
A. Growth curves of individual CH/XPA and control XPA animals from a representative litter. 
B. Food intake of CH/XPA animals vs. XPA littermate controls (42 days old) and 25 day-old controls expressed per gram 
body weight. Asterisks indicate statistical significance (p<0.001) vs. 42-day-old controls; error bars indicate SEM.
C. Photographs of male littermate CH/XPA and control XPA mice over 5.5 months.
D. Kaplan-Meier survival curve of CH/XPA and littermate control XPA mice.
A
C
B
D
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on average 56% of littermate weight and increasingly cachectic, with white adipose tissue 
corrected for body weight on average 43% of controls (perigonadal 43%, mesenteric 32%, 
adrenal 20%, subcutaneous 63%; overall p=0.02) and also reduced interscapular brown 
adipose tissue (62% of control, p=0.01). This decline was accompanied by other progeroid 
features including disturbed gait, frequent loss of balance and kyphosis (Fig. 1C). Kaplan 
Meier survival plots revealed a significant difference between CH/XPA mice and XPA 
littermate controls (log rank p<0.01) (Fig. 1D). Mortality was observed primarily at two 
points, the first around weaning (approximately one month of age) and the second around 
five months of age. Mean lifespan was approximately five months, which is proportional 
to the percent lifespan of the related human progeria, Cockayne syndrome (Nance and 
Berry, 1992). Thus amongst the reported progeroid NER mouse models summarized in 
Table 1, this mutant is unique in its ability to reach adulthood with high penetrance 
despite ataxia and cachectic dwarfism.
Accelerated fibroblast senescence undetected in multiple progeroid NER syndromes
Among NER-deficient mouse models for which cellular growth parameters have been 
reported, an inverse correlation appears to exist between cellular proliferative capacity 
in vitro and progeroid features in vivo. For example, primary mouse embryonic fibroblasts 
(MEFs) from Xpg-/- (Harada et al., 1999) and Ercc1-/- (Weeda et al., 1997) embryos undergo 
premature senescence when cultured under atmospheric (~20%) oxygen tension. XPA 
MEFs, on the other hand, have normal proliferative capacity (Parrinello et al., 2003) and 
the corresponding animals, despite their NER deficiency, lack profound symptoms of 
progeroid NER syndrome (de Vries et al., 1995). 
We tested this correlation in XPD/XPA MEFs by measuring proliferation in log-phase 
cultures at atmospheric (20%) oxygen tension as well as low (3%) oxygen tension in 
which cellular senescence is rescued in wildtype MEFs (Parrinello et al., 2003). Despite 
the severe progeroid symptoms in XPCS/XPA and TTD/XPA mice in vivo, we found no 
difference in the long-term proliferative capacity of XPCS/XPA or TTD/XPA MEFs in vitro 
relative to control or single homozygous mutant littermate controls (Fig. 2A, B). We also 
tested MEFs from another severely affected progeroid NER model, CSB/XPA (Table 1), and 
found no difference between control, single or double homozygous mutant MEFs (Fig. 
2C). As a positive control, Ercc1-/- MEFs (n=4) displayed reduced proliferative capacity vs. 
heterozygous or wt controls (n=4) at 20% oxygen tension (data not shown) as previously 
reported (Weeda et al., 1997). 
In order to see if this unexpected lack of premature cellular senescence extended to 
cells prepared from adult animals or to another cell type, we tested the proliferative 
capacity of dermal fibroblasts prepared from the tails of 10 week old CH/XPA and 
erythroblasts prepared from embryonic day 13.5 fetal livers. Relative to XPA control 
littermates, no proliferative defects were observed in either cell type (Fig 2 D, E). We 
further tested erythroblasts from double mutant  CSB/XPA as well as single mutant CSB 
and XPA fetal livers and found no genotype-specific proliferative differences (Fig 2F).
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Figure 2.  Normal proliferation of progeroid NER primary cells upon chronic and acute oxidative stress in vitro.
A-C. Serial passaging of MEFs from individual litters at 3% (filled symbols) vs. 20% (open symbols) oxygen tension. 
Lines are compiled from the indicated number of fibroblast cultures derived from single embryos and plotted as 
the log of the cumulative cell number over time; error bars indicate SEM. Insets in A-C are the same data plotted to 
indicate the rate of growth; an average daily population doubling (avg daily PDL) of 1 indicates that the cells divide 
on average once a day. A. Black diamonds, control (n=3); blue triangles, XPA (n=1); grey squares, XPCS (n=2); orange 
circles, XPCS/XPA (n=2). B. Blue triangles, XPA (n=4); orange circles, TTD/XPA (n=2). C. Black diamonds, control (n=1);               
blue triangles, XPA (n=2); grey squares, CSB (n=2); orange circles, CSB|XPA (n=3). 
D. Serial passaging of MDFs prepared from tails of 10 week old animals at 3% (filled symbols) vs. 20% (open symbols) 
oxygen tension. Lines are compiled from the indicated number of fibroblast cultures derived from single animals 
and plotted as the log of the cumulative cell number over time; error bars indicate SEM. 
E, F. Serial passaging of erythroblasts prepared from E12.5 embryos from a representative litter. E. Blue squares,   
XPA (n=5); orange diamonds, CH/XPA (n=4). F. Black diamonds, control (n=2); blue triangles, XPA (n=3); grey squares, 
CSB (n=1); orange circles, CSB|XPA (n=2). 
G. Proliferative capacity upon acute treatment with paraquat, ionizing radiation, tert-butylhydroperoxide and UV-C 
as indicated is expressed as a percentage of growth of the untreated samples. Black diamonds, control (n=3); blue     
triangles, XPA (n=1); grey squares, XPCS (n=2); orange circles, XPCS/XPA (n=2); error bars indicate SEM.
Finally, we tested hypersensitivity of primary embryonic fibroblasts to acute oxidative 
stress induced by ionizing radiation, paraquat and tert-butyl hydroperoxide. Similar to         
Xpg-/- MEFs (Harada et al., 1999; Shiomi et al., 2005), we found no significant differences 
between any of the genotypes (Fig. 2H and data not shown). As a control, all single 
and double homozygous mutants tested were hypersensitive to UV-C, consistent with 
their NER deficiencies (Fig. 2H and data not shown). In conclusion, it is unlikely that 
premature senescence or cell death observed in proliferating primary cell cultures under 
conditions of chronic or acute oxidative stress are related to the symptoms common 
amongst the various progeroid syndromes listed in Table 1. 
Purkinje cell death is a late event in disease progression
We next looked for differences in cell death or proliferation in vivo using one of the 
severe progeroid NER syndromes, XPCS/XPA, in comparison to single mutant (XPCS and 
XPA) and heterozygous (control) littermates at postnatal days 5, 12 and 15 coincident 
with growth retardation and ataxia but prior to signs of weight loss or morbidity. We 
focused on this double homozygous mutant due to the 100% penetrance of mortality 
around weaning (Table 1). We first examined cerebellar Purkinje neurons, one of the 
few cell types consistently affected in severe progeroid NER syndromes as reported in 
XPG, CSB/XPA and XPCS/XPA (Table 1). Despite disturbed gait and balance problems 
consistent with cerebellar ataxia, CH/XPA mice showed no detectable degeneration or 
loss of Purkinje neurons or abnormalities in cerebellar morphology upon sacrifice at 
the age of 5.5 months (Fig. 3A). Similarly, Purkinje neurons were morphologically intact 
in all mutant and control XPD/XPA animals at postnatal day 15 (Fig. 3B). These results 
were unexpected based on the almost complete loss of Purkinje cells by postnatal day 
20 in XPCS/XPA mice (Andressoo et al., 2006b) as well as XPG mice (Sun et al., 2001). 
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Except for cellular loss in the cerebellum very late in disease progression, gross 
pathological analysis of double mutant XPCS/XPA mice did not reveal overt defects in any 
other major organ system investigated, similar to reports in TTD/XPA and CSB/XPA mice 
(de Boer et al., 2002; Murai et al., 2001). Furthermore, we failed to observe polyploidization       
of liver nuclei (Fig. 3B) as in Ercc1-/- and Xpf-/- mice (McWhir et al., 1993; Tian et al., 2004; 
Weeda et al., 1997). Cellular proliferation, as measured by BrdU incorporation, Ki67 and          
PCNA immunohistochemistry in 5 and 12 day old mice did not reveal evident genotype-
specific differences in the number of replicating cells in the intestine, liver, kidney, heart 
or lung (data not shown). Nor did we find evidence of increased cell death/apoptosis in 
hematoxylin and eosin- or TUNEL-stained sections of various organs or following sensitive 
ligation-mediated PCR-based analysis of DNA from organs including liver, cerebellum, 
heart and eye (Fig. 3C and data not shown). Taken together, these in vitro and in vivo data 
support neither a vicious cycle of cell death and proliferative exhaustion nor a general 
cell-autonomous proliferative defect per se as causative of the cachectic dwarfism and 
failure to thrive in the developmental period that precedes severe pathology and death 
before weaning in most progeroid NER mice. 
Figure 3.  Proliferation and cell death do not correlate with onset or severity of progeroid NER syndrome.
A. Anti-calbindin staining (brown) of Purkinje neurons of 5.5-month-old CH/XPA and control XPA mice 
(magnification 100X).
B. TUNEL staining (brown) with hematoxylin co-stain (blue) of liver sections and anti-calbindin immunostaining 
(brown) with hematoxylin co-stain (blue) of cerebellar sections of representative XPCS/XPA, CH/XPA and control 
XPA mice at 15 days of age (magnification 400X).
C. Ligation-mediated PCR-based analysis of apoptosis in liver, cerebellum, heart and eye of postnatal d5 and d12 
control (n=2-3), XPA (n=3), XPCS (n=3) and XPA/XPCS (n=3-4) mice. The relative amount of laddered PCR products 
representing apoptosis is presented in arbitrary units on the y axis; error bars indicate SEM.
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Symptoms of progeroid NER syndrome resemble long-lived dwarfism and calorie restriction
We next looked for parameters that were partially rescued by Xpd compound hetero- 
zygosity in CH/XPA mice compared to XPCS/XPA mice in order to elucidate those 
parameters that are important in disease etiology. We focused initially on metabolic       
parameters including body weight, temperature and blood glucose in anesthetized mice.   
As shown in Fig. 4A, significant differences between mutants and controls were observed 
in body weight, temperature and blood glucose in anesthetized mice upon sacrifice 
at postnatal day 15. Interestingly, however, these differences did not reach statistical 
significance between XPCS/XPA and CH/XPA animals despite the large difference in 
lifespan.
Growth retardation, hypothermia, hypoglycemia (Fig. 4A) and reduced body mass 
despite normal to increased food intake per gram body weight (Fig. 1B) are phenotypes 
shared by long-lived mice with defects in growth hormone signalling, including growth 
hormone deficient Ames and Snell dwarfs and growth hormone resistant growth 
hormone receptor knock-out (GHR-KO) mice (Bartke and Brown-Borg, 2004; Longo 
and Finch, 2003). Growth hormone mediates its effects largely through the increased 
secretion of insulin-like growth factor 1 (IGF-1) biosynthesis in target tissues including 
the liver. To determine the status of the growth hormone/IGF-1 axis in progeroid 
NER syndrome, we measured total IGF-1 in serum of postnatal day 15 animals (Fig. 
4B). Compared to normally sized XPA animals, serum IGF-1 was reduced in both XPCS/
XPA and CH/XPA pups, although only to a level of statistical significance in XPCS/XPA 
animals (p<0.05). IGF-1 mRNA from liver, the major source of circulating IGF-1, was 
significantly reduced in both (Fig. 4C, p<0.05). As a control, relative abundance of IGF-
1 and a number of other mRNAs in single mutant XPA, XPCS and TTD livers were not 
significantly different from heterozygous controls (data not shown).
We next measured growth hormone in the serum (Fig. 4B). Despite considerable inter-
animal variation, likely due to the pulsatile nature of growth hormone secretion from 
the pituitary (MacLeod et al., 1991), levels were in the range of control XPA animals 
independent of genotype. Thus, dwarfism in NER progeria is not likely a primary 
pituitary defect as in Ames and Snell dwarf mice, in which the anterior pituitary fails to 
develop properly (Cheng et al., 1983). Consistent with this, no histological or functional 
differences were detected in the pituitary gland of another progeroid NER mutant, CSB/
XPA (van der Pluijm et al. 2007). Growth hormone insensitivity, as in GHR-KO mice, 
can also cause dwarfism (Hauck et al., 2001; Zhou et al., 1997) even in the presence of 
excess growth hormone. Indeed, liver GHR mRNA abundance was significantly reduced 
in both XPCS/XPA and CH/XPA pups. Despite a range of expression levels, maintenance 
of the strong correlation between GHR and IGF-1 mRNA in individual CH/XPA (r=0.84, 
n=12) and XPCS/XPA (r=0.76, n=8) animals relative to control XPA animals (r=0.96, 
n=12) suggests that coordinated transcriptional regulation is intact in progeroid NER 
syndrome (Fig. 4C, inset) and that GHR mRNA levels are a relevant indicator of GHR 
protein function.
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Calorie restriction and growth hormone deficiency/insensitivity both result in 
hypoglycemia and hypoinsulinemia. Increased sensitivity to the effects of insulin is 
thought to underlie the low blood sugar and may also be a key to extended longevity 
(Bartke and Brown-Borg, 2004). We measured serum insulin from day 15 animals and 
found, similar to dwarves and calorie-restricted animals, no evidence of hyperinsulinemia 
as a cause of hypoglycemia (Fig. 4B). IGF-1, IGF-1 binding protein 3 (IGF-BP3, also known as 
growth hormone-dependent binding protein) and acid-labile subunit (ALS) form a ternary 
complex in the serum and are all reduced in growth hormone insensitivity disorders in 
proportion to the severity of growth hormone resistance (Savage et al., 2005). In XPCS/XPA 
and CH/XPA animals, liver IGF-BP3 and ALS mRNA levels were reduced in addition to 
IGF-1, although the reduction in ALS expression in CH/XPA did not meet the criteria for 
statistical significance (Fig. 4C and data not shown). Other key genes involved in postnatal 
growth via the somatotroph axis, including deiodinase 1, which activates thyroid hormone 
precursor, and the prolactin hormone receptor, were significantly reduced as well (Fig. 4C). 
Within this signature group of five somatotroph axis genes, mRNA expression levels were 
significantly different not only between NER progeroid animals and controls, but also 
between XPCS/XPA and CH/XPA animals; in each case, downregulation was more severe 
in XPCS/XPA. Thus, on the level of gene expression, downregulation of the somatotropic 
IGF-1-GH axis correlated with the severity of NER progeria.  
IGF-1, ALS and prolactin receptor are three of a surprisingly limited number of liver 
transcripts reported to be altered in the long-lived GHR-KO dwarf (only 10 genes at a 
significance of p<0.001) while in Snell dwarf mice and calorie-restricted mice hundreds 
of liver transcripts are differentially expressed using the same experimental platform 
and statistical criteria (Miller et al., 2002). From this list of 10 transcripts, we additionally 
tested IGF-BP2, flavin-containing monoxygenase 3 (FMOX3) and apolipoprotein A-
IV (APOA4) expression. Circulating concentrations of IGF-BP2 are inversely related to 
growth hormone status and were significantly upregulated in progeroid NER mice, 
further underlining the down-regulation of the somatotropic axis. FMOX3, which is 
involved in the oxidative breakdown of xenobiotic compounds and downregulated in 
GHR-KO mice, was also down-regulated in progeroid NER mice. Finally, APOA4, a protein 
involved in serum lipid transport that is ~10 fold reduced in GHR-KO mice but 4-5 fold 
increased upon 24-48 hours of starvation (Bauer et al., 2004), was 3-6 fold increased in 
NER-deficient mice. In conclusion, many but not all characteristics of both CH/XPA and 
XPCS/XPA mice resembled either calorie restriction or genetic dwarfism.
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Figure 4.  Perturbation of growth hormone/IGF-1 axis correlates with severity of NER progeria. 
A. Body weight, temperature and whole blood glucose of anesthetized wildtype control (n=4, black); single 
mutant XPA (n=23, blue) and XPCS (n=6, grey); and double mutant XPCS/XPA (n=6, orange) and CH/XPA (n=13, 
beige) animals relative to wildtype controls. Asterisks indicate statistical significance vs. wt controls (** p<.01); 
error bars indicate SEM.
B. Serum IGF-1, growth hormone and insulin as determined by ELISA in XPCS/XPA (n=5) and CH/XPA (n=7) relative 
to XPA (n=6). Asterisks indicate statistical significance vs. XPA controls (* p<.05); error bars indicate SEM.
C. Abundance of liver mRNAs encoding insulin-like growth factor 1 (IGF-1), growth hormone receptor (GHR), IGF-
1 binding protein 3 (IGF-BP3), deiodinase 1 (DIO1), prolactin receptor (PRLR), flavin-containing monoxygenase 3 
(FMO3), IGF-1 binding protein 2 (IGF-BP2), and apolipoprotein A-IV (APOAIV) in XPCS/XPA (n=8) and CH/XPA (n=12) 
relative to XPA (n=12) as determined by quantitative RT-PCR. Asterisks indicate statistical significance vs. XPA 
controls (* p<.05, ** p<.01); number signs indicate statistical significance between XPCS/XPA and CH/XPA (# p<.05, 
## p<.01); error bars indicate SEM. Inset: correlation between relative IGF-1 and GHR mRNA expression values in 
individual animals; correlation coefficients per group: XPA, 0.96 (blue diamonds); XPCS/XPA, 0.76 (orange circles); 
CH/XPA, 0.84 (yellow squares); overall, 0.92. 
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An adaptive response to stress in progeroid NER syndrome
In genetic dwarfism, differences in serum IGF-1 and glucose metabolism are caused by 
congenital, irreversible defects in components of the postnatal growth axis itself. In 
calorie-restricted animals, these differences are reversible and represent an adaptive 
response to the stress of nutritional deprivation. We followed blood glucose and serum 
IGF-1 levels in CH/XPA mice over their lifespan to see if the phenotypic overlap with dwarf 
and calorie-restricted animals was more a structural defect or an adaptive response. At 
ten weeks of age, blood glucose and serum IGF-1 levels were normal in CH/XPA animals 
relative to wt and XPA controls (Fig. 5). This strongly suggests that the reduction of these 
components during early postnatal development (Fig. 4) represents an adaptive response 
rather than a structural defect. At the end of their lives, IGF-1 levels remained within the 
normal range while blood glucose levels once again fell significantly below control wt and 
XPA levels. Low serum glucose levels were also observed in the long-term survivors of a 
cohort of wt mice at the end of their lives (approximately two years; Fig. 5).
Figure 5.  Kinetics of blood glucose and serum IGF-1 levels throughout the life of CH/XPA mice. 
Longitudinal measurements of (A.) blood glucose and (B.) serum IGF-1 in CH/XPA vs. XPA and wt control mice. 
Error bars indicate SEM; 5-15 animals were used per genotype per timepoint. P value indicates the significance 
of the difference relative to WT at that timepoint.
A
B
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Is somatotroph axis dampening common to progeroid genome instability disorders?
Cachectic dwarfism is common in mouse models of genome instability with segmental 
progeria, and has been attributed in many cases to cell-autonomous proliferative defects 
(premature senescence) as observed in cultured MEFs (Lombard et al., 2005). We next 
asked whether the dampening of the somatotroph axis observed here in progeroid NER 
disorder is common to cachectic dwarfism caused by a different primary DNA repair 
defect.  Ku80-/- mice, which are defective in the repair of double-strand DNA breaks via the 
non-homologous endjoining pathway, are smaller than control littermates from E17.5 
on (Nussenzweig et al., 1996) and display multiple symptoms of premature senescence 
including kyphosis, atrophic skin, hepatocellular degeneration and reduced lifespan due 
to cancer and sepsis (Vogel et al., 1999). We looked at blood glucose and serum IGF-1 
levels in 2-week-old animals and found no differences between Ku80-/- and wildtype or 
heterozygous littermate control mice (Fig 6A). Next, we analysed liver mRNA expression 
of signature somatotroph axis genes Ku80-/- vs. littermate controls using QRT-PCR, the 
method found above to be most sensitive at identifying subtle differences between 
progeroid NER mice. Despite 50-60% reduced weight relative to littermate controls, 
Ku80-/- mice did not displayed no evidence of somatotropic axis dampening as observed 
in progeroid NER mice of the same age (Fig 6B). Nor was involvement of long-lived 
dwarf GHR-KO signature genes such as ApoA4 detected.  We also found no evidence of 
somatotroph dampening in Ku80-/- mice at 10 weeks of age when the activity of this axis 
should be near its peak. As a control for the ability to detect somatotropic axis dampening 
in 10 wk old mice, we compared them to older animals (~1 year of age) from the same 
stable and observed the expected age-related reduction in transcript abundance from 
somatotroph axis genes including IGF-1 and DIO1. In conclusion, unlike in NER progeria, 
we found no evidence of reduced GH/IGF-1 signalling contributing to cachectic dwarfism 
in Ku80-/- mice.
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Figure 6.  Analysis of blood glucose, serum IGF-1 and liver gene expression profiling in NHEJ-deficient Ku80-/- mice. 
A. Glucose and IGF-1 levels in the blood serum of 2-week-old ku80-/- vs. wt or heterozygous littermate controls. 
Error bars indicate SEM; six animals were used per group.
B. Abundance of liver mRNAs encoding insulin-like growth factor 1 (IGF-1), growth hormone receptor (GHR), IGF-
1 binding protein 3 (IGF-BP3), deiodinase 1 (DIO1), prolactin receptor (PRLR), flavin-containing monoxygenase 
3 (FMO3), IGF-1 binding protein 2 (IGF-BP2), and apolipoprotein A-IV (APOAIV) in 2-weekold ku80-/- (n=6) vs. 2-
weekold wt or heterozygous littermate controls (n=6); and both 10-week-old ku80-/- (n=4) and ~1 year-old vs. 10-
week-old controls (n=5) as determined by quantitative RT-PCR. Error bars indicate SEM between experiments.
A
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Discussion
We describe a new mouse model for progeroid NER syndrome created by combining 
two different mutant Xpd alleles in an Xpa-/- background. A major benefit of this model 
over existing models (Table 1) is its ability to survive weaning with high penetrance and 
a lifespan proportional to relevant progeroid NER disorders including CS. Furthermore, 
it is simpler than XPG, XPF and ERCC1 models which additionally have profound cell 
autonomous proliferative defects. Using this model we found evidence for an adaptive 
response to genome instability during postnatal development involving dampening of 
the somatotropic GH/IGF-1 axis and perturbation of glucose homeostasis. This response 
appears so far specific to excision repair disorders, as it was not observed in NHEJ 
deficient mice despite cachectic dwarfism and several progeroid features. 
Uncoupling of dwarfism and progeria from premature fibroblast senescence in progeroid NER syndrome
There is a strong correlation between genomic instability disorders with symptoms 
of progeria and premature senescence of the corresponding cultured fibroblasts, for 
example in Werner syndrome, Hutchinson-Gilford progeria and ataxia telangiectasia in 
man (Kipling and Faragher, 1997) and BUB1, PASG, DNA-PK, ERCC1 and KU80 mutants 
in mouse (Lombard et al., 2005). As a result, cell-autonomous proliferative defects are 
generally regarded as strong candidates underlying progeroid phenotypes, including 
cachectic dwarfism (Lombard et al., 2005; Nussenzweig et al., 1996). Mechanistically, this 
may be due not only to reduced proliferative capacity per se but also altered characteristics 
of senescent cells such as secretion of inflammatory cytokines and extracellular matrix-
degrading enzymes (Campisi, 2005). Here, in related NER progerias (CH/XPA, XPCS/XPA, 
TTD/XPA and CSB/XPA), we demonstrated that cell-autonomous proliferative defects as 
observed in two different primary cell types, fibroblasts and erythroblasts, are not an 
absolute prerequisite for postnatal growth retardation or progeria. This makes these 
NER-associated progerias exceptional amongst mouse progeroid syndromes caused by 
genome instability. Consistent with these findings in mice, CS and TTD are peculiar 
amongst human progerias not only due to their lack of cancer predisposition but also the 
failure of cells to undergo premature senescence in culture (Kipling and Faragher, 1997). 
Taken together, these data suggest that defects particularly in transcription-coupled 
NER are not growth limiting in proliferating cells. This may be due to their ability to 
repair (or tolerate) DNA damage by a variety of replication-dependent, NER-independent 
mechanisms. On the contrary, non-dividing post-mitotic cells such as neurons may be 
at greater risk to transcription-coupled NER deficiencies precisely because they do not 
have the opportunity to “clean” their genes or dilute their damage by DNA replication, 
while at the same time they appear to downregulate their ability to repair lesions via 
the global genome NER pathway (Nouspikel and Hanawalt, 2002). 
Instead of any cell autonomous proliferative defect, our data reveal dampening of the 
postnatal GH-IGF-1 axis, making this a much more likely explanation underlying reduced 
postnatal growth and small size. The inability to detect gross differences in cell death or 
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proliferation in vivo except in specific cell types (i.e. cerebellar granular neurons (Murai 
et al., 2001)) or at the end stage of disease (i.e. cerebellar Purkinje loss (Andressoo et 
al., 2006b)) does not rule out the contribution of small but significant differences in the 
number of proliferating or dying cells due to a lack of growth and survival signals. Such 
differences are likely to be found in specific cell compartments such as slowly cycling 
(label-retaining) cells of the germinal layer or chondrocytes in the proliferative zone of 
the growth plate responsible for longitudinal bone growth that are stimulated by growth 
hormone and IGF-1, respectively (Ohlsson et al., 1992).
Perturbation of somatotropic GH/IGF-1 axis and glucose homeostasis: structural defect or adaptive response?
We observed a number of similarities with long-lived dwarf and calorie-restricted 
mice, including small size, hypoglycemia and reduced serum IGF-1 indicative of 
dampening of the postnatal GH/IGF-1 growth axis. In a number of model organisms 
including worms and mice, suppression of the GH/IGF-1 axis is associated with increased 
stress resistance and extended longevity (Bartke and Brown-Borg, 2004). Reduced serum 
IGF-1 can be caused by genetic defects in structural components of the somatotropic 
axis itself (Ames, Snell, GHR-KO mice) or by an adaptive response to environmental cues 
such as starvation or calorie restriction. For example, Ames and Snell dwarf mice suffer 
congential hypopituitarism and lack a number of pituitary hormones including GH 
from birth. Upon dietary restriction, the only intervention known to extend lifespan in 
mammals, reduced blood glucose and IGF-1 appear to be key components of an adaptive 
response to stress (Koubova and Guarente, 2003; Weindruch and Walford, 1988) and 
are entirely reversible. The apparent logic behind this reversible response is to shift 
the metabolism away from energy consumption directed at growth or reproduction 
toward energy conservation and somatic maintenance with a concomitant increase in 
the ability of cells to cope with stress, with an overall aim of enhancing survival until 
favourable conditions return.
In CH/XPA mice, blood glucose and serum IGF-1 were reduced relative to controls at 
two weeks of age but returned to normal by 10 weeks of age. These data strongly argue 
against any structural defect in the components of the somatotropic axis or glucose 
homeostasis itself. This also makes it quite different from what has been proposed for 
progeroid SIRT6-/- mice. Based on the animals’ low blood glucose and serum IGF-1, failure 
to thrive and death with high penetrance before weaning (Mostoslavsky et al., 2006), the 
authors proposed an important role for SIRT6 in maintaining organismal homeostasis in 
addition to a role in DNA repair via the base excision repair pathway. In CH/XPA mice, we 
believe that the reduced blood sugar and serum IGF-1 during early postnatal development 
are components of an adaptive response to some form of stress experienced during this 
period before weaning. Although the nature of this stress is unknown, it appears to 
be initiated soon after birth and may involve the dramatic transition from prenatal to 
postnatal environment, including a different oxygen concentration, a switch in energy 
acquisition from the mother’s blood via her bloodstream to the mother’s milk via the 
pup’s own digestive system, combined with a period of rapid growth. 
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Figure 7.  Model for GH/IGF-1 axis and cell proliferation involvement in segmental progeroid genome instability disorders. 
A. Inverse correlation between IGF-1 and lifespan in progeroid NER syndrome. Decreased IGF-1 signalling usually 
correlates positively with increased longevity; in XPD/XPA mutants lower serum IGF-1 (y axis on the left) instead 
correlates inversely with lifespan. To explain this apparent paradox, we interpret serum IGF-1 levels as indicative 
of the magnitude of the perceived genotoxic stress (red arrows, y axis on the right). This genotoxic stress may 
overrule the efficacy of reduced IGF-1 in XPCS/XPA and TTD/XPA animals, while in CH/XPA animals compound 
heterozygosity partially complements the defect, relieving genotoxic stress and reducing the corresponding 
stress response.
B. Model for the differential contribution of cell autonomous proliferative defects and systemic growth axis 
perturbation to progeria in genome instability disorders. Growth signals from the IGF-1/GH somatotropic axis are 
dampened in progeroid NER syndrome (small red arrow) leading to postnatal growth deficiency; cells removed 
from this environment and provided adequate growth signals proliferate normally (dotted arrow represents 
wildtype proliferative capacity). In other segmental progerias, such as SIRT6 deficiency with a reported defect in 
base excision repair (BER), both appear to be affected. Alternately, cellular proliferation can be affected without 
apparent involvement of the somatotropic axis as in NHEJ-deficient Ku80-/- mice.
Interestingly, although serum IGF-1 levels remained in the normal range at least some 
time before the death of the CH/XPA animals, blood glucose levels dropped significantly 
below age-matched controls, indicating that low IGF1 levels do not always precede 
low glucose. We also observed reduced glucose levels in 15 of the oldest survivors of a 
longevity cohort of wt mice. Recently it was reported that senescent terminal weight loss 
in rats correlated with extended longevity (Black et al., 2003). It is therefore tempting to 
speculate that reduced size and decreased blood glucose are components of an adaptive 
response intended to extend longevity in both normal and some forms of pathological 
aging rather than the unintended consequences of random degenerative processes. 
Differences between progeroid NER mice and long-lived dwarf mice, on the other 
hand, may be better explained by defects in the transcription function of the TFIIH 
complex to which XPD belongs. For example, altered fat metabolism in CH/XPA mice 
may be related to reported defects in the activation of peroxisome proliferator-activated 
receptors implicated in lipid metabolism (Compe et al., 2005).
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Paradox of IGF-1 reduction: extended vs. shortened lifespan
Although reduced serum IGF-1 on its own does not result in dwarfism or extended longevity 
in mice (liver IGF-1 KO; (Liu et al., 2000)), it correlates with both in most reported cases. 
Comparative liver transcriptome analyses of long-lived dwarfism vs. calorie restriction 
also point to IGF-1 as one of the few consistent predictors of extended longevity (Miller 
et al., 2002). If reduced IGF-1 mRNA correlates with increased longevity, why were liver 
IGF-1 mRNA levels observed here lowest in XPCS/XPA animals with the shortest lifespan 
and intermediate in CH/XPA mice with intermediate longevity? Our data demonstrate 
that IGF-1 dampening is reversible (at least in the CH/XPA mice) and thus most likely an 
adaptive response to genotoxic stress. When considering the benefits of reduced IGF-1, 
one must also in this case consider the magnitude of the stress that triggers this response. 
At some level of damage, this stress may overrule the efficacy of the response even at 
its maximal beneficial level. According to this interpretation, the magnitude of the 
dampening of the postnatal growth axis does not correlate directly to lifespan extension, 
but to the magnitude of the perceived stress, be it starvation or genome instability, and 
is independent of whether that stress response is successful in extending longevity (Fig. 
7A). Thus in XPCS/XPA and TTD/XPA mice, this results in death before weaning with high 
penetrance despite the maximal stress response; compound heterozygosity at the Xpd 
locus, which partially complements this defect, results in a less robust stress response due 
to less or slower damage accumulation resulting in longer lifespan.  Whether or not this 
response is adaptive or maladaptive and what actually triggers it (i.e. CNS dysfunction or 
malnutrition) remain important questions for future research. 
Uncoupling of postnatal growth axis dampening from dwarfism in progeroid genome instability disorders
In contrast to certain progeroid NER disorders, cultured Ku80-/- fibroblasts display cell 
autonomous proliferative defects (Parrinello et al., 2003). Furthermore, Ku80-/- dwarfism is 
not exclusively postnatal (animals are already smaller at birth (Nussenzweig et al., 1996)), 
and we found no evidence of perturbation of the GH-IGF-1 postnatal growth axis at two 
weeks, as in progeroid NER disorder, or at 10 weeks near the peak of somatotroph axis 
activity. This suggests a model in which cachectic dwarfism and progeria can be caused 
by at least two fundamentally distinct mechanisms: perturbation of postnatal growth 
signaling independent of cell autonomous proliferative defects, as in NER progeria, or            
cell autonomous proliferative defects without perturbation of the somatotroph axis, as 
in KU80 deficiency. Because these two scenarios are not necessarily mutually exclusive 
(for example, Ercc1-/- and Xpg-/- mice display symptoms of NER progeria (Table 1) but also 
have cell autonomous proliferative defects; SIRT6-/- mice with a reported BER deficiency 
also display cell autonomous proliferative defects in addition to reduced serum IGF-1), 
dwarfism can likely result from combinations of both. In Fig. 7B, we summarize how 
defects in growth factor environment and cell-autonomous proliferative capacity may 
independently or together produce the symptoms of segmental progeria due to NER 
dysfunction or other defects in genome maintenance.
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Conclusions
Taken together, these data reveal perturbation of the growth hormone/IGF-1 axis as a 
novel mechanism underlying the common symptoms of progeroid NER syndromes. 
Downregulation of IGF-1 may thus be part of a general stress response activated not only 
upon conditions such as food scarcity but also in response to the accumulation of certain 
types of DNA damage via congenital repair defects and possibly natural aging. In support 
of this interpretation, end-of-life pathology in TTD mice is consistent with both segmental 
accelerated aging (e.g. increased lipofuscin accumulation in the liver) as well as calorie 
restriction (e.g. reduced incidence of pituitary adenomas) (Wijnhoven et al., 2005); TTD 
liver gene expression also resembled that of long-lived dwarf mice (Suh et al. submitted). 
Similarly, transcriptome analysis of CSB/XPA livers revealed significant downregulation of 
the somatotroph axis as well as upregulation of antioxidant defense (van der Pluijm et al. 
submitted). Finally, reduced serum IGF-1 and glucose levels were observed in segmental 
progeroid SIRT6 knockout mice, with a tentative link to a defect in DNA repair via the 
base excision repair pathway (Mostoslavsky et al., 2006). Extension of these findings from 
mouse models to the related human disorders remains to be determined. Downregulation 
of neuroendocrine IGF-1-GH signaling has not been a consistent finding in CS or TTD            
patients, although the relative paucity of both patients and data prevent firm conclusions 
from being drawn (Itin et al., 2001; Nance and Berry, 1992; Rapin et al., 2000). However, 
as evidenced by the reduced cancer incidence in hypopituitary dwarf mice (Bartke and 
Brown-Borg, 2004), it is a plausible mechanism contributing to the lack of cancer observed 
in these individuals (Itin et al., 2001; Nance and Berry, 1992; Rapin et al., 2000). 
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Materials and methods
Mice
Xpa-/-, XpdTTD (XpdR722W) and XpdXPCS (XpdG602D) mice were generated as described previously 
(Andressoo et al.; de Boer et al., 1998; de Vries et al., 1995). Mice were in a mixed 
129Ola|C57BL/6|FVB background. All experiments involving mice were evaluated and 
approved by the national committee for genetic identification of organisms and the 
animal ethical committee and were conducted according to national and international 
guidelines.
Cells
Embryonic fibroblasts from d13.5 embryos were dispersed by mechanical disruption 
with an Ultra-Turrax T25 Basic and cultured in a 50:50 mix of DMEM:Ham’s F10 
supplemented with 10% fetal bovine serum and antibiotics (pen/strep) in a mixed gas 
incubator with 5% CO2 and 3% 02 (passage 0), unless otherwise noted. For long term 
proliferation assays, cells were counted using a Coulter Multisizer Z2, seeded at 375,000 
cells per 10 cm round bottom TC petridish (Greiner Bio-One) and cultured at both 3% and 
atmospheric oxygen tensions. For subsequent passages, cells were trypsinized before 
they reached ~80% confluence. For acute stress sensitivity assays, early passage cells 
(P1-5) were plated in duplo in 6 well plates (Greiner Bio-One) at a density of 20,000 cells 
per well and treated with the appropriate agent the following day. Cells were counted 
4-5 days after treatment using the Multisizer Z2 and plotted as a percentage of the total 
number of cells from the corresponding untreated cell line. Dermal fibroblasts were 
prepared from the isolated tail skin of euthanized animals. Following mincing with a 
razor, tail skin was incubated overnight in a mixed gas incubator with 5% CO2 and 3% 02 
in DMEM supplemented with 20% fetal bovine serum and antibiotics and 40mg/mL Type 
II Collagenase (Invitrogen Corporation). The next day, cells were resuspended, passaged 
through a 40 micron filter, washed, and replated in media without collagenase. Long-
term proliferation assays were performed as above except that cells were plated at a 
slightly higher density (500,000 cells per 10 cm TC petridish). Erythroblast cultures 
were derived from fetal livers removed from d13.5 embryos. Progenitors were cultured 
as previously described (Prasher et al., 2005) under normoxic conditions.
Apoptosis
Apoptosis was measured by ligation-mediated PCR using the Apo-Alert LM-PCR Ladder 
Assay Kit in combination with Advantage cDNA Polymerase mix (both from Clonetech, 
Palo Alto, CA) according to the manufacturer’s instructions. TUNEL assays were 
performed using the ApoTag Plus Peroxidase In Situ Apoptosis Detection Kit (S7101, 
Chemicon International) according to manufacturer’s instructions.
Immunohistochemistry
For histological examination, mouse samples fixed in formalin were embedded in 
paraffin, sectioned, rehydrated and stained with hematoxylin and eosin or monoclonal 
antibodies against PCNA, Ki67 or calbindin and visualized based on HRP conjugated 
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secondary antibodies. TUNEL staining was performed using ApopTag Plus Peroxidase In 
Situ Apoptosis Detection Kit (Chemicon International, Temecula, CA) according to the 
manufacturer’s instructions. 
Physiologic parameters
Food intake was measured by weighing remaining dry food given to individually 
housed animals (3 per genotype) and the corresponding animals themselves each day 
over the period of four days; the experiment was repeated twice with different litters 
at different times. Body temperature was measured in animals immediately following 
anaesthetization with Isofluran by inserting a surgical thermometer into a small hole 
cut in the abdominal cavity or inserted into the rectum. Blood was collected following 
decapitation. Glucose was measured in whole blood using the Freestyle Mini blood 
glucose meter (Abbott Laboratories, Amersfoort, Nederland) with a range of detection 
between 1.1 and 27.8 mmol/L. Serum was prepared by low speed centrifugation 
following clotting. Serum IGF-1, growth hormone and insulin were measured by ELISA 
using Mouse/Rat IGF-I (DSL-10-2900) with a range of detection between 50 and 3500 
ng/mL, Mouse/Rat GH (DSL-10-72100) with a range of detection between 1 and 100 ng/
mL, both from Diagnostic Systems Laboratories (DSL Deutschland), and Ultrasensitive 
Mouse Insulin ELISA (10-1150-01) with a range of detection between 0.188 and 3.75 ug/L 
from Mercodia (Uppsala, Sweden), according to manufacturer’s instructions. 
Quantitative real-time PCR
Total RNA was extracted from the liver using TRIzol reagent (Invitrogen) and oligodT 
or hexamer-primed cDNA synthesized using SuperScript II (Invitrogen) according to 
the manufacturer’s instructions. Quantitative real-time PCR was performed using an 
Opticon2 DNA Engine (MJ Research) or a MyIQ (BioRad) with SYBR Green incorporation. 
Relative expression was calculated using the equation 1.8-(ΔCt sample – ΔCt control) (Pfaffl, 2001). 
Each sample was tested in duplo at least two times.
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Abstract
Dietary restriction, or reduced food intake without malnutrition, is synonymous with 
extended longevity and increased stress resistance in many model organisms. While the 
kinetics of onset and loss of benefits are rapid in lower organisms, they are unknown in 
mammals. Using a mouse model of surgical ischemia reperfusion injury to the kidney 
and liver, we found profound benefits of short-term dietary restriction, including four 
weeks of thirty-percent reduced food intake as well as three days of water-only fasting, 
against organ dysfunction and death. Significant protection occurred within one day, 
increased for up to three days of water-only fasting and lasted for several days beyond 
the fasting period. The benefits of fasting were not adversely affected by glucose-water 
ingestion during the fasting period in either kidney or liver, suggesting that the benefits 
of preoperative fasting are not necessarily incompatible with the current practice of 
preoperative carbohydrate loading. The mechanisms of protection overlap those 
associated with long-term dietary restriction, including reduced insulin/IGF-1 signaling, 
improved insulin sensitivity, improved antioxidant defense and reduced inflammation. 
Our data suggest that benefits of dietary restriction occur rapidly in mammals, with 
implications for protection against acute organ stress in the clinic.
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Introduction
Dietary restriction (DR) is defined as reduced food intake without malnutrition  and is 
associated with the benefits of extended longevity, prolonged healthspan and improved 
multiple stress resistance in model organisms including yeast, worms, flies and rodents 
(Bishop and Guarente, 2007; Brown-Borg, 2006; Masoro, 2003; Sinclair, 2005; Weindruch 
et al., 1986). In non-human primates and people, effects on longevity and acute stress 
protection are not yet known but the benefits on general health are clear, including 
improved cardiovascular fitness, body-mass index and insulin sensitivity (Fontana and 
Klein, 2007; Weiss et al., 2006). 
In experimental rodents, DR is achieved by either restricting total food intake (often 
called calorie restriction, or CR) or by altering temporal patterns of food availability, 
generally referred to as intermittent fasting (IF), and including such diets as alternating 
days of ad libitum feeding and fasting (also known as every-other-day fasting). Because 
animals on CR diets are hungry and consume their food allotment quickly when fed, 
CR is usually accompanied by extended periods of fasting between meals, with the 
period of fasting depending on how often food is provided (typically once daily to thrice 
weekly) (Masoro, 2004; Masoro et al., 1995; Weindruch et al., 1986). Similarly, IF is often 
associated with reduced total food intake and reduced body weight typical of CR in 
some rodent strains, but still produces tangible health benefits in rodents that maintain 
or even gain weight (Varady and Hellerstein, 2007). Thus although conceptually distinct, 
the relative contributions of periods of fasting versus reduction of total calorie intake 
to the benefits of DR, and whether they act by different mechanisms, remain unknown 
(Mattson, 2005). 
An understanding of the underlying mechanistic basis of DR in experimental 
organisms is far from complete, particularly in mammals. However, reduced signaling 
through insulin and insulin-like growth factor (IGF) receptors appears to be one 
evolutionarily conserved mechanism regulating the beneficial effects of DR. This 
may occur in part through a transcriptional program that is normally repressed by 
insulin/IGF signaling, including upregulation of stress response genes, altered energy 
metabolism and reduced inflammation. In mammals, heterozygous deletion of the IGF-
1R or adipose tissue-specific homozygous deletion of the insulin receptor results in 
extended longevity and/or increased stress resistance (Bluher et al., 2003; Holzenberger 
et al., 2003). DR is similarly characterized by reduced serum levels of IGF-1 and insulin, 
and presumably reduced signaling through these pathways, but also by improved 
sensitivity to their action. Whether this improved sensitivity is simply a marker of DR 
or contributes to its beneficial effects remains unresolved. 
In the fruit fly, the maximal benefits of DR on longevity, measured as a function of daily 
mortality rate, are achieved within 1-3 days of switching from a normal to a restricted diet 
(Mair et al., 2003). Similarly, the benefits are lost rapidly upon switching from a restricted 
to a normal diet. Because thousands of animals are required for accurate assessment of 
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daily mortality rates, such experiments using longevity as an endpoint in mammals are 
not considered practical. We thus chose to assess the speed of onset and loss of another 
benefit of DR, namely increased stress resistance. As an acute stress, we chose ischemia 
reperfusion injury (IRI), which is initiated by a lack of blood flow (ischemia) resulting in a 
state of tissue oxygen and nutrient deprivation characterized chiefly by ATP depletion, loss 
of ion gradients across membranes and buildup of toxic byproducts. Restoration of blood 
flow (reperfusion) causes further damage at first by inappropriate activation of cellular 
oxidases and subsequently by inflammatory mediators in response to tissue damage 
(Friedewald and Rabb, 2004). IRI can occur both naturally (stroke, myocardial infarction, 
hypovolemic shock) or unavoidably during surgery (cardiovascular, transplantation). 
Previously it has been shown that long-term DR regimes, including both CR and IF 
regimes for between 3 months and 1 year,  are effective at reducing ischemic injury to the 
heart and brain in rodent models (Ahmet et al., 2005; Chandrasekar et al., 2001; Yu and 
Mattson, 1999). Here we tested the ability of short-term nutritional interventions (defined 
here as less than 1 month), including periods of reduced daily food intake and water-only 
fasting, to protect against renal ischemia reperfusion in mice.
Figure 1. DR protects against the damaging effects of renal IRI.
A. Survival curves of wildtype male mice fed ad libitum, restricted to 70% of ad libitum food consumption 
for 4 weeks, or fasted for 3 days prior to induction of 37 minutes of bilateral renal IRI (n=10 per group). No 
further mortality was observed beyond day 4 after surgery. Both dietary treatments led to a significant survival 
advantage by Kaplan Meier analysis (log rank test, p<0.01).
B. Body weight of mice over a 28-day time course following renal IRI.
C, D. Kidney function as measured by serum urea (C) and creatinine (D) concentrations on the indicated days 
following surgery. Asterisks indicate the significance of the difference as compared to the ad libitum group at 
the same time point (* p<0.05; ** p<0.01).
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Results 
Short-term dietary restriction and fasting protect against ischemia-reperfusion injury
Adult male mice were fed 70% of their normal food intake once a day (30% dietary 
restriction, DR) for four weeks prior to challenge with renal IRI. Both renal pedicles were 
clamped for 37 minutes (bilateral occlusion), followed by clamp removal to reinitiate 
blood flow to the kidneys. Under these conditions, 60% of control mice fed ad libitum 
prior to surgery died or were sacrificed due to morbidity indicative of irreversible kidney 
failure by the fourth day following surgery. 
In striking contrast, survival in the DR group was 100% (Fig 1A). Two weeks of 30% 
DR resulted in the same strong protection against mortality (100% survival 1 week after 
reperfusion). Intermittent fasting regimens with reported health benefits in rodents vary 
from every-other-day feeding (Goodrick et al., 1982) to four days fasting once every two 
weeks (Sogawa and Kubo, 2000). We chose to test the potential benefits of three days of 
fasting. Despite significant weight loss, mice fasted for 3 days prior to surgery had 100% 
survival rates following 37 minutes of bilateral renal IRI, similar to 4 or 2 weeks of 30% 
DR (Fig 1A). Both fasted and restricted mice also gained weight faster after IRI and with 
similar kinetics, reaching their preoperative/pretreatment weight of approximately 
24 grams within two weeks; survivors fed ad libitum prior to IRI failed to reach their 
starting weight for up to one month following IRI (Fig 1B). Mortality following renal IRI 
usually occurs 2-4 days after the injury due to kidney dysfunction and the associated 
buildup of toxic waste products in the blood. We analyzed kidney function indirectly by 
measuring serum metabolites normally cleared by the kidneys. In the ad libitum group, 
serum urea concentrations continued to rise for at least 2 days following the injury 
and remained significantly elevated above preoperative levels for up to one month in 
surviving animals (Fig 1C). In both fasted and 30% restricted animals, blood urea values 
increased only slightly following the injury and returned to preoperative levels within 
seven days. A similar profile was seen for serum creatinine (Fig1D), a byproduct of 
muscle metabolism removed by the kidneys and largely unaffected by feeding state.
Protection against ischemia is rapidly gained and lost
In lower organisms such as the fruit fly D. melanogaster, the effects of dietary restriction 
on daily mortality rate are gained and partially lost in the time frame of 1-3 days (Mair et 
al., 2003). We next tested how rapidly the protective effects of fasting appeared in mice. 
To do this, as well as to extend our results from the bilateral renal ischemia model, we 
used a unilateral occlusion model in which the left kidney was clamped for 37 minutes. 
After clamp release, the right (undamaged) kidney was removed so that kidney function 
and animal survival depended on the single damaged kidney. Under these conditions, 90% 
of wildtype male ad libitum fed mice died or were sacrificed due to morbidity indicative 
of irreversible kidney failure by the fourth day following IRI. However, mice fasted for 
three days, two days or even overnight had significantly elevated survival rates (100%, 
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100% and 90%, respectively; Fig 2A). Despite reaching maximal survival by two days of 
fasting, protection against kidney dysfunction increased in a dose-dependent manner for 
up to three days of fasting (Fig 2B). Interestingly, despite robust increase in survival by 
overnight fasting, significant effects on kidney function were observed only on the third 
day following the injury. On this critical day, the ad libitum group continued to worsen 
while the overnight fasted group showed signs of recovery. 
The protective effects of fasting and their rapid onset were further confirmed with 
a more direct measure of kidney function. The uptake of technetium-99m-radiolabeled 
dimercaptosuccinic acid (99mTc-DMSA) by the kidneys is directly related to their function 
(namely tubular reabsorption) and can be determined by measuring the radioactivity that 
collects in kidneys with a gamma counter. 24 hours after IRI we observed significantly less 
accumulation of 99mTc-DMSA in all groups relative to the mock-treated animals; however, 
mice fasted 48 and 72 hours prior to IRI accumulated significantly more 99mTc-DMSA and 
thus retained better renal function than ad libitum fed animals (Fig S1).
In order to determine the half-life of fasting-based protection from renal ischemia 
reperfusion, we tested the effects of refeeding after fasting on survival and organ function 
following renal IRI. To do this, we fasted animals for 3 days and then allowed ad libitum 
access to food for between two hours and seven days prior to induction of bilateral renal 
IRI. Animals fed ad libitum or fasted for 3 days without refeeding prior to surgery served as 
negative and positive controls, respectively. Significant benefits on animal survival remained 
for at least two days after refeeding (Fig 2C). Despite these lingering survival benefits, 
significant protection from kidney dysfunction was lost by as little as two hours of refeeding 
prior to surgery (Fig 2D). These results suggest that the benefits of fasting on kidney function 
are separable from those on animal survival. A similar separation of benefits was observed 
previously in the protection afforded by overnight fasting, namely improved survival but 
no significant effect on kidney function on the first two days following reperfusion (Fig 2A, 
B, Fig S1). Taken together, these data suggest that the total protection afforded by fasting 
against renal IRI is both gained and lost within a period of just a few days. This is consistent 
with findings in lower organisms of the rapid onset of benefits of DR against mortality and 
acute stress (Chippindale et al., 1993; Mair et al., 2003). 
Nutrition-based protection is a preconditioning effect
Restricted mice were typically observed eating soon after awaking from anesthesia and, 
likely as a result, maintained or gained weight in the days following the surgery (Fig 1B). 
Mice fed ad libitum prior to the surgery were never observed exhibiting this postoperative 
eating behavior and lost weight in the days following the surgery (Fig 1B). We thus asked 
if the survival and functional differences were due to diet-induced changes present at the 
time of renal IRI (preconditioning) or due to differences in eating behavior occurring after 
the injury. To do this, we prevented access to food for one day following the surgery in 
ad libitum fed animals vs. those fasted for two days prior to bilateral renal IRI. Although 
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Figure 2.  Rapid onset and loss of protective effects of fasting.
A, B. Rapid onset: A. Survival curves of wildtype male mice fed ad libitum or fasted for 1-3 days prior to induction 
of 37 minutes of unilateral renal IRI with contralateral nephrectomy (n=10-18 per group). B. Kidney function as 
measured by serum urea following 37 minutes of unilateral renal IRI in the indicated groups (serum from 4-10 
individual animals was sampled per data point). Asterisks indicate the significance of the difference as compared 
to the ad libitum group at the same time point (** p<0.01).
C, D. Rapid partial loss: C. Survival curves of the indicated groups. Survival of animals refed for 2hr, 1 and 2 days 
was significantly different than ad lib fed animals (p<0.002); survival of animals refed for 4 and 7 days was not 
significantly different than ad lib fed animals. D. Kidney function as measured by serum urea prior to and one 
day following IRI. Data from three independent experiments with 4-12 animals per group are averaged. Asterisk 
indicates significant difference between 3 days of fasting without refeeding and ad libitum (AL) fed animals as 
well as each of the refed groups (p<0.05). There were no significant differences between the ad libitum group and 
any of the refed groups on day 1 following renal IRI
both groups continued to lose weight following the surgery (Fig 3A), animals fasted for 
two days prior to IRI had a significant survival advantage (Fig 3B) and significantly better 
renal function on the second day following the injury (Fig 3C). We conclude that the 
impact of diet on the ability to withstand renal IRI is largely due to a preconditioning 
effect. The best known example of this is ischemic preconditioning, the phenomenon by 
which a brief period of ischemia followed by reperfusion protect against a longer bout of 
subsequent ischemia reperfusion injury (Murray et al., 1986). We thus refer to effects of 
short-term DR and fasting observed here as “nutritional preconditioning”. 
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Figure 3.  Benefits of fasting do not require refeeding in the first 24 hours after surgery. 
A. Black bars indicate periods of free access to chow; red bars indicate periods without access to chow. Body 
weights of the two groups around the time of surgery (day 0) are indicated. 
B. Survival following renal IRI; fasted animals retained their survival advantage (p < 0.02) despite lack of refeeding 
for one day following renal IRI. 
C. Kidney function as measured by serum urea before and after IRI. Asterisk indicates a significant difference 
between the fasted and ad libitum fed groups (p<0.05) on the second day following surgery. 
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Preoperative carbohydrate loading does not interfere with nutritional preconditioning
Benefits of preoperative fasting against IRI as shown above are in apparent conflict with 
reported benefits of a very different nutritional intervention: preoperative carbohydrate 
loading. The use of liquid carbohydrate beverages up to two hours prior to surgery has 
been reported to improve postoperative outcomes including insulin resistance and 
subjective well-being (Ljungqvist and Soreide, 2003). We thus tested the effects of glucose 
water ingestion on nutritional preconditioning against renal IRI in mice. Four groups of 
mice were given access to either water, 54% glucose water, chow and water or chow and 
54% glucose water. Mice with ad libitum access to 54% glucose water during the three 
day fasting period lost less weight than the water-only fasted group, but had the same 
advantages in terms of survival and kidney function (Fig S2) versus the chow fed groups 
either with or without glucose water. In conclusion, although preoperative glucose 
consumption had no clear benefits on organ function or survival in this model, neither 
did it interfere with the benefits of nutritional preconditioning. Importantly, with respect 
to optimization of preoperative nutrition, these data suggest that the potential benefits 
of fasting and nutritional enhancement with liquid carbohydrates are not mutually 
exclusive.
Nutritional preconditioning is not organ specific
To find out if the protection afforded by brief fasting against IRI was specific to the kidney 
or more broadly applicable, we used a model of liver IRI in which the portal triad is 
clamped for 75 minutes, resulting in ischemic damage to approximately 75% of the liver. 
Because no mortality is associated with this model, we monitored ischemic liver damage 
by measuring the release of the liver-specific enzyme ALAT from dead or damaged cells 
into the blood for up to 24 hours (Fig 4A) and hemorrhagic necrosis in histological 
sections prepared 24 hours after reperfusion (Fig 4B). As in the renal ischemia model, 1-3 
days of water-only fasting significantly protected against ischemic damage to the liver. 
Furthermore, significant protection against necrosis was observed in animals with access 
to glucose water during the 3 day preoperative fasting period (Fig 4B). Thus, nutritional 
preconditioning against IRI by fasting is not specific to the kidney.
Overlap between mechanisms of DR-induced longevity and protection against ischemia-reperfusion injury
Although the molecular mechanisms underlying extended lifespan/healthspan by long-
term DR remain largely unknown in mammals, a number of potential candidates have 
been identified, including reduced insulin/IGF-1 signaling, increased insulin sensitivity, 
increased antioxidant protection and reduced inflammation. Proposed mechanisms 
of protection against ischemic insult by long-term DR are overlapping and include 
attenuation of oxidative stress, upregulation of stress proteins and reduced inflammation 
resulting in less cell death (Ahmet et al., 2005; Chandrasekar et al., 2001; Yu and Mattson, 
1999). We asked if mechanisms of nutritional preconditioning by short-term DR and 
fasting against renal IRI overlap these as well. 
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We followed markers of insulin/IGF signaling, antioxidant protection and inflammation 
on the transcriptional level using quantitative real-time PCR on kidney cDNA from 3 day 
fasted vs. ad libitum fed animals at baseline and over a 2-day time course following renal 
IRI (Fig 5A). Transcription of Igf-1 is dependent on binding of growth hormone to its 
cognate receptor, Ghr. At baseline, steady-state levels of kidney Ghr and Igf-1 mRNAs were 
significantly reduced in fasted animals. In the hours following reperfusion, Ghr and Igf-1 
mRNA levels fell below baseline in both groups, but stabilized (Ghr) or rose above baseline 
(Igf-1) only in the fasted group. This is consistent with an increase in local Igf-1 production 
relative to baseline in fasted but not ad libitum fed mice following injury.
  
Reduced signaling through insulin and insulin-like peptides including Igf-1 is thought 
to represent an evolutionarily conserved switch away from growth and reproduction and 
toward conservation and cytoprotection. In mammals, this includes increased expression 
of genes such as the inducible form of hemeoxygenase (HO-1) and components of the 
glutathione system, including glutathione reductase (Gsr). HO-1 and Gsr are both involved 
in protection from oxidative stress, and both were significantly elevated in fasted kidneys 
relative to ad libitum controls at baseline. Following injury, HO-1 was strongly induced in 
both groups but to significantly lower levels and with a more rapid return to baseline in 
the fasted group. Gsr mRNA levels fell in the fasted group and increased in the fed group 
over the 48-hr time course following reperfusion. 
Figure 4.  Protection from IRI by fasting is not specific to the kidney. 
A. Reduced injury markers upon liver IRI in fasted mice. Mice (5-8 animals per group) were fasted for the 
indicated times prior to induction of 75 minutes of warm ischemia to the liver. Serum concentration of the liver-
specific enzyme alanine aminotransferase (ALAT) indicative of liver damage was measured at the indicated times 
following reperfusion. Asterisks indicate the significance of the difference as compared to the ad libitum group 
at the same time point using a Mann-Whitney U-test (* p<0.05; ** p<0.01).
B. Representative hematoxylin/eosin-stained liver sections from mice 24 hours after reperfusion. Note the large 
areas of hemorrhagic necrosis (in red) in the mouse fed ad libitum prior to IRI and its relative absence in the 
mouse fasted for 3 days prior and those with access to glucose water during the fasting period. Magnification 
100X. Below: Quantification of hemorrhagic necrosis. Asterisks indicate the significance of the difference as 
compared to the ad libitum group (* p<0.05; ** p<0.01). There was no significant difference in % hemorrhagic 
necrosis in the fasted group between those with access to normal water (n=11) vs. glucose water (n=6; p=0.14).
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Inflammation is a significant mediator of cell death and organ dysfunction following 
IRI in multiple organs (Friedewald and Rabb, 2004). Reduced markers of inflammation 
generally correlate with improved outcome. Following renal IRI, markers of inflammation 
including the proinflammatory cytokine IL-6 and the neutrophil-recruiting endothelial 
adhesion molecule P-selectin were significantly activated in both groups with similar 
kinetics, but to a significantly lower degree in the fasted group.
Changes in glucose metabolism, including improved ability to clear glucose from the 
blood upon challenge with either glucose or insulin, are further hallmarks of extended 
longevity by long-term DR. To test these parameters in our model, we performed glucose 
tolerance and insulin sensitivity tests by injecting a bolus of glucose or insulin, respectively, 
and then monitoring blood glucose levels in mice fed ad libitum, fasted overnight or for 
3 days, or 30% restricted for 4 weeks (Figs 5B, C). The area under each curve is inversely 
proportional to that group’s ability to clear glucose or respond to insulin following glucose 
or insulin challenge, respectively. Fasting and short-term DR resulted in improved glucose 
disposal and improved insulin sensitivity relative to ad libitum fed mice, correlating with 
improved outcome following renal IR among our experimental groups. We therefore 
reasoned that if improved insulin sensitivity is a consistent marker of, or possibly causally 
related to, improved outcome following IR injury, then this should also not be adversely 
affected by ingestion of glucose water during a 3-day fast. Glucose tolerance and insulin 
sensitivity tests were thus performed on ad libitum fed or 3-day fasted animals with access 
to either normal water or glucose water. Consistent with the lack of an effect of glucose 
water ingestion on the course of IR injury, glucose water ingestion changed baseline 
glucose levels but did not significantly alter the relative insulin sensitivities of the fed vs. 
fasted groups (Fig S3).
Increased antioxidant capacity and reduced inflammation are predictive of reduced 
damage and death at the cellular level. To confirm this, we followed time-dependent leakage 
of the cytoplasmic enzyme lactate dehydrogenase (LDH) into the blood and histological 
evidence of acute tubular necrosis as injury markers. Although LDH levels were significantly 
elevated above baseline at 2 and 6 hours following reperfusion in all groups, at 24 hours 
they remained significantly elevated only in the ad libitum group (Fig 5D). Comparisons 
between treatments at individual time points revealed significantly lower LDH in the DR 
vs. ad libitum groups at 2 hrs, and significantly elevated LDH at baseline in the fasted vs. ad 
libitum group. Acute tubular necrosis was scored on a scale of 1-5 in a blinded fashion with 
histological sections from kidneys before and one and two days after IRI. Both short-term 
DR and 3 day fasting resulted in significantly less acute tubular necrosis on days 1 and 2 
following IRI (Fig 5E). To look at replacement of lost cells, we measured the proliferative 
markers PCNA and Ki67 on the second day following reperfusion, coincident with the onset 
of organ regeneration. Surprisingly, we observed as much proliferation in the ad libitum 
group as in the DR and fasted groups (Fig 5F). However, considering the significantly higher 
damage load in the ad libitum group, the ratio of living to dead cells was higher in the 
DR and fasted groups. This is consistent with better preservation of organ function, faster 
return to function and improved survival in nutritionally preconditioned animals.
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Taken together, these data suggest a model of protection against acute IR injury by fasting 
and short-term DR involving reduced insulin/IGF signaling, concomitant upregulation of 
cellular stress resistance mechanisms and downregulation of inflammatory mediators 
(Fig 5G). As a consequence, oxidative injury, cell death and inflammation are all reduced 
subsequent to IR injury. Our data further suggest a relative increase in insulin/IGF 
signaling above baseline following IR injury in the fasted group. This unexpected finding is 
consistent with the beneficial role of these factors in survival signaling and regeneration, 
for example following myocardial infarction and cerebral ischemia (Guan et al., 2003; 
Suleiman et al., 2007). 
Discussion
Fasting has been reputed to have healthful benefits at least since the time of Hippocrates 
but is largely absent from Western medicine today. Instead, fasting is often associated 
with malnutrition, which was first reported in 1936 to be a risk factor for postoperative 
recovery and survival following abdominal surgery (Studley, 1936) and has since been 
associated with negative outcomes including poor wound healing, increased risk of 
infection and multiple organ failure (Chung, 2002). One of the few modern clinical 
applications of fasting is to reduce the risk of pulmonary aspiration of regurgitated 
stomach contents prior to operations involving anesthesia. While the origins in the 1960s 
of the standard “nil by mouth after midnight” preoperative fast are somewhat obscure 
(Maltby, 2006), today even this relatively short fast is perceived as overcautious and 
possibly detrimental to patient subjective well-being and postoperative recovery (Diks 
et al., 2005). Current more liberal guidelines allow consumption of solids up to six hours 
prior to surgery and recommend consumption of liquids, including carbohydrate-rich 
beverages, up to two hours prior to surgery (Soreide et al., 2005). In rodents, preoperative 
fasting for this purpose is considered unnecessary since they lack the ability to vomit. 
Our data suggest that slightly longer periods of DR and/or fasting prior to surgery may 
be beneficial for an entirely different purpose – protection against certain types of acute 
organ stress. Importantly, these benefits do not appear to be mutually exclusive with 
existing preoperative nutritional strategies including carbohydrate supplementation. This 
may be due in part to the different endpoints addressed by these two different nutritional 
interventions. Whereas fasting may activate endogenous stress resistance, carbohydrate 
beverage consumption may ameliorate measures of subjective well-being such as thirst, 
hunger, irritability and headache associated with fasting (Crenshaw and Winslow, 2002). 
The fact that consumption of calories in the form of glucose water does not interfere with 
the benefits of fasting on protection from IRI suggests that the lack of carbohydrates (or 
calories) in the diet on its own is not the trigger underlying the benefits of fasting.
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Figure 5.  Mechanisms of protection against renal IRI by nutritional preconditioning.
A. Fasting results in differential expression of markers of antioxidant protection, inflammation and somatotroph 
axis at baseline and in response to renal IR. Changes in steady state mRNA levels of the indicated genes over a two 
day time course following renal ischemia reperfusion by quantitative real-time PCR. All data points are expressed 
relative to the ad libitum group at t=0 prior to renal IR. Each data point represents the mean expression value 
from 5 animals. HO-1, hemeoxygenase-1; Gsr, glutathione reductase; IL-6, interleukin-6; Ghr, growth hormone 
receptor; Igf-1, insulin-like growth factor-1.
B, C. Improved glucose tolerance and insulin sensitivity in preconditioned mice. Whole blood glucose levels at 
the indicated timepoints following intraperitoneal injection of glucose (B) or insulin (C) into animals following 
the indicated preconditioning regimens. Insets: areas under the curves (AUC). Statistically significant differences 
relative to the ad libitum group are indicated by asterisks (** p<0.01; * p<0.05).
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Previous reports of benefits of donor fasting in a rat model of liver transplantation 
following warm and cold organ preservation (Nishihara et al., 1997; Sumimoto et al., 1993) 
remain controversial with little if any followup reported on their potential translation to 
the clinic. There are likely several reasons for this. First is the aforementioned association 
between fasting and malnutrition, a known risk factor for postoperative recovery. Second, 
the reported benefits of fasting prior to organ transplantation are at apparent odds with 
reports of increased injury to organs from fasted donors using isolated perfusion models 
(Arnault et al., 2002; Domenicali et al., 2001). Third, the reported benefits of preoperative 
carbohydrate loading have been proposed to work by avoiding a catabolic state, such as 
that induced by fasting, altogether (Ljungqvist and Soreide, 2003). While the benefits of 
long-term DR (including both CR and IF feeding regimes and lasting between 3 months 
and one year) against ischemia reperfusion injury to the brain and heart in rodent models 
(Ahmet et al., 2005; Anson et al., 2003; Chandrasekar et al., 2001; Yu and Mattson, 1999) are 
not controversial, their practical translational potential is considered extremely limited 
for the purposes of preoperative nutrition. This is due both to the extended periods of 
time thought to be required for benefit as well as the difficulty in voluntary compliance 
with reduced calorie diets over extended periods of time. Furthermore, long-term DR 
is  not necessarily beneficial in all cases, as it exacerbates gut IRI (Ueno et al., 2005) and 
has been interpreted as detrimental in models of chemically-induced peritonitis due to 
reduced host neutrophil exudation (Ikeda et al., 2001). It remains to be seen if the benefits 
of short-term DR or fasting against renal or hepatic IRI observed in rodents will translate 
to humans. However, the fact that long-term DR extends healthspan in both non-human 
primates (Colman et al., 2008) as well as in humans (Fontana and Klein, 2007) suggests that 
it might. The observation that the kinetics of onset and loss of DR benefits are similarly 
rapid in rodents (Fig 2) as they are in fruit flies (Mair et al., 2003) further suggests that this 
may be an evolutionarily conserved characteristic of DR applicable in humans as well.
Figure 5.  Mechanisms of protection against renal IRI by nutritional preconditioning.
D. Blood serum LDH of the indicated groups over a time course following reperfusion. Asterisks indicate 
significant differences relative to time 0 of the same treatment; crosses represent significant differences relative 
to the ad libitum group at the indicated time point.
E. Quantification of acute tubular necrosis on a 5 point scale before and after renal IRI based on blind scoring 
of hemotoxylin/eosin stained kidney sections as described previously (Leemans et al., 2005). Asterisks represent 
significant differences relative to the ad libitum group at the indicated time point (* p<0.05; ** p<0.01).
F. Percentage of cells expressing Ki67 or PCNA proliferative markers in a microscopic field of the indicated group 
on the second day following IRI. All groups were significantly elevated vs. the mock control. 
G. Model for nutritional preconditioning. Dietary restriction produces a preconditioned (before) state of reduced 
insulin signaling resulting in improved cytoprotective gene expression, reduced inflammation and improved 
insulin/IGF-1 sensitivity. After an acute stress such as ischemia reperfusion injury, ROS cause less tissue damage 
and less subsequent inflammation. Improved insulin/IGF-1 sensitivity from the preconditioned state allows 
better survival signaling and enhanced cell division/regeneration after the injury. Extension of this model to 
a lifetime of acute stressors incorporates the benefits of both reduced and increased insulin/IGF signaling, but 
separated by time relative to an acute stress.
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Fasting and short-term DR are known to induce many of the transcriptional changes 
observed upon long-term DR including activation of genes involved in cellular stress 
resistance and repression of those involved in the inflammatory response (Bauer et 
al., 2004). Reduced insulin/IGF-1 signaling is one evolutionarily conserved mechanism 
through which DR may mediate such changes (Tatar et al., 2003). In C. elegans, reduced 
signaling through the insulin/insulin-like growth factor receptor Daf-2 results in extended 
longevity and increased stress resistance, both of which depend on relocalization of the 
Daf16 transcription factor to the nucleus and upregulation of target genes including those 
involved in antioxidant defense. However, depending on the method of DR employed, 
extended longevity in worms is dependent either on Daf16 (Greer et al., 2007) or Pha4 
(Panowski et al., 2007).Whether the mammalian Daf 16 or Pha4 homologs FoxO or 
FoxA, respectively, are required for any of the benefits of DR in mammals remains to be 
determined.
The so-called IGF-aging paradox points out apparent inconsistencies between the 
longevity effects of reduced insulin/IGF signaling on the one hand and the pro-growth, 
pro-survival effects of these factors on the other (Rincon et al., 2004; Tang, 2006). Our data 
suggest that the benefits of reduced and increased insulin/IGF signaling can be separated 
by time relative to an acute injury, and are thus not mutually exclusive. The enigmatic 
role of improved insulin/IGF sensitivity in DR may be to facilitate improved survival 
signaling following an acute stress, as summarized in Fig 5G. An extension of this model 
from acute stress protection to extended longevity would involve repetition of this cycle 
over a lifetime of acute stress events. Accordingly, DR could extend lifespan by increasing 
the likelihood of surviving an acute stress event such as an ischemic insult on any given 
day. This may occur independently of its ability to reduce the oxidative molecular damage 
that accumulates with age as a consequence of normal metabolism.
The ability of dietary restriction to extend longevity was first reported in rats in 
1935 (McCay et al., 1935). Nearly eight decades later, basic questions about the relative 
importance of energy restriction vs. nutrient restriction (Mair et al., 2005) or the role of 
fasting between meals (Mattson, 2005) still remain. Nonetheless, a consensus has begun 
to emerge linking DR to hormesis, the phenomenon first described in toxicology in which 
low doses of toxic substances elicit beneficial effects. In the case of DR, nutrient or energy 
restriction is the low-level stressor  eliciting an evolutionarily conserved adaptive responses 
resulting in stress resistance and extended longevity (Sinclair, 2005). One characteristic of 
hormetic substances is that they induce resistance to multiple forms of stress. Consistent 
with this notion, two days of fasting in mice was recently shown to protect against a stress 
very different than ischemic insult: acute toxicity associated with chemotherapeutic 
agents (Raffaghello et al., 2008). Fasting may thus represent a non-invasive, cost-free 
method of protecting against multiple types of acute stress including surgical ischemia 
reperfusion injury unavoidably encountered in elective surgeries including living-donor 
organ transplantation, cardiac surgery, vascular surgery and liver resection.
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Materials and Methods
Mice
Male C57BL/6J mice in the age/weight range of 22-25 grams/10-14 weeks were purchased 
from Charles River Laboratories, Maastricht, the Netherlands. Animals were kept under 
standard laboratory conditions (temperature 20-24ºC, relative humidity 50-60%, 12 h 
light/12 h dark) with 3-4 animals per cage and allowed free access to water and food (Hope 
Farms, Woerden, The Netherlands) except where noted. All experiments were performed 
with the approval of the appropriate local ethical board. 
Dietary regimens
The amount of food eaten ad libitum was approximately 3.5 gram/day as determined by 
weighing the remaining food on a daily basis for one week. DR was applied for 2-4 weeks 
by feeding mice 70% of this amount on a daily basis. Fasting was applied by transferring 
mice to a fresh cage without food for 1-3 days. 
Renal ischemia model
Mice were anaesthetized by isoflurane inhalation (5% isoflurane initially and then 2-2.5% 
with oxygen for maintenance). Body temperature was maintained by placing the animals 
on heating pads until recovery from anesthesia. Following a midline abdominal incision, 
the left renal pedicle was localized and the renal artery and vein were dissected. An 
atraumatic microvascular clamp was used to occlude the left kidney for 37 minutes. For 
bilateral occlusion, the procedure was repeated immediately on the right kidney. After 
inspection for signs of ischemia (purple color), the wound was covered with phosphate-
buffered saline (PBS)-soaked cotton and the animal placed under an aluminum foil blanket 
to maintain body temperature. After release of the clamp, restoration of blood-flow was 
inspected by return of the kidney to normal color. In the case of unilateral occlusion, 
a contralateral nephrectomy was performed immediately following clamp release. The 
abdominal wound was closed in two layers using 5/0 sutures. Animals were given 0.5 
mL PBS subcutaneously for maintenance of fluid balance and kept warm under a heat 
lamp. All animals were observed to have regained consciousness before moving their 
cages from the operating room to the stable.
Kidney function analysis
Unlabeled DMSA kits were purchased from GE Healthcare (Roosendaal, the Netherlands) 
and radiolabeled with 99mTc according to manufacturer’s instructions. Mice were injected 
in a lateral tail vein with 30 MBq 99mTc-DMSA. Four hours post injection the mice were 
sacrificed, the kidney was removed, and the absorbed radioactivity was measured in a 
gamma counter (Perkin Elmer, Groningen, the Netherlands) and expressed as percentage 
of injected dose per kidney (%ID/kidney).
Liver ischemia model
Liver IRI was performed by visualizing the liver hilus and clamping the portal triad with 
an atraumatic microvascular clamp for 75 minutes. In this model, 70% of the liver tissue 
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becomes ischemic, and blood outflow from the small intestine is preserved through the 
right anterior and caudate liver lobes. Mortality associated with this amount of ischemic 
damage to the liver was not observed. Liver samples were fixed in formalin for 24 hr         
prior to embedding in paraffin. 4 µm sections were cut and stained with hematoxylin and 
eosin. Liver necrosis was scored blindly on a scale from 0-4, with 4 representing 100% of 
the area covered by hemorrhagic necrosis.
Serum measurements
Blood samples were collected by retro-orbital puncture. Serum urea and creatinine levels 
were measured using QuantiChrom assay kits based on the improved Jung and Jaffe 
methods, respectively (DIUR-500 and DICT-500, Gentaur, Brussels, Belgium). Serum ALAT 
levels were determined using an ELAN analyzer (Eppendorf Merck, Hamburg, Germany) 
with Ecoline S+ reagents (Diagnostic Systems GmbH, Holzheim, Germany) according to 
manufacturer’s instructions. Serum LDH levels were determined using Ecoline S+ reagents 
according to manufacturer’s instructions in a 96-well format on a Varioskan microplate 
reader (Thermo Scientific).
Histology
Organs were harvested, fixed for 24 hr in formalin and embedded in paraffin. 3 µm 
sections were stained with hematoxylin and eosin. Tubular injury was assessed in a blind 
fashion on a five point scale as described previously. 
Glucose tolerance and insulin sensitivity tests
Following baseline blood glucose determination from tail blood of conscious, restrained 
mice, animals were injected with a bolus of glucose (1.5 mg/g body weight) or insulin 
(Novorapid; 0.75 U/kg body weight) into the intraperitoneal cavity. Blood glucose 
determinations were performed at the indicated times after injection using a HemoCue 
glucose 201 RT blood glucose analyzer (HemoCue, Ängelholm, Sweden) according to the 
manufacturer’s instructions.
Quantitative real time PCR
Total RNA was extracted from frozen kidney tissue using TRIzol reagent (Invitrogen) and 
oligodT or hexamer-primed cDNA synthesized using SuperScript II (Invitrogen) according 
to the manufacturer’s instructions. Quantitative real-time PCR was performed using a 
MyIQ (BioRad) with SYBR Green incorporation. Relative expression was calculated using 
the equation 1.8-(∆Ct sample – ∆Ct control). Each sample was tested in duplo at least two times. 
Statistics
Data are expressed as the mean ± SEM. Statistical analyses of data on urea, creatinine, 
histomorphology, immunohistochemistry and immunoblot was preformed using a 
Student’s T test unless otherwise indicated. Survival was analyzed by Kaplan-Meier 
(SPSSv11). Area under the curve was calculated using GraphPad Prism 4.0, and the 
significance calculated using a Student's T test.
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Supplementary figures
Fig. S1.
Mice fasted for 0-3 days (4-10 animals per group) were analyzed for kidney function either in the absence of renal 
ischemia (-renal IRI) or one day following 37 minutes renal ischemia (+renal IRI) by measuring radioactivity in the 
kidney with a gamma-counter 4 h after injection of 99mTc-DMSA, expressed as a percentage of the injected dose 
per one kidney (% ID/kidney). Note the reduced percentage of 99mTc-DMSA in the kidneys of the ad libitum group 
24 hours after renal IRI (12.4% to 5.6%), indicative of renal dysfunction. Asterisks indicate the significance of the 
difference as compared to the ad libitum group one day after renal IRI (p<0.05).
Fig. S3.  Neutral effects of glucose-water ingestion on insulin sensitivity. 
Whole blood glucose levels at the indicated timepoints following intraperitoneal injection of glucose (upper) 
and insulin (lower) into animals following the indicated preconditioning regimes. Insets: Area under the curve. 
Statistically significant differences between glucose water and normal water controls within ad libitum fed or 
fasted groups are indicated by asterisks (** p<0.01).
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Fig. S2.  Neutral effects of glucose-water ingestion on nutritional preconditioning.
A. Preoperative, 1d and 2d postoperative weights as indicated of mice allowed ad libitum access to chow and 
water, chow and 54% glucose water, water only  or 54% glucose water only for 3 days prior to 37 min bilateral 
renal ischemia (n=8 per group). In the ad libitum groups, animals with access to 54% glucose water drank 
equal volumes of liquid (3.5 +/- 0.4 mL glucose water vs. 3.5 +/- 0.3 mL water per mouse per day) and consumed 
significantly less chow (2.0 +/- 0.2 vs. 4.0 +/-0.2 g/mouse/day; p=0.00002) without any significant effect on body 
weight over the three day period. In the fasted groups, animals with access to glucose water drank significantly 
more than those with access only to normal water (5.2 +/- 0.2 mL glucose water vs. 0.4 +/- 0.1 mL water per 
mouse per day; p=0.00004) and lost significantly less weight during the 3 day fast as a result. Following surgery, 
all animals had ad libitum access to chow and water. Both ad libitum groups (with and without prior access to 
glucose water) continued to lose weight at similar rates. Among fasted mice, postoperative weights increased in 
the water-only group as observed previously (Fig 1B) but decreased significantly in the sugar water-only group, 
albeit proportionately less than in either of the ad libitum groups.
B. Kaplan-Meier survival data indicate significant differences between fed and fasted groups, but no significant 
effects of glucose water ingestion on survival in either group. 
C. Serum urea values of the corresponding groups as indicated. Asterisks represent significant differences relative 
to the ad libitum group at the indicated time point (* p<0.05; ** p<0.01). Consistent with the survival data, glucose 
water ingestion had no consistent effects on renal function in either the ad libitum fed or fasted groups in the 
two days following renal IRI.
A
B
C
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Abstract
Cockayne syndrome and other segmental progerias with inborn defects in DNA 
repair mechanisms are thought to be due in part to hypersensitivity to endogenous 
oxidative DNA damage. The accelerated aging-like symptoms of this disorder include 
dysmyelination within the central nervous system, progressive sensineuronal hearing 
loss and retinal degeneration.  We tested the effects of congenital nucleotide excision 
DNA repair deficiency on acute oxidative stress sensitivity in vivo. Surprisingly, we 
found mouse models of Cockayne syndrome less susceptible than wildtype animals to 
surgically-induced renal ischemia reperfusion injury, a multifactorial injury mediated 
in part by oxidative damage. Renal failure-related mortality was significantly reduced 
in Csb-/- mice, kidney function was improved and proliferation was significantly higher 
in the regenerative phase following ischemic injury. Protection from ischemic damage 
correlated with improved baseline glucose tolerance and insulin sensitivity and a 
reduced inflammatory response following injury. Protection was further associated 
with genetic ablation of a different Cockayne syndrome-associated gene, Csa. Our data 
provide the first functional in vivo evidence that congenital DNA repair deficiency can 
induce protection from acute stress in at least one organ. This suggests that while 
specific types of unrepaired endogenous DNA damage may lead to detrimental effects 
in certain tissues, they may at the same time elicit beneficial adaptive changes in others 
and thus contribute to the tissue specificity of disease symptoms. 
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Introduction
The case for the involvement of oxidative damage to macromolecules in the etiology 
of aging, aging-related disorders and so-called “premature aging” disorders (here 
referred to as segmental progerias) is compelling. The free radical theory as originally 
proposed by Harman (Harman 1956) and extended in recent years (Beckman and Ames 
1998) posits that reactive oxygen species (ROS), byproducts of endogenous cellular 
metabolism, inflict damage on lipids, protein and DNA. Despite defense systems to 
prevent or repair such damage, oxidized macromolecules accumulate over time in vivo 
and are thought to underlie both normal and pathological aging. When combined with 
congenital defects in certain of these defense systems, for example genome stability 
mechanisms, endogenous oxidative damage may also contribute to the symptoms of 
segmental progerias, which display some but not all of the characteristics of normal 
aging in accelerated or exacerbated forms (Martin and Oshima 2000). 
Nucleotide excision DNA repair (NER) is one such defense system that removes a range 
of damages, including helix distorting lesions induced either by exogenous ultraviolet 
radiation (e.g. pyrimidine dimers) or endogenous oxidative radicals (e.g. cyclopurines) 
(Brooks et al. 2000). Two basic modes of lesion recognition have been defined. In the first, 
lesions occurring anywhere in the genome are recognized by damage-binding proteins 
such as the XPC-HR23A/B-CEN1 complex. This triggers the assembly of the multiprotein 
NER machinery which functions via a cut and patch mechanism to remove the damage 
and fill the remaining single-strand gap (Hoeijmakers 2001). In the second mode of 
recognition, transcription-coupled (TC)-NER, lesions that block an elongating RNA 
polymerase trigger assembly of the NER machinery in a process which depends on the 
chromatin remodeling protein CSB (Citterio et al. 2000) and a ubiquitin ligase complex 
containing the TC-NER specific protein CSA (Groisman et al. 2003; Fousteri et al. 2006). 
Defects in CSA or CSB can give rise to Cockayne syndrome, a severe neurodevelopmental 
disease marked by photosensitivity (but curiously without skin cancer predisposition), 
dysmyelination within the central nervous system, progressive sensineuronal hearing 
loss, retinal degeneration and cachectic dwarfism resulting in an aged appearance 
(Nance and Berry 1992). Mouse models lacking Csa or Csb function recapitulate some 
progeroid characteristics of the human disease, including cachexia and progressive loss 
of photoreceptor cells, but with a normal lifespan and an overall milder phenotype 
than in humans (van der Horst et al. 1997; van der Horst et al. 2002; Dolle et al. 2006). In                 
support of the role of oxidative stress hypersensitivity in Cockayne syndrome etiology, 
an increase in photoreceptor cell loss following whole-body ionizing radiation was 
observed in both Csa-/- and Csb-/- mice (Gorgels et al. 2006). Thus, at least particular CS 
cell types appear hypersensitive to the effects of oxidative DNA damage, a property that 
may underlie tissue-specific disease phenotypes. 
Contrary to the notion of hypersensitivity to oxidative stress in Cockayne syndrome 
is the observation that mouse models of Cockayne syndrome and related NER-deficient 
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segmental progerias (NER progerias) display characteristics of hypopituitary dwarf 
mutants or dietary restricted wildtype mice (Wijnhoven et al. 2005; Niedernhofer et      
al. 2006; van de Ven et al. 2006; van der Pluijm et al. 2006; Schumacher et al. 2008). In 
dwarf and dietary restricted mice, these phenotypes, including hypoglycemia, reduced 
body weight and temperature, hypoglycemia, hypoinsulinemia and reduced serum IGF-
1, are correlated not only with extended longevity but also resistance to acute oxidative 
stress (Bartke and Brown-Borg 2004). In progeroid NER mice, these phenotypes have 
been interpreted as an adaptive response to unrepaired endogenous DNA damage 
engaged to protect from further oxidative stress injury (van de Ven et al. 2007). One 
important prediction of this interpretation is that mice should be resistant rather than 
hypersensitive to acute oxidative stress.
Ischemia reperfusion injury is a complex insult initiated by loss of blood flow to 
an organ. During the ischemic period, the lack of molecular oxygen as an electron 
acceptor in oxidative phosphorylation prevents ATP generation and compromises 
processes with high energy demand, such as maintenance of ion gradients across 
intracellular membranes. Reinitiation of oxygenated blood flow, or reperfusion, results 
in inappropriate activation of cellular oxidases and ROS generation, which can affect 
not only the reperfused organ but distant sites in the body as well (Kelly 2003). Following 
reperfusion, a maladaptive inflammatory response mediated in part by the release of 
ROS from neutrophils infiltrating the tissue causes further injury (Friedewald and Rabb 
2004). In the kidney, ischemia reperfusion injury is associated with cell death primarily 
in the stripe between the cortex and medulla consisting mainly of tubular epithelial 
cells via necrosis or apoptosis, depending on the severity of the insult (Padanilam 2003). 
Recovery and a return to proper kidney function depends on regeneration of the tubular 
epithelial cells and remodeling of the renal tubules, a process which takes place in the 
days and weeks following the injury.
We used surgically-induced renal ischemia reperfusion injury to test whether mouse 
models of Cockayne syndrome are susceptible to acute oxidative stress, as predicted 
by photoreceptor sensitivity to ionizing radiation, or protected from it, as predicted by 
physiological similarities between other short-lived progeroid NER mice and long-lived, 
stress resistant mice. Here we report resistance to renal ischemia reperfusion injury in 
mouse models of Cockayne syndrome.
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Results
Warm ischemia was induced in the left kidney of male wildtype and Csb-/- (subsequently 
referred to as WT and CSB, respectively) mice for 37 minutes by clamping the renal 
artery/vein with a nontraumatic surgical clamp. The 37 minute time point was chosen 
based on the results of preliminary experiments in which ischemia times were titrated 
between 30 and 45 minutes. Following clamp release, the undamaged right kidney was 
removed so that animal survival depended on the function of the damaged kidney; 
mice entirely lacking kidney function build up toxic compounds in their blood and die 
within 2-4 days. Survival of CSB mice was significantly higher than WT (Fig. 1A). On 
post-operative day (POD) 7, survival was 56% in CSB mice but only 30% in the WT group 
(log rank score p<0.0033; n=24 CSB, 40 WT). 
Figure 1.  CSB mice are better protected against warm renal ischemia reperfusion injury than WT.
A. Kaplan-Meier survival curves of CSB (n=24) and WT (n=40) animals; a log rank score of p<0.0033 indicates a 
highly significant difference between the genotypes.
B, C. Kidney function following IRI as determined by serum levels of urea (B) and creatinine (C). Statistically 
significant differences in magnitude observed at individual timepoints between genotypes following injury are 
indicated by asterisks (** p<0.01, * p<0.05). Groups receiving a mock treatment that did not involve ischemia are 
indicated. 
A B
C
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Kidney function was determined by measuring the concentrations of urea and 
creatinine in the blood serum. High levels of these waste products indicate an inability 
of the kidney to remove them from the blood and thus correlate inversely with kidney 
function. Interestingly, pre-operative urea and creatinine values were slightly but 
significantly lower in CSB mice than in WT mice (urea 8.5 ± 1.3 mmol/L (CSB) vs 9.7 ± 
1.2 mmol/L (WT), p=0.0007; creatinine 95 ± 17 umol/L (CSB) vs. 122 ± 34 umol/L (WT), 
p=0.002). Following ischemia-reperfusion injury, these markers of kidney function rose 
with similar kinetics, suggesting maximal dysfunction on POD 2 and a return to function 
beginning on POD 3. However, average values were significantly lower in CSB animals 
on POD 1 for urea and on PODs 1 and 2 for creatinine (Fig 1B, C), consistent with better 
survival in the CSB group.
Figure 2.   Cell loss and regeneration following 37 min warm renal ischemia reperfusion injury.
A. Cell death as determined by H&E-stained paraffin sections on the indicated day following IR. Day 0 kidneys 
were contralateral kidneys harvested immediately after clamp release.
B-D. Regeneration as determined by mitotic index in H&E stained sections (B);  relative number of cells expressing 
PCNA as determined by IHC (C); and total PCNA protein level as determined by immunoblotting on the indicated 
days following ischemia reperfusion injury (D). Statistically significant differences between CSB and WT on a 
given day are indicated by asterisks (** p<0.01, * p<0.05).
A B
C D
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We next analyzed cell death at various timepoints after the injury to look for differences 
that could explain the observed survival and functional benefits in CSB animals vs. WT 
controls. We used histology to score for acute tubular necrosis, the major form of cell 
death due to this type of injury (Fig. 2A). In both groups, acute tubular necrosis peaked 
on POD2; in the CSB group, average total cell death was lower at all time points, reaching 
statistical significance on PODs 1 and 2. The high mortality due to kidney dysfunction in 
the wildtype group prevented meaningful comparisons beyond POD 3. 
Figure 3.   Kidney function, cell death and regeneration following 25 min warm renal ischemia reperfusion injury in 
 CSB and WT animals.
A. Kidney function of the indicated genotypes following IRI or mock treatment as determined by concentration 
of serum urea (top) or creatinine (bottom). Statistically significant differences between CSB and WT on a given 
day are indicated by asterisks (** p<0.01, * p<0.05). 
B-E. Regeneration as indicated by mitotic figures in H&E stained sections (B) and immunohistochemistry against 
PCNA (C), Ki67 (D), and p21 (E) as indicated. Statistically significant differences between CSB and WT on a given 
day are indicated by asterisks (** p<0.01, * p<0.05).
A B
D
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Following cell death and clearance of cellular debris by shedding into the lumen of the 
tubules, kidneys damaged by ischemia reperfusion injury may undergo a regenerative 
phase in which cellular proliferation can be observed. Since the survival benefit of the 
CSB mice was likely only partially explained by the lower cell death on PODs 1 and 
2, we next asked whether regeneration of the kidney was enhanced. We used three 
different assays to gauge this parameter: histology, or the presence of mitotic figures 
in H&E stained sections; immunohistochemistry against the proliferating cell nuclear 
antigen (PCNA); and PCNA immunoblotting of total kidney homogenates to assess total 
levels of this protein. In both groups, mitotic figures were first seen on POD 3, with 
significantly higher scores in CSB mice (Fig. 2B; p = 0.025). We next looked at PCNA on 
the single-cell level by immunohistochemistry. The number of PCNA positive cells was 
significantly increased in the CSB group on POD 1 (Fig. 2C; p = 0.035), possibly indicative 
of its additional role in DNA repair. We further analyzed PCNA levels in total kidney 
homogenates by immunoblot. Although pre-operative PCNA levels were similar between 
groups, significantly higher levels of PCNA were observed on POD 3 in the CSB group (Fig. 
2D; p = 0.042). Taken together, these results are consistent with enhanced proliferation 
leading to better regeneration and survival in CSB vs. WT animals.
Previously it was reported that wildtype C57BL/6 mice subjected to 30-50 minutes of 
warm ischemia to one kidney followed by contralateral nephrectomy had a one-week 
survival of approximately 80%, with no statistically significant differences between 
ischemia times (Megyesi et al. 2002). We consistently found mortality of approximately 
70% due to kidney failure following 30-37 minutes warm ischemia (Fig 1A and data 
not shown), making it difficult to study the course of organ recovery beyond POD3. To 
circumvent this problem, we repeated our experiments in WT and CSB mice using 25 
minutes of warm renal ischemia. With this amount of ischemic damage, survival was 
100% in both WT and CSB groups (data not shown). However, 25 minutes of ischemia 
resulted in significantly less kidney dysfunction in mice lacking the CSB protein relative 
to WT controls at all timepoints following ischemic damage as measured by serum urea 
(Fig.  3A, top). A similar trend was seen for creatinine (Fig. 3A, bottom). 
Analysis of total cell death by histology revealed a significant elevation above 
preoperative values in CSB and WT (although less than after 37 min warm ischemia) on 
all PODs examined, but no significant differences between genotypes (data not shown). 
Despite similar low amounts of cell death between groups, we observed large differences 
in proliferation following 25 min warm renal ischemia. As with 37 min ischemia, 
proliferation was elevated in CSB vs. WT mice. Regeneration scored by mitotic figures 
in histological sections was first seen in wildtype mice on POD 3, while regeneration 
was already significantly elevated relative to baseline in CSB mice on PODs 2 and 3 (Fig. 
3B; p=0.035 and p=0.021, respectively). The number of PCNA positive cells on PODs 1 
and 2 was also significantly increased in the CSB group (Fig. 3C; p = 0.005 and p = 0.002, 
respectively). Because PCNA is involved in DNA repair as well as proliferation, we stained 
sections for an additional proliferative marker, Ki-67, which is expressed during all 
active phases of the cell cycle (G1, S, G2 and mitosis) but is absent from resting cells (G0) 
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(Scholzen and Gerdes 2000). Ki-67 positive cells were also increased in CSB mice, with a 
maximum on POD 2 (Fig. 3D; p = 0.016). 
The cyclin-dependant kinase inhibitor p21, which binds stoichiometrically to PCNA 
and inhibits its action in DNA replication, is a key regulator of proliferation following 
renal ischemic injury. Mice lacking p21 display hyperproliferation and greatly reduced 
survival (Megyesi et al. 2002). We tested p21 protein levels by immunohistochemistry (Fig. 
3E). Consistent with increased proliferation in CSB relative to wildtype on PODs 1 and 2, 
the number of p21 positive cells was significantly reduced in CSB mice (POD 2, p = 0.016). 
Interestingly, p21 staining was equal in wildtype and CSB on POD3, coincident with a 
decline in the first wave of proliferation following injury.
Figure 4.  Mechanisms of reduced susceptibility to renal ischemia reperfusion injury in CSB vs WT mice.
A. Time course of hemeoxygenase-1 (HO-1),  P-selectin and ICAM-1 mRNA expression as indicated in the kidney 
following 37 min renal ischemia reperfusion injury using quantitative real time PCR. Statistically significant 
differences between genotypes at a given time point day are indicated by an asterisk (* p<0.05).
B. Improved glucose clearance and insulin sensitivity in CSB vs. WT mice as indicated. Whole blood glucose levels 
at the indicated timepoints following intraperitoneal injection of insulin (E; n=11 WT, 7 CSB) or glucose (D, n= 9 
WT, 5 CSB)  into overnight fasted animals. Statistically significant differences between genotypes at a given time 
point day are indicated by asterisks (** p<0.01, * p<0.05).
A B
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We next turned to potential mechanisms of protection against renal ischemia 
reperfusion injury specific to CSB animals. Addition of antioxidants is a proven way to 
ameliorate the effects of this injury (Devarajan 2005). Furthermore, antioxidant capacity 
is increased in multiple organs in both genetic dwarfism and dietary restriction, a 
property thought to contribute to stress resistance and increased longevity in these mice 
(Bartke and Brown-Borg 2004). We thus looked for evidence of increased antioxidant 
capacity on the level of gene expression. We used quantitative RT-PCR over a time 
course before and after renal ischemia reperfusion injury to analyze antioxidant defense 
capabilities as represented by the steady state levels of candidate mRNAs including 
superoxide dismutase 1, glutathione reductase and hemoxygenase 1 (Fig 4A and data 
not shown). At baseline, steady state amounts of these mRNAs were not significantly 
different between WT and CSB groups. Similarly, over a 24 hour period following 25 
or 37 minutes warm renal ischemia, some of these genes (e.g. hemoxygenase-1) were 
significantly upregulated above baseline but none were consistently, significantly 
differentially regulated between CSB and WT groups (Fig. 4A and data not shown).
Another proven way to reduce the effects of ischemia reperfusion injury is to prevent 
the inflammatory response that follows tissue injury, for example by neutralization of 
cellular adhesion molecules that serve to recruit  neutrophils to the site of tissue injury 
by genetic or antibody-based methods (Takada et al. 1997). We examined the expression 
of  P-selectin and ICAM-1, endothelial adhesion molecules that are upregulated upon 
tissue injury and whose expression correlates negatively with survival and functional 
outcomes. We observed a significant increase in both markers following renal IRI above 
baseline levels; this increase, however, was less in the CSB animals (Fig. 4A). An area-
under-the-curve analysis revealed significant differences in expression of both P-selectin 
(p=0.02) and ICAM-1 (p=0.05) following renal ischemia reperfusion injury, consistent 
with less damage subsequent to the reperfusion and a better outcome.
Finally, enhanced sensitivity to the effects of insulin on glucose metabolism  is a 
property shared by dwarf and dietary restricted mice that had been proposed to 
underlie longevity benefits observed in these models (Bartke and Brown-Borg 2004). We 
chose to analyze glucose metabolism by performing both glucose tolerance and insulin 
sensitivity tests in overnight fasted CSB and WT mice. We found a significant increase 
in the ability of CSB animals to clear glucose from the circulation in response to a bolus 
injection of insulin or glucose, respectively (Fig. 4B). It should be noted that despite 
the slight but significant elevation of fasting glucose levels observed at baseline in CSB 
animals subject to the glucose tolerance test, no significant difference was observed in 
the insulin tolerance test between CSB and WT (p=0.34) nor in the combined data set 
(p=0.41). This lack of a significant difference is consistent with previous reports of fed 
glucose levels of single mutant CS and XPCS mice at postnatal day 15 prior to weaning, 
while in more severe XPA-deficient double mutant animals hypoglycemia was observed 
(van de Ven et al. 2006; van der Pluijm et al. 2006)
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Figure 5.   Protection from renal ischemia reperfusion correlates with genetic defects in TC-NER and extends to CSB  
 females. 
A. Functional response of TC-NER deficient CSA vs. WT animals to 25 and 37 min warm IRI according to serum 
urea (top) and creatinine (bottom) values on the indicated days after IRI. Statistically significant differences 
between genotypes at a given time point day are indicated by asterisks (** p<0.01, * p<0.05).
B. Functional response of WT vs. CSB females to 37 min warm renal IRI as measured by serum urea (top) and 
creatinine (bottom) values prior to and 24 hours after injury.
Cockayne syndrome can also be caused by defects in the CSA gene. In mice, Csa-/- 
(subsequently referred to as CSA) mice are nearly indistinguishable from CSB mice (van 
der Horst et al. 2002). We tested the resistance of CSA mice to renal ischemia reperfusion 
injury and found evidence of protection against both 25 and 37 min warm ischemia in 
CSA mice vs. WT controls as at the level of kidney function (Fig. 5A). 
No sex bias has been previously reported for Cockayne syndrome (Nance and Berry 
1992)or for mouse models of this disease. To see whether the protective effects we 
observed are specific to males, we tested CSB females for resistance to 37 minutes of 
warm renal ischemia. Female mice are in general less susceptible to this injury than 
males (Kher et al. 2005), and as expected we observed less evidence of kidney dysfunction 
and inflammation following 37 min warm ischemia in females than in males. However, 
CSB females displayed evidence of increased resistance to injury, including significantly 
lower urea and creatinine in the serum 24 hours after reperfusion (Fig. 5B). 
A B
H5.indd   115 20-04-2009   13:29:07
chapter 5
116
chapter 5
Discussion
Although the genetic lesions causative of Cockayne syndrome are known, the molecular 
defect(s) leading to the observed symptoms remains unclear. The prominent inability 
to repair UV-induced DNA lesions in Cockayne cells from both man and mouse models 
has led to the hypothesis that hypersensitivity to DNA damage, presumably oxidative in 
nature, is primarily responsible for disease symptoms. Consistent with this, CSB mice 
are hypersensitive to the effects of whole-body ionizing irradiation, a potent oxidative 
stress (de Waard et al. 2003), and both CSA and CSB mice demonstrate an increase in 
photoreceptor cell loss following ionizing radiation (Gorgels et al. 2006). However, primary 
CSB cells (van de Ven et al. 2006) as well as immortalized CSA cells (de Waard et al. 2004) 
are not hypersensitive to oxidative stress.
A number of recent reports have described overlap between short-lived segmental 
progeroid NER models and long-lived hypopituitary dwarfs or dietary restricted wildtype 
mice on the level of physiology and gene expression (Wijnhoven et al. 2005; Niedernhofer     
et al. 2006; van de Ven et al. 2006; van der Pluijm et al. 2006; van de Ven et al. 2007; 
Schumacher et al. 2008). These phenotypes have been interpreted as an adaptive response         
to genotoxic stress overlapping with the starvation response. A previously untested 
prediction of this interpretation is increased resistance rather than hypersensitivity to 
acute oxidative stress in these models. 
Consistent with this prediction, we showed here that mouse models of Cockayne 
syndrome deficient in either Csa or Csb are less susceptible to renal ischemia reperfusion 
injury than wildtype mice. Susceptibility was measured in terms of animal survival, 
kidney function and histological evidence of damage and organ regeneration. In all cases, 
CSB mice did significantly better than WT mice. On the molecular level, we observed 
less upregulation of the cell-cycle inhibitor p21 after injury in CSB mice, consistent 
with less damage and/or better proliferative potential. Upregulation of inflammatory 
markers ICAM-1 and P selectin were also significantly reduced following injury in CSB 
mice, consistent with either reduced damage and/or a dampened ability to mount an 
inflammatory response. Finally, improved glucose tolerance and insulin sensitivity at 
baseline were observed in overnight fasted CSB animals relative to WT controls. Taken 
together with previous studies demonstrating hypersensitivity to ionizing radiation in 
certain tissues, these data suggest that hypersensitivity and resistance to oxidative stress 
can coexist in the same animal, depending on the tissue or cell type involved.
Although the mechanism of protection against acute stress in the long-lived dwarf or 
dietary restricted models is not known, a number of plausible candidate mechanisms have 
been identified. These include increased antioxidant capacity, reduced inflammation and 
improved glucose homeostasis due to heightened insulin sensitivity (Bartke and Brown-
Borg 2004). The induction of genes including hemeoxygenase-1 upon ischemic injury 
demonstrated that the capacity of CSB animals to mount a transcriptional response is 
normal despite a defect in the repair of RNA polymerase-stalling bulky DNA lesions. 
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However, we did not observe any differences in antioxidant capacity on the level of gene 
expression between WT and CSB mice. We did find a difference in the upregulation of two 
markers of inflammation, P selectin and ICAM-1. Reduced inflammation is associated with 
improved outcome following renal ischemia (Friedewald and Rabb 2004), suggesting that 
these differences may in part underlie the stress resistance observed in the CSB model.
Glucose tolerance and insulin sensitivity tests were both consistent with improved 
response of CSB animals to the effects of insulin. Improved insulin sensitivity is 
associated with extended longevity in various models including genetic dwarfism and 
dietary restriction and is usually associated with reduced IGF-1 and improved glucose 
metabolism. How improved insulin sensitivity might underlie protection from acute 
stress observed here, or extended longevity observed in other models, remains unknown. 
As insulin and insulin-like growth factor signaling are pro-survival, and growth factor 
delivery can improve outcome after ischemic injury to other organs including the 
brain (Tang 2006), we speculate that increased sensitivity to these growth factors may 
result in both better cell survival as well as improved proliferation following ischemia 
reperfusion injury. 
Which defective biochemical activity (or activities) of CSB is causative of disease 
phenotypes, possibly including protection from renal ischemic insult? We speculate 
that a defect in TC-NER is the likely culprit based on the following genetic argument. 
CSB and other proteins implicated in Cockayne syndrome are multifunctional and have 
roles in various cellular processes, defects in any of which could in principle give rise to 
disease symptoms. Nonetheless the symptoms of Cockayne syndrome are remarkably 
similar regardless of the underlying genetic lesion, particularly in mice including 
CSA, CSB, XPCS or TTD models in an XPA deficient background, as well as in XPG, 
XPF and ERCC1 single mutant animals (van de Ven et al. 2007). We speculate that this 
common phenotype likely stems from a defect in a shared process in which each of 
these proteins participates directly. To date, the only common pathway in which each of 
these multifunctional proteins has a direct role is TC-NER. It should be noted, however, 
that the presumed unrepaired lesion or repair intermediate remains to be identified.
We propose a model in which a congenital DNA repair deficiency results in activation 
of systemic protective mechanisms including a reduced inflammatory response and 
improved insulin sensitivity. These mechanisms would then lend resistance to certain 
forms of acute stress in some tissues (renal ischemia reperfusion injury to the kidney, 
as shown here) but not others (ionizing radiation in the photoreceptor layer of the eye 
(Gorgels et al. 2006)) . We can envision at least two distinct mechanisms by which this 
organ/tissue specificity could occur. Based on the neuronal phenotypes in Cockayne 
patients and mouse models, TC-NER deficiency could in principle result in neuronal 
deficiencies causing a state of real or perceived dietary restriction, for example through 
defective function of neurons involved in nutrient sensing, or neuronal control of 
the gut leading to malabsorption. Extended periods of dietary restriction in wildtype 
mice have been shown to protect against ischemic damage to organs including the 
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heart (Chandrasekar et al. 2001) and the brain (Yu and Mattson 1999). Alternately, 
unrepaired TC-NER substrates in the genome may elicit an adaptive stress response 
similar to dietary restriction but in the absence of reduced food intake. Consistent 
with this latter interpretation is the adaptive response involving transient alterations 
in glucose homeostasis and serum IGF-1 levels observed in a related TC-NER deficient 
mouse model during the potentially stressful period of postnatal development (van de 
Ven et al. 2006). 
Hormesis is a common biological phenomenon in which exposure to a low intensity 
stressor induces a general adaptive response that has net beneficial effects on the 
cellular and/or organismal level, including protection against subsequent, higher dose 
exposures as well as to different types of stress (Murray et al. 1986; Mattson 2008). Dietary 
restriction has been proposed to act as a mild stressor that extends longevity through 
hormetic mechanisms (Turturro et al. 2000; Sinclair 2005). Interestingly, ischemic 
preconditioning, a procedure used to protect against ischemic insult that entails brief 
period(s) of ischemia prior to a longer ischemia time, is also thought to function via 
hormesis (Arumugam et al. 2006). Our data suggest that specific types of unrepaired 
endogenous DNA lesions may also be hormetic in nature. The interplay between tissue-
specific sensitivities to endogenous DNA damage and the resulting adaptive responses 
may underlie the complex phenotypes observed in segmental disorders such as 
Cockayne syndrome. Having identified such unexpected benefits associated with DNA 
repair deficiency, further elucidation of underlying mechanisms may allow exploitation 
of the benefits without suffering the severe complications associated with congenital 
DNA repair insufficiencies.
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Materials and Methods
Animals
Animals were allowed free access to food and water throughout the experiments. All 
experiments were performed with the approval of the appropriate ethical board. Male 
Csb-/- (van der Horst et al. 1997) and Csa-/- (van der Horst et al. 2002) mice in a C57BL/6J 
background were bred at the animal facility of the Erasmus Medical Centre; C57BL/6J 
mice were purchased from Harlan, Horst, the Netherlands. 
Ischemia model
Mice between 12 and 16 weeks of age were anaesthetized by isoflurane inhalation. 
Following a midline abdominal incision, an atraumatic microvascular clamp was used 
to occlude the left kidney for 25-37 minutes. After release of the clamp a contralateral 
nefrectomy was performed.
Kidney functional  measurements
Blood samples were collected by retro-orbital puncture. Blood serum urea and creatinine 
levels were measured using QuantiChrom assay kits based on the improved Jung 
and Jaffe methods, respectively (DIUR-500 and DICT-500, Gentaur, Brussels, Belgium) 
according to the manufacturer’s instructions, or were determined using an ELAN 
analyzer (Eppendorf Merck, Hamburg, Germany) with Ecoline S+ reagents (Diagnostic 
Systems GmbH, Holzheim, Germany) according to manufacturer’s instructions.
Histology
Kidneys were harvested, bisected longitudinally, fixed for 24 hr in formalin and 
embedded in paraffin. 3 µm sections were stained with hematoxylin and eosin, modified 
Jones staining and periodic acid Schiff (PAS). Immunohistochemistry was performed on 
deparaffinzed sections following antigen retrieval in boiling 10 mM sodium citrate.
mRNA expression analysis
Total RNA was extracted from frozen kidney using TRIzol reagent (Invitrogen) and 
oligodT or hexamer-primed cDNA synthesized using SuperScript II (Invitrogen) according 
to the manufacturer’s instructions. Quantitative real-time PCR was performed using an 
Opticon2 DNA Engine (MJ Research) or a MyIQ (BioRad) with SYBR Green incorporation. 
Each sample was tested in duplo at least two times. 
Glucose tolerance and insulin sensitivity tests
Mice were fasted overnight prior to testing. Following baseline blood glucose 
determination from tail blood of conscious, restrained mice, animals were injected 
with a bolus of glucose (1.5 mg glucose/gram body weight) or insulin (0.75 U/kg body 
weight) into the intraperitoneal cavity. Blood glucose determinations were performed 
as above at the indicated times following injection using a HemoCue glucose 201 RT 
blood glucose analyzer (HemoCue, Ängelholm, Sweden).
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Statistics
Data are expressed as the mean ± SEM. Statistical analyses of data on urea, creatinine, 
histomorphology, immunohistochemistry and immunoblot was preformed using a 
Student’s T test. Survival was analyzed by Kaplan-Meier (SPSSv11).
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Abstract
XPD is a helicase subunit of the transcription factor IIH, a ten-protein complex involved in 
a wide range of cellular activities including transcription initiation by RNA polymerase II 
and I, activated transcription via nuclear hormone receptor activation, and various DNA 
repair systems. Some mutations in the XPD gene can lead to xeroderma pigmentosum (XP), 
a disease characterized by an extreme predisposition to sun-induced skin cancer. Different 
mutations in XPD can lead to trichothiodystrophy (TTD), a severe neurodevelopmental 
disorder with multiple symptoms of accelerated aging and characteristic brittle hair and 
nails, but with a distinct lack of cancer predisposition. Also XPCS mutations are known, 
this is XP combined with the progeroid disorder Cockayne syndrome.
We have reported that mouse models of two XPD-related human disorders, XPCS and TTD, 
share a subset of metabolic phenotypes, like lower body weight and reduced metabolism, 
resembling calorie-restricted wildtype animals. Furthermore, the phenotypes are largely 
rescued in compound heterozygous animals (CH) derived from crosses between these two 
different mutant XPD animals. Here we tested the effects of compound heterozygosity 
on the repair of distorting DNA lesions, such as those induced by UV, using a variety 
of cell-based and in vivo assays including UV carcinogenicity and cellular survival. We 
found no correlation between the ability to repair UV lesions and the rescue of metabolic 
phenotypes in the CH state, suggesting that inability to repair bulky DNA lesions is not 
a driving force behind the segmental progeria/calorie restricted-like phenotype observed 
in these disease models.
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Introduction
DNA contains the genetic information of an organism and should be passed on in an error 
free manner from generation to generation. To preserve genome integrity, a network of 
genome maintenance mechanisms has evolved, including repair processes. Defects in 
genome maintenance can lead to different pathologies ranging from cancer to metabolic 
syndrome to premature ageing (van de Ven et al., 2007). One of these repair processes is 
nucleotide excision repair (NER), which eliminates a wide diversity of helix distorting 
DNA lesions, including cyclobutane pyrimide dimers, (6-4) photoproducts (main damage 
induced by UV light), intrastrand cross-links, and bulky chemical adducts. In addition, 
NER has been implicated in the repair of lesion, including several forms of oxidative 
lesions such as cyclo-purines (Brooks, 2007). NER has two sub pathways with partly 
distinct substrate specificity: global genome NER (GG-NER) surveys the entire genome for 
distorting lesions, and transcription-coupled nucleotide excision repair (TC-NER) focuses 
only on distorting damage in the transcribed strand of active genes that blocks elongating 
RNA polymerase (Batty and Wood, 2000; de Laat et al., 1999; Hanawalt and Spivak, 2008; 
Tornaletti and Hanawalt, 1999).
XPD is a helicase component of basal transcription/DNA repair factor IIH (TFIIH). TFIIH 
consists of ten subunits, which together form a multifunctional complex that is essential 
for multiple processes, of which basal transcription initiation and DNA damage repair 
via the NER pathway are two (Giglia-Mari et al., 2004; Schaeffer et al., 1993). Mutations 
in XPD affect TFIIH function and are associated with different UV-sensitive, disorders like 
xeroderma pigmentosum (XP), XP combined with Cockayne syndrome (CS) (XPCS), and 
trichothiodystrophy (TTD) (Broughton et al., 2001; Hoeijmakers, 2001; Lehmann, 2001). 
XP is associated with a dramatic incidence of sun-induced skin cancer. The frequency of 
internal tumors is modestly elevated, and in addition accelerated neurodegeneration is 
often noted (Lehmann, 2001). CS, on the other hand, is a TC-NER specific disorder, and is 
caused by mutations in the CSA or CSB genes. The disorder is characterized by progressive 
post-natal growth failure and primary demyelization, resulting in severe neurodysfunction, 
but without a clear cancer predisposition (Nakura et al., 2000). XPCS is displaying both the 
cancer predisposition of XP, and the neurodevelopmental complications of CS (Lehmann, 
2001). Finally, TTD is a condition sharing many symptoms with CS, but with the additional 
hallmarks of brittle hair, nails and scaly skin (Itin and Pittelkow, 1990).
Previously, TTD and XPCS mouse models, mimicking known human point mutations 
(R722W and G602D respectively) in the mouse Xpd locus, have been made. These mice 
exhibit striking phenotypic resemblance with the human syndromes (Andressoo et al., 
2006b; de Boer et al., 1999). XPCS mice, like XPCS patients, show a mild accelerated 
ageing phenotype, including cachexia and have a high UV-induced cancer susceptibility. 
TTD patients also show this accelerated ageing phenotype but, despite their partial NER 
deficiency, do not seem to be cancer prone. TTD mice develop UV-induced skin cancers 
when subjected to a high dose of UV, and are therefore considered more susceptible 
to UV carcinogenesis than wildtype (WT) mice (de Boer et al., 1999). This modest skin 
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cancer susceptibility is only apparent after extensive UV exposure. Spontaneous cancer 
frequency in TTD mice, particularly lymphoma’s and pituitary adenomas are reduced 
(Wijnhoven et al., 2005). TTD mice, like patients, also show segmental accelerated 
ageing and have a calorie restricted-like phenotype with liver gene expression profiles 
that resemble those of long-lived dwarf mice (Park et al., 2008; van der Pluijm et al., 
2007; Wijnhoven et al., 2005). Unfortunately, the initial studies on UV-sensitivity and 
skin cancer susceptibility have been performed in mice and cells in varying genetic 
backgrounds, therefore making it difficult to accurately compare these experimental 
outcomes.
Many NER patients, including approximately half of those in the XPD complementation 
group, are compound heterozygotes carrying a different mutation in each of the two 
Xpd alleles. In the absence of a WT allele, genetic interactions between recessive alleles 
(referred to here as “biallelic” effects) can result in a variety of phenotypic outcomes 
(Andressoo et al., 2006a; Oh et al., 2006). Because genetic heterogeneity and environmental 
exposure are impossible to control for in patients (Lehmann et al., 1988; Stefanini et al., 
1992), we demonstrated this the occurrence of biallelic effects in NER-related disorders 
using a variety of Xpd mutant mouse models. Intercrosess of mice heterozygous for 
viable TTD mutations and homozygous lethal XPCS or XP mutations result in compound 
heterozygous (CH) mice with a TTD mutation in one allele and a XPCS or XP mutation 
in the other. For some phenotypes associated with these alleles in the homozygous state 
(brittle hair in TTD homozygotes; embryonic lethality in XPCS and XP homozygotes due to 
reduced expression of the engineered allele) the compound heterozygous mice are more 
like wildtype than either of the corresponding homozygous animals, consistent with 
interallelic complementation. In other words the combined mutated alleles can do what 
neither one in homozygous state can do on its own. Other phenotypes (UV sensitivity, 
developmental delay) show dominance of one mutant allele (TTD) over the other (XPCS, 
XP) (Andressoo et al., 2006a).
Previously, we showed that a NER deficiency in mice is associated with a number of 
overlapping features of segmental progeria and dietary restriction. These phenotypes 
include changes in energy metabolism, reduced blood glucose and serum insulin-
like growth factor (IGF-1), and reduced growth hormone receptor (GHR) signaling 
(Niedernhofer et al., 2006; Schumacher et al., 2008; van de Ven et al., 2006; van der Pluijm 
et al., 2007). Furthermore, in the severely affected XPD|XPA (this is a Xpd mutant with 
a simultaneous inactivation of the Xpa gene (de Vries et al., 1995; Niedernhofer et al., 
2006), which is central for GG-NER and TC-NER of bulky distorting DNA lesions), many of 
these phenotypes were partially rescued in the context of Xpd compound heterozygosity 
(van de Ven et al., 2006). XPD|XPA double mutant mice have growth retardation and are 
hypoglycemic around the time of weaning.
Here, we report the use of homozygous viable Xpd alleles of TTD and XPCS in an attempt 
to understand which activity of Xpd is complemented in compound heterozygous mutants. 
To do this, we first looked for evidence of complementation of calorie restricted/progeroid 
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phenotypes, as previously reported in related studies (Andressoo et al., 2006a; van de Ven 
et al., 2006). Next we measured a variety of endpoints of DNA repair capacity both in vitro 
and in vivo. Finally, we asked if the ability of compound heterozygosity to rescue calorie 
restricted/progeroid phenotypes correlated with its ability to complement measures of 
DNA repair. We used TTD and XPCS mice, which both show segmental progeria/calorie 
restriction-like symptoms as well as differential UV sensitivity in the homozgygous state 
(Andressoo et al., 2006b; van de Ven et al., 2006; Wijnhoven et al., 2005) in an isogenic 
C57Bl/6J background to isolate the effects of the NER mutations from effects of genetic 
background. 
Results
Compound heterozygosity of TTD|XPCS partially rescues calorie restricted-like phenotype.
We investigated the effects of compound heterozygosity between TTD and XPCS alleles at 
the Xpd locus on metabolic phenotypes, including body weight and glucose metabolism 
in adult male animals using littermate controls in an isogenic C57BL6 background. First 
we measured the body weight of the different adult (10 week old) mutant animals. TTD 
and XPCS mice had a significantly lower weight than WT animals (p = 0.0164 and 0.0355 
respectively) (Figure 1A). CH animals were not significantly different from either WT or 
XPA mice, indicating that reduced body weight in homozygous Xpd mutants is rescued 
by compound heterozygosity. No differences were found in insulin levels or levels of 
IGF-1 in the serum of these different groups of animals. We next performed glucose 
tolerance and insulin sensitivity tests as a measure of glucose metabolism. It is known 
that dietary restriction improves glucose tolerance and insulin sensitivity and these 
measurements are therefore a good test for our segmental progeria/calorie restricted-
like phenotypes. Furthermore, mouse models of Cockayne syndrome have improved 
glucose tolerance and insulin sensitivity (Susa et al., 2009). These tests have never been 
performed in the XPD/XPA animals, because these very short lived double mutants are 
to weak and cannot be fasted overnight before weaning.  To this end, mice of each 
genotype (WT, XPA, XPCS, TTD, CH) were injected with a bolus of either glucose or 
insulin and measurements of blood glucose were taken over a time course following 
injection (Figure 1B,C). The area under each curve (AUC) is a measurement of the overall 
response or sensitivity, with smaller areas representing improved glucose tolerance or 
insulin sensitivity, respectively (Figure 1B,C). TTD and XPCS mice showed improved 
glucose tolerance, as measured by individual time points in the glucose curve  (XPCS 
p < 0.05 at t = 120min.; TTD p < 0.01 at t = 60, 120 min.) and overall according to 
the AUC (Figure 1B). TTD and XPCS mice also displayed improved insulin sensitivity 
according to the AUC (Figure 1C). CH mice were not significantly different than WT or 
XPA in either test. We conclude that the calorie restricted-like phenotype is rescued 
in CH animals. Taken together, differential body weight and glucose metabolism are 
phenotypes present in both homozygous single mutant animals that are complemented 
by compound heterozygosity.  
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Figure 1.  Partial reversal of the calorie restricted-like phenotype by interallelic complementation.
A. Bodyweights of ten week old XPCS and male TTD mice (n=9). Error bars indicate SD. Note the significant 
difference between WT and TTD and XPCS homozygous but not compound heterozygous mutants. Error bars 
indicate SEM (* p < 0.05). 
B. Glucose tolerance test (male mice n=9): whole blood glucose levels at the indicated time points following 
intraperitoneal injection of glucose (1.5 mg per gram body weight). At 60 and 120 minute time points blood 
glucose is significantly lower in TTD vs. WT (p < 0.01) and at the 120 minute time point lower in XPCS vs. WT (p < 
0.05). Insert: the area under each curve is represented in arbitrary units. Asterisk indicates the significance of the 
difference vs. WT (** p < 0.01). Error bars indicate SD.
C. Insulin sensitivity test (male mice n=9): whole blood glucose levels at the indicated time points following 
intraperitoneal injection of insulin (0.75 U/kg body weight). Insert: the area under each curve is represented in 
arbitrary units. Asterisk indicates the significance of the difference vs. WT (* p < 0.05). Error bars indicate SD.
B
C
A
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Dominance of TTD allele over XPCS allele in measures of UV-sensitivity.
We next looked on both the organismal and cellular sensitivity to UV irradiation as a 
measure of NER capacity. UV-induced inflammation is expressed as the minimal UV-B 
dose required to induce erythema, or edema (minimal erythemal dose, MED). As shown in 
Figure 2A, TTD mice have a slightly reduced MED compared to WT (1200 J/m2 versus 1500 
J/m2). The MED of XPCS animals was more comparable to the one of XPA animals (100 J/m2 
versus 150 J/m2 respectively). However, the MED of CH mice was 1000 J/m2, between XPCS 
and TTD animals, but much closer to the value observed for TTD mice. Thus, the TTD 
allele is dominant over the XPCS allele with respect to MED.
Another measure of acute UV sensitivity is hyperplasia, or the thickening of the 
epidermal layer that occurs as an adaptive response to acute UV exposure. To measure 
this, mice were depilated on the back and exposed to UV-B light with a dose of 200 J/
m2/day for 4 days. Histological analyses of skin sections were made 1 week after the 
start of UV-B treatment (3 days after the final treatment) (Figure 2B). XPCS and XPA skin 
revealed pronounced epidermal hyperplasia, consisting of an increased number of cell 
layers (acanthosis) as shown before (Andressoo et al., 2006b; de Vries et al., 1995) and 
with no significant difference observed between them. Neither erythema nor hyperplasia 
was observed in the UV-exposed skin of WT or TTD animals (de Boer et al., 1999). Only 
minor hyperplasia was found in sections of UV-exposed CH skin. Unirradiated skin 
of all animals served as a negative control. In conclusion, the XPCS mutation induces 
severe photosensitivity in mice, and the TTD allele is dominant in CH animals, with the 
difference in CH vs. wildtype likely due to dosage effects.
Next we determined skin cancer susceptibility, fifteen XPCS and XPA animals and five 
CH animals were exposed daily to an incremental low UV-B dose up to a maximum of 
100 J/m2/day, until a total amount of 11 kJ/m2 was reached. For the remaining ten CH 
mice and fifteen WT and TTD mice a higher daily and cumulative dose was selected (650 
J/m2/day and 103 kJ/m2 respectively), because of the higher MED and reduced skin cancer 
susceptibility (de Boer et al., 1999). In Figure 3A the percentage of tumor free mice (that is, 
the time when the first tumor was noted) is depicted. In all cases soon after the treatment 
stopped the first tumors appeared. There was no significant difference in latency time 
of developing tumors between CH and TTD mice (Log rank 0.2579) or between XPA and 
XPCS mice (Log rank = 0.9969). Significant differences were detected between WT and 
TTD or CH mice (Log rank = 0.0013 and 0.0060 respectively) and between CH and XPCS 
or XPA animals (Log rank = 0.0099 and 0.0054 respectively). In Figure 3B, the time until 
at least one tumor reached a diameter of 4 mm (upon which the animal was sacrificed) is 
depicted. Outcomes were approximately uniform (Log rank WT/TTD = 0.0031, WT/CH = 
0.0055, CH/XPA = 0.0063, CH/XPCS = 0.0093, XPA/XPCS = 0.7836), except for TTD and CH 
animals which were significantly different (Log rank = 0.0299). This could be because of 
the observed slow tumor growth and therefore increased tumor yield in TTD animals. 
This higher tumor yield was also noted by de Boer et al. (1999). An example of smaller 
tumors in TTD mice vs. XPCS, XPA, CH and WT mice is shown in Figure 3C. All tumors 
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were histopathologically identified as squamous cell carcinomas (SCCs) (data not shown) 
consistent with previous studies in which only SCCs were found in UV-irradiated TTD and 
XPA mice (de Boer et al., 1999; de Vries et al., 1995) and only few squamous cell papillomas 
(SSPs) were found in XPCS mice (Andressoo et al., 2006b). During the experiment, corneal 
opacity and bulging of the eyes were also observed in XPA and XPCS mice but not in TTD, 
CH or WT mice (data not shown). In conclusion, in all UV sensitivity experiments the TTD 
allele is dominant over the XPCS allele, on the organismal as well as cellular level.
Figure 2.   Acute effects of UV-B on the skin in mice with different Xpd mutations in vivo.
A. The Minimal Erythemal Dose (MED), a quantification of UV-induced inflammation or sunburn as determined by 
an increase in skin thickness following acute UV-B. Ear skin was exposed to different doses of UV-B. Ear thickness 
was measured before and 24h after UV-B exposure using an engineer’s micrometer. The lowest dose that was able 
to induce a significant increase in thickness was designated the MED for that genotype (n = 9 per genotype 3 per 
dose). 
B. Depilated backs of isogenic C57BL6 mice of the indicated genotypes were exposed to 200 J/m2 UV-B daily for 
four consecutive days and sacrificed one week after the start of the treatment. Note the pronounced epidermal 
hyperplasia (purple, indicated by horizontal and vertical bar), consisting of increased number of viable cell layers 
(acanthosis and hyperkeratosis), in the XPA and XPCS skin after UV treatment. The prominent cornified layer 
(indicated by horizontal bar) and thicker granular layer (indicated by an arrow) in TTD skin (scaling skin) is also 
clearly visible (n = 4 per genotype).
B
A
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Figure 3.  Differential UV sensitivities of mice with different Xpd mutations in vivo.
A,B. UV-induced carcinogenesis was studied in isogenic C57BL6/J mice of the indicated genotype by chronically 
exposing the depilated backs of mice with an incremental-dose to 650 J/m2/day (WT, TTD, and CH animals; 103KJ 
total (n = 15 per genotype)), or 100 J/m2/day (XPA, XPCS and CH animals; 11KJ total (n = 15 per genotype)). The percent 
of mice without a visible tumor from onset of UV exposure is plotted in A. In B, percent survival represents the time 
from the onset of UV exposure until at least one tumor was > 4 mm diameter and the mouse was sacrificed. Note 
the significant difference between TTD and CH animals in percent survival (* p < 0,05; ** p < 0.01).
C. UV-induced skin cancers in WT (top left), XPCS (top right) and TTD (bottom right) mice. Note the lack of tumors 
in the first mouse; the second showing a tumor after UV-B in a XPCS mouse that is typical of that seen in all the 
genotypes except TTD; and third, small, slower growing tumors typical of TTD mice. 
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We next turned to cell-based endpoints of radiation exposure in primary dermal 
fibroblasts prepared from each genotype in order to further focus in on the DNA repair 
characteristics of these different genotypes. Using a proliferation-based assay, we found 
that primary MDFs from XPCS and XPA mice were hypersensitive to UV irradiation, and 
that TTD and CH MDFs were far less sensitive, consistent with the in vivo data (Figure 4A). 
Using the same assay, no difference in sensitivity to ionizing radiation was observed in 
any of the mutant cells relative to the WT MDFs (Figure 4B). This is consistent with the 
lack of oxidative stress sensitivity in any of these NER mutants (van de Ven et al., 2006), 
although it also induces single stranded and double stranded breaks of different kinds.
We next focused more specifically on NER characteristics of primary MDFs derived from 
the tail skin of adult mice of each genotype. The UV-induced unscheduled DNA synthesis 
(UDS) assay reflects GG-NER of bulky lesions anywhere in the genome. Specifically, this 
assay measures the incorporation of radiolabelled nucleotides that constitute the “patch” 
part of the NER reaction following removal of the lesion 2 hours after UV irradiation. XPA 
cells, which lack GG-NER altogether, were used as negative controls. As found previously 
in dermal fibroblasts from patients as well as in mouse embryonic fibroblasts (MEFs), 
XPCS MDFs retained ~40% of WT UDS activity (Andressoo et al., 2006b; Theron et al., 
2005). This is a result of “phantom UDS”, which is dependent on the NER factor XPA but 
does not reflect efficient repair of UV lesions (Andressoo et al., 2006b; van Hoffen et al., 
1999). TTD and CH had a UDS around 60% of WT and therefore significantly differed in 
the amount of UDS as compared to XPCS (p = 0.0004 and 0.00002, respectively) but were 
not significantly different from each other (p = 0.2518). In conclusion, the TTD allele is 
dominant over the XPCS allele with respect to GG-NER capacity in MDFs. 
Figure 4. Differential UV sensitivities of cells with different Xpd mutations in vitro.
A. Early passage C57BL6 mouse dermal fibroblasts (MDFs) from the indicated genotypes were treated with the 
indicated dose of UV-C (A.) or ionizing radiation (B.). The number of cells remaining after three days was plotted as a 
percentage of the total number of cells from the corresponding untreated cell line. Note that the outcome of the UV 
cell survival curve (but not ionizing radiation) follows the same pattern as the skin cancer survival curve, with NER-
deficient XPA and XPCS both highly hypersensitive, and CH and TTD much closer to WT. Error bars indicate SEM.
H6.indd   136 20-04-2009   13:30:00
chapter 6 chapter 6
137
To confirm these UDS data with a different assay, we followed the phosphorylated 
histone H2AX (γH2AX) 3hr after UV treatment of confluent, non-dividing MDFs. γH2AX 
staining reflects the incision activity of NER, which is low in XPA deficient cells (O'Driscoll 
et al., 2003; Theron et al., 2005) and in TTD cells (Andressoo et al., 2006b). In MDFs, γH2AX 
staining was consistent with previous results reported on MEFs (Andressoo et al., 2006b) 
as well as the relative percent of UDS activities (Figure 5A, B). As with the UV-UDS assay, 
XPCS cells displayed γH2AX staining unrelated to their repair capacity, with an increased 
number of incisions despite reduced UDS. This is also consistent with what has been 
previously reported in XPCS cells from both mice and humans (Andressoo et al., 2006b).
Figure 5.  UV-induced DNA damage repair characteristics.
A. UV-induced DNA repair synthesis capacity. Cells were irradiated with 16 J/m2 UV-C followed by incubation 
with [methyl-3H]thymidine for 2 hours. Incorporation of radioactivity was counted in individual cells (n = two cell 
lines per genotype; 25 nuclei per line). Error bars indicate SEM. Asterisks indicate significant differences between 
indicated lines (** p < 0.01).
B. Quantification of γH2AX immunofluorescence indicative of DNA breaks in MDF nuclei with and without UV-C 
irradiation.1x relative intensity represents the average amount of γH2AX immunofluorescence in the corresponding 
unirradiated cell line. Error bars indicate SD. Asterisks indicate significant differences between indicated lines (** 
p < 0.01).
C. RNA synthesis recovery in MDFs, measured 16 hours after exposure to 10 J/m2 UV-C followed by a 1hr pulse 
labeling with [3H]uridine. UDS and RRS are each expressed as a percentage of WT. Error bars represent SEM. 
Asterisks indicate significant differences between indicated lines (** p < 0.01).
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Recovery of RNA synthesis (RRS) is a specific measure of TC-NER in transcribed regions 
of the genome. It is measured by incorporation of radiolabelled uridine 16 hours after 
UV irradiation. Similar to XPA cells, which lack TC-NER capacity entirely, XPCS cells had 
no detectable RRS (Figure 5C). However, a small but significant residual TC-NER activity 
(~15%) was detectable in CH and TTD cells. 
Dominance of TTD allele over XPCS allele in UV-induced stress response.
Steady state levels of insulin-like growth factor 1 receptor (IGF-1R) mRNA and protein are 
reduced after UV irradiation in WT MDFs. This reduction is prolonged in cells from NER 
progeria models largely correlated with the severity of the progeroid phenotype in vivo 
(Garinis et al., 2009). We thus analyzed this parameter to explore if level of IGF-1R mRNA 
correlated with progeroid characteristics in our mutants. To this end we measured the 
amount of IGF-1R mRNA in the primary MDFs of the different cell lines in a time course 
following UV irradiation by quantitative RT-PCR. Figure 6 shows the relative amount of 
IGF-1R mRNA of each cell line at the different time points after the different doses of 
UV. IGF-1R expression in WT cells was reduced within 6 hours after UV exposure in a 
dose dependent manner, and returned to baseline levels 12 hours after exposure. The 
IGF-1R downregulation in the mutant MDFs was exacerbated, and the reduction lasted 
longer in each of the NER mutant lines. These effects were most pronounced in XPCS 
and XPA cells, with an intermediate phenotype in CH and TTD cells. This measure of the 
UV-induced stress response correlates in these mutants with most of the former UV-based 
experiments (in which XPA=XPCS < CH=TTD<WT). From these data we conclude that the 
severity of progeriod symptoms in XPCS, TTD and CH mice does not correlate with the 
UV-induced down regulation of IGF-1R.
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Figure 6. Relative IGF-1R abundance in MDFs after UV treatment.    
                  
Steady-state levels of IGF-1R in different MDF cell lines 6, 12 or 24hr after indicated amount of UV as determined by 
quantitative real-time PCR. Within each time point the value of each cell line is set relative to its own 0 joule value. 
Each value off each cell line is set relative to the 0 Joule outcome of that cell line at each time point. Error bars 
indicate SD. Asterisks indicate statistical significance versus 0 Joule controls (* p < 0.05; ** p < 0.01). 
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Discussion
Here, using mouse models containing different non-lethal mutations in the Xpd gene, 
we show for the first time that, compound heterzygosity complemented the progeriod 
and calorie restricted-like phenotypes found in TTD and XPCS mice. However, this 
complementation was not found for the repair of UV lesions in various cell-based and 
in vivo assays. We therefore conclude that defects in transcription-coupled nucleotide 
excision DNA repair activity in vitro and in vivo are unlikely to be causative of progeroid/
calorie restricted-like phenotypes.
Complementation of the calorie restricted-like phenotype in compound heterozygous mice.
The aim of this study was to investigate the previous found interallelic complementation 
of calorie-restricted like phenotypes by analysis of body weight and glucose metabolism 
of  (WT, XPA, TTD, XPCS and CH) mice. Previous studies reported calorie restricted-like 
phenotypes that are observed in these accelerated aging models (Niedernhofer et al., 2006; 
van de Ven et al., 2006; van der Pluijm et al., 2007), likely as an adaptive survival response 
to endogenous genotoxic stress. First, we confirmed that a number of calorie restricted-
like phenotypes, like reduced body weight and insulin sensitivity, were complemented 
in these mice. Previously, when looking at compound heterozygous mice with a lethal 
XPCS or XP allele also a rescue of developmental delay and progeriod features such 
as premature cachexia and loss of bone mineral density was found (Andressoo et al., 
2006a). Later, a partial rescue of progeriod features was found in compound heterozygous 
animals with a viable XPCS allele in a XPA deficient background (van de Ven et al., 2006). 
Here we show that in the compound heterozygous progeny (CH), derived from crosses 
between XPCS an TTD animals (and thus carrying two different viable mutant Xpd alleles 
in the same animal without the XPA background), the accelerated aging and calorie 
restricted-like phenotypes were rescued to near completion, as shown in Figure 1A and 
B. While the mechanism of these rescues is currently unknown, we believe it to involve 
complementation between the two mutant proteins, so that together they can complete 
a required XPD activity relevant to aging whereas neither can on its own (Andressoo et 
al., 2006a).
Dominance of the TTD allele over the XPCS allele in UV sensitivity of the mouse skin.
We next tested the mechanistic hypothesis that defective NER of bulky lesions, and in 
particular TC-NER, is causative of these phenotypes by measuring parameters of DNA 
repair in CH vs. control mice. These studies were based on the logic that the XPD activity 
underlying the calorie-restricted phenotype should be rescued or partially rescued in the 
compound heterozygous state in which these phenotypes are complemented in vivo. To 
this end we performed an in-depth analysis of the effects of compound heterozygosity on 
the repair of UV-lesions in various cell-based and in vivo assays. Contrary to our hypothesis, 
not a single measure of TC-NER (or GG-NER) of UV induced lesions in vivo nor in vitro was 
complemented in CH animals. Instead, the TTD allele dominated in all of these readouts. 
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This means that defects in transcription-coupled DNA repair activity in vitro and in vivo 
are unlikely to be causative of progeroid/calorie restricted-like phenotypes.
Repair deficient TTD patients seem to be free of cancer, despite their NER defect, 
and occasionally mild photosensitivity (Botta et al., 1998; Itin and Pittelkow, 1990). This 
contrasts XPCS patients, which are highly cancer prone while having mutations in the 
same gene (Broughton et al., 1995; Lafforet and Dupuy, 1978; Lindenbaum et al., 2001). 
A similar situation is observed for XPCS mice, which are cancer prone (Andressoo et 
al., 2006b). In contrast with TTD mice which are found to be only mildly cancer prone 
when exposed to a high dose of UV-B (de Boer et al., 1999), however they have a lower 
spontaneous tumor incidence than WT mice (Wijnhoven et al., 2005). Explanations 
for the low UV sensitivity could be the thick cornified skin of TTD patients and mice, 
which will protect them for the UV irradiation, however there were also no eye lesions 
registered. Keratinocytes of the mouse TTD skin have a defect in later stage of terminal 
differentiation, and therefore tumor cell transformation could be different (de Boer et 
al., 1998). Another important explanation for the absence of cancer predisposition could 
be that TTD patients die young because of the severe ness of the disease; which does not 
allow time to develop skin tumors (de Boer et al., 1999). XPCS mice seem to be equally 
cancer prone as completely NER deficient XPA mice, despite the residual UDS activity. 
However this residual UDS does not mean that lesions are actually removed (Andressoo 
et al., 2006b; Theron et al., 2005). This is in contrast with previous data, where XPCS mice 
were found to be more cancer prone than XPA mice (Andressoo et al., 2006b). This could 
be due to differences in background of the mice compared in that experiment. Our data fit 
those of de Boer et al. (1999), he also found a higher tumor yield in TTD mice compared to 
WT mice. As with the acute UV sensitivity, CH mice show a tumor incidence comparable 
to TTD animals, only the tumor growth, and therefore tumor yield are different.
Dominance of the TTD allele over the XPCS allele in UV sensitivities of cells. 
Looking at UV sensitivity of mutant MDFs, a same picture is drawn as for the comparison 
of UV sensitivity of the different mutant mice, with TTD cells mildly sensitive to UV 
compared to WT, and the CH MDFs a bit more sensitive, but comparable to TTD, while 
XPA and XPCS are evenly high sensitive to UV. 
Dominance of the TTD allele over the XPCS allele in UV-induced repair characteristics.
As found earlier, unlike in TTD or other NER deficient cells UDS (a GG-NER readout) failed 
to correlate with lesion removal in XPCS cells. This is a property only found in XPCS cells, 
mutated in XPD. While XPCS cells fail to remove UV lesions, they still show an uncoupled 
cut and path mechanisms resulting in high γH2AX foci and ‘phantom’ UDS (Andressoo et al., 
2006b; Theron et al., 2005). Meaning that the level of UDS is high despite the lack of removal 
of UV lesions. The UDS level of CH and TTD relative to WT cells may still suggest lesion 
removal but at a reduced rate. This also counts in a lower degree for the RRS experiment (a 
readout for TC-NER), however no residual activity is found in XPA and XPCS cells. 
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Dominance of the TTD allele in UV-induced stress response.
Down regulation of the IGF-1 axis, including the IGF-1 receptor on the level of mRNA, 
has been proposed as a potential general adaptive stress response mechanism that could 
be activated by a number of stressors including food scarcity or accumulation of DNA 
damage (Niedernhofer et al., 2006; Schumacher et al., 2008; van de Ven et al., 2007; van 
de Ven et al., 2006; van der Pluijm et al., 2007). Previously, the duration of reduction of 
IGF-1R steady state mRNA levels upon UV has been proposed to correlate with the severity 
of progeria in vivo, such that cells from double mutant CSB-XPA and ERCC1 animals with 
the most severe phenotypes had reduced IGF-1R for the longest period of time after UV 
(Garinis et al., 2009). Similarly, we found the greatest magnitude and duration of IGF-
1R mRNA reduction after UV treatment to be associated with the most UV sensitive 
genotypes, XPCS and XPA. However, this correlation between in vivo progeroid/calorie-
restricted like phenotypes and cellular IGF-1R down regulation after UV was lost in TTD 
and CH MDFs. Despite the rescue of in vivo progeriod/calorie-restricted like phenotypes in 
CH vs. TTD mice, the dampening of the IGF-1R mRNA level was similar in both and less 
pronounced and shorter than in XPA or XPCS cells. In other words, in these genotypes 
the mRNA level of IGF-1R nicely correlated with the UV sensitivity of the cells, but not 
with the progeroid phenotype. If our hypothesis that the XPD activity complemented in 
the compound heterozygous state is causally related to the progeroid/calorie restricted-
like symptoms is correct, then defects in transcription-coupled DNA repair activity 
as measured in skin fibroblasts in vitro and skin in vivo are unlikely to be causative of 
progeroid/calorie restricted-like phenotypes.
Conclusion 
Taken together, the severity of progeria and the presence of calorie restricted-like 
symptoms are tightly linked in the different NER mutant mouse models (XPCS=TTD >> 
CH > XPA=WT). The calorie restricted-like phenotypes observed in both XPCS and TTD 
mutant animals (reduced weight, improved insulin sensitivity) were partially reversed in 
XPCS/TTD or so-called CH mice, likely by interallelic complementation. The UV sensitivity 
tests performed on mice and cells in vivo (sunburn, cancer) and in vitro (UDS, RRS and 
γH2AX) did not show a rescue or complementation. Instead, the TTD allele was shown 
dominant over the XPCS allele with respect to these parameters. Therefore, defects in 
transcription-coupled DNA repair activity of bulky lesions in vitro and in vivo are unlikely 
to be causative of progeroid/calorie restricted-like phenotypes. However, interstrand cross-
links are also found to be repaired by TC-NER (Ahn et al., 2004). We therefore hypothesize 
that it could well be defects in interstrand cross-link repair that is causative of progeriod/
calorie restricted-like phenotypes. However, to test this hypothesis, more studies need to 
be conducted.
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Materials and methods
Mice
C57Bl/6J mice (10-16 weeks of age with the start of the experiment) were kept under 
standard laboratory conditions (temperature 20-24oC, relative humidity 50-60%, 12h light/
12h dark) with 3-4 animals per cage before and after the experiment, and allowed free 
access to water and food (Hope Farms, Woerden, The Netherlands) except where noted 
differently. XPA, XPCS, TTD mice are used that have been described earlier (Andressoo 
et al., 2006b; de Boer et al., 1998; de Vries et al., 1995). CH mice are derived from crosses 
between mice that are heterozygous for XPCS and TTD. All animal experiments were 
performed with the approval of the appropriate ethical board. 
Glucose tolerance and insulin sensitivity tests
Mice were fasted overnight prior to testing. Following baseline glucose determination 
from tail blood of restrained mice, animals were injected with a bolus of glucose 18 mmol/
kg body weight (D (+)-glucose monohydrate, Fluka Biochemica, Sigma-Aldrich Chemie 
GmbH, Steinheim), or insulin 0.75 U/kg body weight (Insuline aspart rDNA, NovoRapid, 
Novo Nordisk A/S, Novo Allé, DK-2880 Bagsveard, Denmark) into the peritoneal cavity. 
Blood glucose determinations were performed as above at the indicated times following 
injection using a HemoCue glucose 201 RT blood glucose analyzer (HemoCue, Ängelholm, 
Sweden) according to the manufacturer’s instructions.
MED
Ear skin was exposed to a broadband UVB radiation from a filtered (Schott-WG305 filter) 
Hanovia Kromayer Lamp Model 10S (Slought, UK), because ear skin does not contain fur. 
Ear thickness was measured prior to and 24 hrs after UVB exposure using an engineer’s 
micrometer (Mitutoyo model 193-10, Veenendaal, The Netherlands). The lowest dose 
that was able to induce a significant swelling response (i.e edema reaction) was denoted 
to be the MED for that strain of mice.
UV-induced carcinogenesis
The depilated backs of 15 animals from each genotype were exposed to an incremental 
dose starting with 40 J/m2 a day for XPCS and XPA (plus 5 CH animals) gradually increasing 
to 100 J/m2. For CH, WT and TTD animals we started with 100 J/m2 a day till 650 J/m2 
(250-400 nm). Timer-controlled American Philips F40 sunlamps were positioned 33 cm 
above the cage and yielded a dose rate of 13.3 J/m2/min. Mice were checked for tumor 
appearance once a week. Skin tumors were routinely processed for histopathological 
examination.
Cells
Dermal fibroblasts were prepared from isolated tail skin of euthanized animals. Following 
mincing with a razor, tail skin was incubated overnight in a mixed gas incubator with 5% 
CO2 and 3% O2 in DMEM supplemented with 20% fetal bovine serum and antibiotics and 
40 mg/ml Type II collagenase (Invitrogen, http://www.invitrogen.com) (van de Ven et al., 
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2006). The next day, cells were resuspended, passaged through a 40 µm filter, washed, and 
replated in medium without collagenase.
Cell survival
Early passage MDFs were plated in duplo in six well plates a a density of 20,000 cells 
per well and treated with the appropriate dose of UV or IR the following day. Cells were 
counted 3-4 days after treatment using the Coulter Multisizer Z2 (Beckman Coulter, http://
www.beckmancoulter.com), and plotted as a percentage of the total number of cells from 
the corresponding untreated cell line.
UDS
UV-induced UDS assays were performed on primary MDFs as described previously (de 
Waard et al., 2003; Vermeulen et al., 1994). In brief, coverslip-grown cells were exposed to 
16 J/m2 of 254 nm UV light and labeled with [3H]thymidine. Repair capacity was quantified 
by grain counting after radiography and expressed as percentage of WT. Experiment 
repeated twice; each time at least 30 nuclei were counted.
RRS
UV-induced RRS assays were performed on primary MDFs as described previously (Ma 
et al., 1997). In short, coverslip-grown cells were exposed to 10 J/m2 of 254 nm UV light, 
allowed recover for 16hr, labeled with [3H]uridine, and processed for autoradiography. 
The relative rate of RNA synthesis was expressed as a percentage of WT. Experiment 
repeated twice; each time at least 30 nuclei were counted.
γH2AX
Cells were grown to confluency and checked if the primary MDFs stopped dividing by Ki67 
staining. Cells were treated with 10 joules of UV and after 3 hrs washed twice with cold 
PBS and subsequently fixed and lysed by addition of PBS containing 2% formaldehyde for 
15 min. and 2x 10 min. PBS with 0.1% Triton X-100 (Fluka). Cells were washed twice with 
cold PBS+. Then cells were incubated with the appropriate primary antibodies (diluted 
1:1000 in PBS+) for 2 hr at room temperature, and washed three times and two times 
10 min. with PBS with 0.1% Triton X-100. Incubation with secondary antibodies (diluted 
1:1000 in PBS+) was performed at room temperature for 1 hr, followed by three wash steps 
and 2x 10 min. PBS with 0.1% Triton X-100. Cells were mounted in mounting medium 
containing DAPI-Vectashield (50/50). After staining at least 50 cells for each genotype were 
randomly chosen. Of these, total nuclear intensity of γH2AX signal was measured using 
Adobe Photoshop. 
Quantitative real time PCR
Total RNA was extracted from the primary MDFs cells from a 6 well plate using TRIzol 
reagent (Invitrogen) and hexamerprimed cDNA synthesized using SuperScript II 
(Invitrogen) according to the manufacturer’s instructions. Quantitative real-time PCR 
was performed using a Bio-Rad MyIQ Real time PCR machine with Bio-Rad IQ5 program 
(Bio-Rad, http://www.bio-rad.com) with SYBR Green incorporation (primers: Tubg2 F: 
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CAGACCAACCACTGCTACAT, R: AGGGAATGAAGTTGGCCAGT, mHprt F: CGAAGTGT TGG 
ATACAGGCC, R: GGCAACATCAACAGGACTCC, IGF-1R F:ACGACAACACAACGTGCGT, R: 
AACGAAGCCATCCGAGTCA). Relative expression was calculated using the equation 
(Pfaffl, 2001) ratio = (Etarget)
∆CPtarget (control-sample)/ (Eref) )
∆CPref (control-sample) where E is calculated by 
E = 10 (-1/slope). Each sample was tested in duplo at least two times.
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Abstract
DNA methylation is a covalent postreplicative modification of genomic DNA that 
induces and maintains a transcriptionally silent state of gene expression. It has been 
implicated in development, differentiation and cancer. GADD45a (Growth arrest and 
DNA damage inducible gene) has recently been shown to be a key regulator of active DNA 
demethylation (Barreto et al, 2007). The GADD45a gene is stress inducible and functions 
in numerous biological processes, including the cell cycle, senescence, apoptosis and NER 
(nucleotide excision DNA repair) (Hollander and Fornace, 2002), but its mechanistic role 
in these processes remains unclear. Barreto et al. (2007) found that GADD45a is targeted 
to specific sites of demethylation and recruits the DNA repair machinery through 
core NER components XPG and XPB, thus linking the processes of UV-induced DNA 
demethylation and DNA repair through excision of methylated cytosines. We explored 
the genetics of GADD45a-dependent demethylation using cell lines from a variety of 
NER-deficient mice. We found that all core NER components tested were required for 
GADD45a demethylation activity. Furthermore, GADD45-dependent demethylation was 
absent in CSA- and CSB-deficient cells but not XPC-deficient cells, suggesting initiation 
by the transcription-coupled rather than the global genome branch of the NER pathway. 
We also found that previously identified ‘phantom UDS’ observed upon UV in XPCS cell 
lines is partially dependent on GADD45, and thus likely reflects NER activity at sites of 
DNA methylation rather than removal of DNA damage.
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Introduction
Mammalian cells are continuously exposed to damage by genotoxic agents against which 
they have evolved a variety of defense mechanisms in order to maintain their genomic 
integrity. In dividing cells, key components of this defense mechanism are cell cycle arrest 
checkpoints, which give cells time to repair DNA, and programs of activated cell death in 
cases in which damage is irreparable (Hartwell and Weinert, 1989). In different screens 
looking for genes that were induced by DNA damage, and therefore could have protective 
roles, Growth Arrest and DNA Damage inducible gene GADD45, MyD118 and CR6 (later 
named as GADD45a, GADD45b and GADD45g respectively) were found (Abdollahi et 
al., 1991; Fornace, 1992; Fornace et al., 1992; Zhang et al., 1999). All GADD45 proteins 
encode for a small 18 kDa acidic nuclear protein with a 55-57% amino acid overlap with 
each other. GADD45a can be induced by DNA damaging agents including UV, ionizing 
radiation (IR) and MMS, or by growth arresting treatments such as serum depletion from 
the medium (Fornace et al., 1992; Papathanasiou and Fornace, 1991).
The elucidation of the molecular function (or functions) of GADD45a has been a 
longstanding puzzle. Based on its structure, very little is revealed about its function. 
Still, a number of potential roles have been proposed. One is in cell cycle control 
and apoptosis via its interaction with MEKK4, an upstream activator of the p38/JNK 
kinases. Binding to the N-terminal domain of MEKK4 by GADD45a stimulates MEKK4 
and mediates activation of the p38/JNK pathway (Hildesheim et al., 2002; Takekawa 
and Saito, 1998; Wang et al., 1999). Another is in DNA repair through interactions with 
proliferating cell nuclear antigen (PCNA) (Jung et al., 2007; Smith et al., 2000) in both 
NER and BER as described below.  
Nucleotide excision repair (NER) is a versatile DNA repair mechanism in which 
damage recognition, local opening of the DNA helix around the lesion, damage excision 
and gap-filling are successive steps (Aboussekhra et al., 1995; de Laat et al., 1999). NER is 
composed of two sub pathways that differ in the way lesions are recognized. The first NER 
pathway, which is named transcription coupled repair (TC-NER), starts with the proteins 
CSB and CSA assisting the polymerase II (RNApolII) in dealing with bulky lesions that 
provide a steric block to transcription. The precise role of CSA and CSB in this pathway 
remains elusive, however CSB could act as a chromatin-remodeling factor allowing the 
other NER factors to access the lesion for repair so transcription can proceed (Citterio et 
al., 2000; Sarasin and Stary, 2007). Both CSA and CSB bind to the hypophosphorylated 
RNApolII that is recruited to the transcription initiation complex (Groisman et al., 2003; 
Rockx et al., 2000). Lesions located anywhere in the genome are removed by the second 
NER pathway, known as global genome repair (GG-NER) in which the XPC complex 
carries out the first step by recognizing mutations throughout the genome. The rest 
of the NER proteins are indispensable for both GG-NER and TC-NER like XPA. Its role 
is currently described as damage verification, and is thought to be vital for correct 
alignment of NER proteins like the nucleases ERCC1 and XPG (Hoeijmakers, 2001a). 
Different mutations in various components of the NER pathway give rise to distinct 
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clinical syndromes, including xeroderma pigmentosum (XP), Cockayne syndrome (CS), 
or XP combined with Cockayne syndrome (XPCS), a segmental premature aging or 
progeroid disease with a high skin cancer risk, and trichothiodystrophy (TTD), another 
progeroid disorder with additional scaling skin and fragile hair.
GADD45a is not an enzymatic component of the NER pathway and is not required in 
vitro for the reaction to occur. However, GADD45a deficient cells display an enhanced 
UV sensitivity (Smith et al., 2000) and a reduction in UDS (unscheduled DNA synthesis) 
following UV irradiation, indicative of a deficiency in GG-NER. One way in which 
GADD45a may function in DNA repair is via its interaction with PCNA, a protein involved 
in loading and stimulation of DNA polymerase. In this way GADD45a may participates 
both in NER as well as long patch base excision repair (BER) (Smith et al., 2000; Xia et al., 
2005). Via PCNA it also may participate in the coupling between chromatin assembly and 
DNA repair (Smith et al., 2000). On the other hand, GADD45a is also found binding to 
UV-damaged chromatin and improving accessibility of DNA repair proteins to the sites of 
damage (Carrier et al., 1999; Smith et al., 2000). 
Recently a novel role of GADD45 in DNA demethylation was reported. Substrates 
of GADD45-dependent demethylation include in vitro methylated reporter plasmids, 
promoter-specific CpG islands and global DNA following UV irradiation (Barreto et al 2007). 
Furthermore, GADD45a interacts genetically and biochemically with components of the 
NER pathway. Thus although GADD45a itself has no homology to known demethylases, 
its mechanism of action is proposed to be through recruitment of the NER machinery 
via repair proteins including XPG and XPB. The methylated cytosines are then excised 
via the NER cut and patch mechanism and replaced with unmethylated nucleotides. A 
subsequent study was unable to find any role of GADD45a in DNA demethylation (Jin et 
al., 2008).  
We therefore wanted to test if the NER proteins are in fact required for DNA demethy-
lation in a GADD45-dependent reaction, and if so, what those genetic requirements 
were and which NER recognition pathway functioned in the demethylation reaction. 
Our data confirmed a role for essential NER components Xpa and Ercc1 in a GADD45a-
dependent demethylation reaction and implicated essential TC-NER components Csa 
and Csb as required. Furthermore, our data expand the genetic requirements to Xpd, 
and show that Xpd mutations with different disease susceptibilities behave differently 
with respect to GADD45-dependent DNA demethylation. 
Results
To test which components of the NER machinery are required for GADD45-dependent 
demethylation as reported previously, we made use of cells derived from transgenic 
mice with deletions of individual components of the NER pathway. Homozygous mutant 
cell lines (Xpa -/-, Ercc1-/-, Xpc -/-, Csa -/- and Csb -/-) will for simplicity hereafter be referred to as 
XPA, ERCC1, XPC, CSA and CSB. All experiments were done in spontaneously transformed 
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MEF cell lines, unless noted otherwise. We first looked at the ability of NER-defcient vs. 
control cell lines to reactivate an in vitro methylated luciferase reporter plasmid. To this 
end we co-transfected NER deficient and control cell lines with an in vitro-methylated 
plasmid containing a firefly luciferase gene under the control of a viral promoter. A 
plasmid encoding renilla luciferase under control of the constitutive thymidine kinase 
promoter was included as a transfection control. GADD45-dependence was tested 
by transfecting each well either with the murine GADD45a cDNA under control of a 
constitutive promoter or with the corresponding empty expression vector. Two days after 
transfection, cells were harvested and the relative light units (RLU) measured (Figure 
1). The RLU is depicted as a ratio between the outcome with vs. without the GADD45a 
plasmid following normalization to the renilla activity. In WT cells we observed a 2.2 
fold increase in firefly luciferase upon co-transfection with GADD45 relative to control 
plasmid, indicative of promoter demethylation and resulting transcriptional activation. 
In cells deficient in the core NER components XPA and ERCC1 cells, we observed a ratio of 
RLU around one, indicating that these essential NER genes are also required for GADD45a 
dependent demethylation (t-test WT with XPA p = 0.033, ERCC1 p = 0.016). 
We next asked if demethylation by GADD45a in this assay is dependent on either 
of the known NER subpathways, TC-NER or GG-NER, which differ only in the way a 
lesion is recognized. In XPC cells, which are deficient in GG-NER, the ratio of RLU was 
similar to WT. However, TC-NER deficient CSA and CSB cells behaved like the other NER 
deficient cell lines (t-test WT with CSB p = 0.005, CSA p = 0.016 and XPC p = 0.806; t-test 
XPC with XPA p = 0.026, ERCC1 p = 0.009, CSB p = 0.011, CSA p = 0.006). These data 
confirm the requirement for core NER components in GADD45a dependent methylated 
plasmid reactivation assay, and further suggest that the initiating event requires TC-NER 
but not GG-NER. As a control, we also examined the ability of GADD45a to activate the 
unmethylated plasmid (Figure 1B). Although the magnitude of initial expression from 
the unmethlated plasmid was higher than the in vitro methylated one, it still responded 
to exogenous GADD45a, likely because unmethylated DNA plasmids become methylated 
following transient transfection (Escher et al., 2005). Using XPA and CSB cells, we saw 
similar trends in the unmethlylated as the methylated plasmid.
We next looked at two different mutants of XPD, a core helicase component of the 
TFIIH complex required for both GG and TC-NER. XPD is an interesting gene because 
mutations in XPD can give rise to different diseases. Here we used cells of mice with a 
R722W mutation that gives rise in mice and humans to TTD a segmental progeria with 
scaling skin and fragile hair (de Boer et al., 1999). And a G602D mutation, that gives rise 
in humans, as well as in mice, to the disease XPCS, that is the XP combined with CS, an 
accelerated segmental progeroid disease with a high risk of early onset of skin cancer 
(Andressoo et al., 2006). While these cell lines are both mutated in the same gene and 
the syndromes have overlapping symptoms, the cell lines give very different results (t-
test between WT and XPCS cells p = 0.668, TTD p = 0.011) (Figure 1C). TTD cells showed 
similar response as XPA cells, indicating that wildtype XPD is required for GADD45a-
dependent and NER-dependent DNA demethylation as predicted from the XPA and 
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Figure 1,   Demethylation by GADD45a involves DNA repair.
A. XPA, ERCC1, CSA and CSB but not XPC are required for GADD45a function in the plasmid reactivation assay. There 
was no difference between the ratio of relative light units (RLU) in the Luciferase reporter assay in spontaneously 
transformed cell lines (n = 2 per genotype), except for XPC, that were transiently transfected with methylated CMV 
promoter in combination with an empty plasmid or plasmid with GADD45a. Error bars indicate standard error of 
the mean (SEM) (* p < 0.05). 
B. Transfection with an unmethylated CMV promoter in combination with an empty plasmid or plasmid with 
GADD45a gave the same result as transfection with a methylated CMV promoter. Error bars indicate SEM (* p < 
0.05). 
C. Different XPD mutants have different requirements for GADD45a function in the plasmid reactivation assay. No 
difference was observed in RLU in TTD cell lines, but a clear difference in XPCS cell lines (n = 2 per genotype). Error 
bars indicate SEM (* p < 0.05).
A
B
C
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ERCC1 results. This is consistent with reduced NER activity in these cells. However, 
XPCS cells with a different point mutation in Xpd gave the same result as XPC and WT 
cells, inconsistent with the complete lack of NER in these cells. 
XPCS cells have the unusual property of high DNA repair synthesis following UV, but 
without actually repairing the lesions (Andressoo et al., 2006; Berneburg et al., 2000). 
While in cells completely lacking NER, such as XPA, UV-UDS is reduced to background 
levels, human XPD-XPCS cells were found to retain a significant percent of their UDS 
despite their inability to actually remove any of the lesions. A similar phenomenon was 
observed in cells from the XPCS mouse model dubbed ‘phantom’ UDS. Whether or not 
these breaks occur at sites of DNA damage, transcription initiation or both remains 
controversial (Andressoo et al., 2006; Berneburg et al., 2000). In order to gain further 
insight into the nature of these breaks, we tested their dependence on GADD45a. 
To do this, we pursued a knockdown strategy to reduce GADD45a levels in WT and 
mutant cells and subsequently monitor the GADD45a activity. First, we determined 
the efficiency of anti-GADD45a siRNA in our various cell lines using the GADD45a-
dependent methylated plasmid reactivation assay (Figure 2A). The RLU was significantly 
decreased to one (WT siRNA Control vs. GADD45a siRNA p = 0.015, XPCS siRNA Control 
vs. siRNA GADD45a p = 0.030). Then we checked the lowering of GADD45a expression 
after transfection with siRNA against GADD45a in primary MEF cell lines via RT-PCR 
(Figure 2B). In all cell lines (WT, XPA, XPCS, TTD) endogenous GADD45a expression went 
down significantly compared to the cell lines transfected with control siRNA (p = 0.032, 
0.005, 0.015, 1,37 x 10 -5, respectively), while levels of GADD45a RNA in untransfected 
cells were not significantly different among the different cell lines.
Next we performed UV-UDS assays on these cells following anti-GADD45a siRNA 
treatment to reveal if the unexpected GADD45a-dependent demethylation is linked to 
‘phantom’ UDS found in XPCS cells (Andressoo et al., 2006; Theron et al., 2005). Primary 
MEF cell lines were co-transfected with GADD45a siRNA or control siRNA together with 
a green fluorescent indicator (siGLO). Two days later, cells where FACS sorted for the 
presence of siGLO and plated on cover slips for UV-UDS (Figure 2C). UDS counts measured 
in WT cells transfected with the control siRNA were set as 100% (Andressoo et al., 2006; 
de Boer et al., 2002). Note the rather high UDS in both XPCS and TTD. This relative 
high level of UDS in TTD is linked to partial damage removal (de Boer et al., 2002). 
However, in XPCS residual UDS is uncoupled to actual UV-lesion removal (Berneburg et 
al., 2000). This so called ‘phantom’ UDS decreases significantly in XPCS cells transfected 
with GADD45a siRNA  (p = 3.95x10-10), whereas GADD45a reduction in WT and TTD cells 
does not show a decrease in UDS. Thus a significant fraction of the breaks seen after UV 
damage in XPCS cells (Theron et al., 2005) are dependent on GADD45a and likely related 
to DNA demethylation unrelated to the repair of UV lesions. 
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Figure 2.  GADD45a down regulation by siRNA and measurements of repair.
A. Reduction of RLU after transfection with siRNA against GADD45a. The ratio of RLU with vs. without GADD45a is 
back to one if the cells that are transfected with a methylated CMV-luciferase plasmid are co-transfected with siRNA 
against GADD45a. Error bars indicate SEM (* p < 0.05). 
B. Lower expression of endogenous GADD45a after transfection with siRNA against GADD45a. Expression of 
GADD45a RNA is significantly lower ( p < 0.05) in the different spontaneously transformed cell lines (WT, XPA, XPCS 
and TTD) after transfection with siRNA against GADD45a compared to the cells transfected with the control siRNA. 
The amount of endogenous GADD45a RNA expression was not significantly different between the untranfected cell 
lines (data not shown). Error bars indicate standard deviation (SD). 
C. UV-induced DNA repair synthesis capacity in mutant cell lines is considered a measure for GG-NER. UDS is shown 
in spontaneously transformed MEFs of the different genotypes transfected with Control siRNA or siRNA against 
GADD45a. UDS was significantly lower in all the mutant cell lines compared to the WT cell line. Transfection with 
GADD45a siRNA lowered the UDS in the XPCS cell line compared to the one transfected with Control siRNA as well 
as the WT, although the later did not reach the level of statistical significant (p = 0.1753). Error bars indicate SEM 
(** p < 0.01). 
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Discussion
GADD45a has long been associated with DNA repair via multiple pathways, including 
NER, but its exact biochemical role in repair has remained a mystery. Early research 
indicated that GADD45a has functions in DNA repair via BER  (Xia et al., 2005), and NER 
(Smith et al., 1994; Vairapandi et al., 1996). Further research on this subject showed that 
GADD45a functions in GG-NER, one of the two sub pathways of NER (Amundson et al., 
2002; Smith et al., 2000), because reduction of GADD45a protein expression has been 
found to reduce GG-NER, as measured by the significantly lower GG-NER in GADD45a-
null cells have (UDS ~70% of WT). Interestingly, TC-NER as measured by a strand-specific 
repair assay, was equivalent to WT levels (Smith et al., 1994; Smith et al., 2000). GADD45a 
can also recognize damaged chromatin and could potentially modify DNA accessibility 
after UV (Carrier et al., 1999). It has also an association with chromatin assembly after 
NER via PCNA (Aboussekhra and Wood, 1995; Vairapandi et al., 1996). 
More recently, GADD45a and NER have been connected by the process of DNA 
demethylation. Barreto et al. (2007) found that two proteins that work in NER, XPB 
and XPG are necessary for GADD45a dependent demethylation of DNA, including at 
promoters during development and likely in response to stress. This result was contested 
in a study of Jin et al (2008). Using the same HEK293 cell line, they found no effect of 
exogenous GADD45a on the expression of a methylated plasmid based reporter gene 
expression. 
In this report we confirmed the data of Barreto et al. (2007) by showing that transfection 
of a mouse GADD45a construct has an effect on expression of a reporter gene under 
control of the CmV promoter in an in vitro methylated plasmid in WT cells. We further 
confirmed a role for NER in this GADD45a dependent activity in cells that are defective 
in NER proteins other than XPB and XPG. In our hands also XPA, CSB, CSA as ERCC1 
are necessary for demethylation that is GADD45a dependent, while XPC is not. This 
suggests that demethylation relevant in the methylated plasmid reporter assay goes via 
the TC-NER pathway, one of two pathways in which to initiate the NER reaction. Both 
pathways are essentially the same except for the initial damage recognition step. 
Former studies already suggested a model whereby demethylation of CpG rich DNA 
sequences resembled NER activity such that methylated cytosines are excised and 
replaced by unmethylated cytosines, the same way damaged nucleotides would be 
substituted (Barreto et al., 2007). Our data supports this model and shows that DNA 
promoter demethylation needs TC-NER proteins CSA and CSB, and late NER proteins 
like ERCC1, but not the GG-NER-specific protein XPC (Model Figure 3A).  
In the second experiment we clearly established that the majority of the NER factors 
participate in GADD45a dependent demethylation, surprisingly however, different 
mutations in the Xpd gene have an entirely differential effect on promoter demethylation 
that is GADD45a dependent. The TTD causing mutation in Xpd gave a similar absence 
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Figure 3.   Model
A. Methylated cytosines block transcription by allowing binding of transcriptional repressors, therefore RNA 
polymerase II can not bind to the DNA. GADD45a recruits CSA and CSB and the rest of the NER complex and excises 
the methylated cytosine and replace it with unmethylated ones. 
B. In XPCS cells GADD45a demethylation works as in WT cells, however removal of lesions doesn’t work.
A
B
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of demethylation as in other NER mutants tested (except for XPC cells). Contrary to 
our expectations the XPCS causing mutation showed normal GADD45a dependent 
demethylation. We did not expected this outcome, firstly because XPD is necessary 
for GADD45a dependent demethylation based on the results in the TTD cell lines, and 
secondly because the other helicase that unwinds the DNA on the other site of the damage 
in NER, XPB (Evans et al., 1997) is also necessary in the active demethylation by GADD45a 
(Barreto et al., 2007). Hence, contrary to our expectations, XPCS cell lines give high levels 
of RLU, meaning that there is GADD45a dependent demethylation in these cell lines.
Earlier work in our lab and other labs on XPCS cells show that these cells behave 
differently as expected in other experiments too, like in the experiments that measure 
repair characteristics of cell lines. XPCS cell lines show 30-40% UDS level compared to 
WT levels after UV. However there is no evidence for repair, since lesions remained for 
up to 8 hr following UV treatment (Andressoo et al., 2006; Theron et al., 2005). Thus 
unlike WT cells, the relative high level of repair synthesis (UDS) observed in XPCS cells 
does not represent actual lesion removal. Theron et al (2005) even found that these 
‘repair breaks’ are distributed throughout the nucleus after local damage, and that the 
number of ‘breaks’ is substantially diminished after treating the cells with transcription 
inhibitors following UV treatment. They therefore state a model whereby there is 
induction of breaks by NER close to the sites of transcription initiation in XPCS cell lines. 
In contrast, we found (Andressoo et al., 2006) that UV-induced ‘breaks’ were confined to 
locally UV-induced areas, not expanding to the rest of the nucleus. These findings made 
us to propose a model in which the NER induced incision is targeted to the wrong (non-
damaged) strand, thereby inducing DNA repair synthesis (UDS) without actual damage 
removal. To investigate if the high level of GADD45a dependent demethylation, that 
presumably occurs via NER dependent cutting and pasting of nucleotides, could have a 
correlation with the relative high level of UDS in XPCS cell lines, we first checked γH2AX 
levels in the different NER deficient MEFs following UV. These levels are indicative of 
DNA breaks by DNA repair, and were identical to those found previously in MEF cell 
lines as demonstrated before (Andressoo et al., 2006) (data not shown). Functioning of 
the siRNA was examined (Figure 2A and B), whereupon the UDS with siRNA against 
GADD45a could be performed. Surprisingly, the amount of UDS reduces significantly in 
a XPCS cell line after transfection with GADD45a siRNA. There is still residual UDS ~30% 
of WT, so the reduction of UDS is only partly. Hence, some of the UDS observed upon 
UV is not repair of lesions, but likely GADD45-dependent removal of methylated CpGs. 
This is likely a very small fraction of the observable UDS in WT cells, and therefore 
also a small, but significant fraction of the so called ‘phantom UDS’ in XPCS cells ~18%. 
The rest of the ‘phantom’ UDS can still be cutting on the opposite strand across from a 
lesion, because no repair occurs (Model Figure 3B) 
In eukaryotes, methylation of DNA is mostly on the cytosines of CpG dinucleotides and 
it induces and maintains a transcriptional silent state of genes. DNA promoter methylation 
can directly interfere with transcriptional factors that require contact with cytosine in 
the major groove of the double helix of promoter DNA (Bird and Wolffe, 1999). However 
H7.indd   161 20-04-2009   13:31:09
chapter 7
162
chapter 7
hypermethylation downstream of promoter regions, in the gene itself, does not block 
transcription elongation (Gonzalgo and Jones, 1997; Jones, 1999). How DNA methylation 
occurs is known, but how the demethylation of DNA occurs is a matter of debate. One 
potential mechanism involves RNA and a possible ribozyme-mediated DNA demethylation 
(Bhattacharya et al., 1999; Weiss et al., 1996), although this was later contested (Swisher et 
al., 1998). Later Bhattacharya et al. (1999) found a human protein with DNA demethylase 
activity MBD2b, although other labs failed to confirm the demethylase activity of this 
protein (Ng et al., 1999; Wade et al., 1999). Two demethylases, hABH2 and hABH3, are 
found that repair cytotoxic 1-methyladenie and 1-methylcytosine in DNA and single 
stranded RNA by methyl group hydroxylation, followed by a retro-aldol reaction (Aas et 
al., 2003; Duncan et al., 2002). However, a global demethylase that promotes epigenetic 
gene activation was never found. Therefore it is interesting that Barreto et al. (2007) 
found that GADD45a is expressed in Xenopus oocytes and required for site specific oct4 
demethylation in these cells. Furthermore, GADD45a over expression induces global DNA 
hypomethylation in HEK293 and 3T3 cells. 
In the future it will be essential to determine if NER is also required for global DNA 
demethylation observed upon acute stress such as UV. Finally, a role for DNA methylation 
status in the etiology of the various NER disorders must now be considered. 
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Materials and methods
Cells
Mouse embryonic fibroblasts (MEFs) were cultured in a 50:50 mix of DMEM:Ham’s F10 
supplemented with 10% fetal bovine serum and antibiotics (pen/strep) in a mixed gas 
incubator with 5% CO2 and 3% O2 at 37
0C on TC petridishes (Greiner Bio-One). Cells were 
trypsinized before they reached 80% confluence. 
Transfection
Transient DNA transfections were carried out using FuGENE6 transfection reagent (Roche) 
following the manufacturers instructions. MEFs were transfected with ON-TARGETplus 
SMARTpool siRNA against mouse GADD45a (L-042505-00 Dharmacon) or Non-Targeting 
Control siRNA #5 (D-001210-05-20 Dharmacon, together with siGLO, green transfection 
indicator (D-001630-01-05 Dharmacon) using DharmaFECT 1 Transfection reagent (T-
2001-02 Dharmacon) following the manufacturers instruction. For luciferase reporter 
assay, DNAs (with or without siRNAs) were transfected 12h after plating the cells.
Luciferase reporter assay
Dual-luciferase reporter assays (E1960 Promega) were performed on spontianiously 
immortalized MEFs 48 hr following transient transfection of MEFs carried out in 96-well 
plates with ≈ 10.000 cells per well, containing 40 ng GADD45a cDNA clone in pCMV-
SPORT6 vector ( IRAVp968FO326D, RZPD) or empty pCMV-SPORT6 vector, 20 ng Tk-firefly 
luciferace control plasmid and 20 ng Renilla luciferase reporter plasmid (Andressoo et 
al., 2006) with in vitro methylated CmV promoter, using the CpG DNA methylase (M.Ssi 
methylase), in Optimem. Each sample was performed in two cell lines for the different 
genotypes at least in triplicate. Each experiment was repeated at least three times.
UDS
UV-induced UDS assays were performed on primary MEFs as described previously (de 
Waard et al., 2003; Vermeulen et al., 1994). Cells were transfected with siGLO and 
GADD45a siRNA 24hr later the cells were FACS sorted for green fluorescence and plated 
back in a 6 wells plate (Greiner Bio-One) with coverslips. UDS was performed 12hr later 
and repeated twice; each time at least 30 nuclei were counted.
γH2AX
Plates were grown completely full and checked if the primary MEFs stopped dividing 
by Ki67 staining. If cells stopped they were treated with 10 joules of UV and after 3 
hrs washed twice with cold PBS and subsequently fixed and lysed by addition of PBS 
containing 2% formaldehyde for 15 min. and 2x 10 min. PBS with 0.1% Triton X-100 
(Fluka). Cells were washed twice with cold PBS+ Then cells are incubated with the 
appropriate primary antibodies (diluted 1:1000 in PBS+) for 2 hr at room temperature, 
and washed three times and two times 10 min. with PBS with 0.1% Triton X-100. 
Incubation with secondary antibodies (diluted 1:1000 in PBS+) was performed at room 
temperature for 1 hr followed by three wash steps and 2x 10 min. PBS with 0.1% Triton 
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X-100. Cells were mounted in mounting medium containing DAPI-Vectashield (50/50). 
After staining at least 50 cells for each genotype were randomly chosen. Of these, total 
nuclear intensity of γH2AX signal was measured using Adobe Photoshop. 
Quantitative real-time PCR
Total RNA was extracted from the primary MEFs cells from a 6 well plate using TRIzol 
reagent (Invitrogen) and hexamerprimed cDNA synthesized using SuperScript II 
(Invitrogen) according to the manufacturer’s instructions. Quantitative real-time PCR 
was performed using a Bio-Rad MyIQ Real time PCR machine with Bio-Rad IQ5 program 
(Bio-Rad, http://www.bio-rad.com) with SYBR Green incorporation. (primers GADD45a 
2F: TGGAGGAAGTGCTCAGCAAG, 3R: GGTGAAATGGATCTGCAGAG, GADD45a F: 
CGAGAACGACATCAACATCC, R: ACTTAAGGCAGGATCCTTCC, Tubg2 F: CAGACCAACC 
ACTGCTACAT, R: AGGGAATGAAGTTGGCCAGT, mHprt F:CGAAGTGTTGGATACAGGCC, 
R: GGCAACATCAACAGGACTCC). Relative expression was calculated using the equation 
(Pfaffl, 2001) ratio = (Etarget)
∆CPtarget (control-sample)/ (Eref) )
∆CPref (control-sample) where E is calculated by 
E = 10 (-1/slope). Each sample was tested in duplo at least two times.
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DNA, het erfelijke materiaal, oftewel de blauwdruk van het leven genoemd, wordt continu 
bedreigd door invloeden van buitenaf die schade (mutaties) geven aan het DNA. Deze 
schade kan leiden tot kanker of veroudering, maar gelukkig beschikken de cellen waaruit 
een lichaam is opgebouwd over een uitgebreid pakket aan maatregelen om het genetisch 
materiaal intact te houden. Over één van deze onmisbare maatregelen waarmee de cel 
haar DNA beschermt gaat dit proefschrift. 
Elk levend wezen is opgebouwd uit cellen. Er zijn organismen die uit één of een paar 
cellen zijn opgebouwd, maar ook organismen die uit vele honderden miljarden cellen zijn 
opgebouwd, zoals de mens. De mens heeft ongeveer 200 verschillende soorten celtypes 
(bijvoorbeeld huid-, lever-, bloed-, niercellen). Een groep van verschillende soorten cellen 
bij elkaar vormt een orgaan dat een bepaalde functie in het lichaam vervult. Elke cel heeft 
een apart compartiment, de kern genaamd, waarin de informatie ligt die nodig is voor het 
functioneren van een cel. Deze informatie ligt opgeslagen in codevorm in het DNA. De celkern 
ligt vol met DNA. Organismen kunnen een verschillend aantal DNA-moleculen per celkern 
hebben. Die afzonderlijke DNA-moleculen opgerold om eiwitten worden chromosomen 
genoemd. Een DNA-streng lijkt op een wenteltrap en bestaat uit twee in elkaar gedraaide, 
antiparallelle polymeren waarvan de ruggengraat gevormd wordt door een keten van 
afwisselend suiker en fosfaat groepen. De verbinding tussen de twee spiraalvormige ketens 
wordt gevormd door vier verschillende basen van het DNA: A (adenine), C (cytosine), G 
(guanine) en T (thymine). C hecht altijd aan G in de tegenoverliggende keten en A hecht aan 
T in de tegenoverliggende keten. Zo vinden we op het DNA een lange reeks basenparen G-C, 
A-T, C-G en T-A, in een wisselende volgorde die uniek is voor ieder individu. Tijdens replicatie 
(verdubbeling van het DNA voor celdeling) ontwindt de dubbele DNA spiraal en hecht zich 
aan de oude DNA streng een complementaire nucleotide (met behulp van DNA polymerase). 
Bij elke stap wordt hieraan een nieuwe complementaire nucleotide vastgemaakt, tot de hele 
streng is afgelezen. Dit gebeurt in beide strengen, zodat er een exacte verdubbeling van het 
DNA plaatsvindt en de cel zich kan gaan delen. De code in het DNA, geschreven in een 
vier-letterig alfabet, biedt de mogelijkheid om de erfelijke eigenschappen van een individu 
vast te leggen.  Dit wordt gedaan in de kleinere stukjes van een chromosoom, de genen. 
De genen bepalen telkens één van de erfelijke eigenschappen van een individu. Een mens 
heeft ongeveer 20.000 tot 25.000 verschillende genen, gelegen in totaal op 3 miljard basen 
(2 meter DNA). Elk gen codeert voor één bepaald eiwit. Sommige eiwitten zijn essentieel 
als structureel element van een cel, terwijl andere betrokken zijn bij biologische processen 
in de cel. Elke cel in een organisme bevat hetzelfde DNA, maar door het wel of niet actief 
zijn van verschillende genen kunnen cellen verschillende functies hebben. Actieve genen 
zijn genen die vertaald worden van gen naar eiwit. Dit gebeurt in twee stappen. Eerst 
wordt in de kern de DNAcode van het gen afgeschreven oftewel gekopieerd (dit proces 
heet transcriptie), waarna de kopie in de vorm van een boodschapper (m)RNA molecuul 
buiten de kern wordt vertaald naar een eiwit (dit heet translatie). Zo schrijft elk celtype 
verschillende soorten genen af, waardoor de verschillende bouwstenen of processen de cel 
zijn specifieke eigenschappen geeft.
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Het DNA in elke cel wordt continu beschadigd, naar schatting wel zo’n 10.000 keer 
per dag. Hierbij moet men niet alleen denken aan toxische stoffen en stralingsbronnen 
uit het milieu (bijvoorbeeld zonlicht, kosmische straling, uitlaatgassen, sigarettenrook 
of andere chemische middelen), maar ook door stoffen die vrij komen bij chemische 
processen van het eigen lichaam (zoals vrije zuurstofradicalen, ook wel ROS genoemd). 
Deze beschadigingen kunnen leiden tot het verhinderen van het afschrijf (kopieer) proces, 
het stoppen van de celdeling en zelfs celdood, waardoor de weefsel samenstelling wordt 
verstoord met als consequentie veroudering. Ook kunnen beschadigingen in het DNA 
leiden tot veranderingen in de DNA code (mutaties), waardoor cellen ongecontroleerd 
kunnen gaan delen en uiteindelijk kanker kunnen veroorzaken. Als de verkeerde code 
wordt doorgegeven aan het nageslacht via de geslachtscellen spreekt men van een 
erfelijke ziekte. Het is duidelijk dat het opruimen van DNA schades van levensbelang is. 
Om het DNA in de cel intact te houden is de cel uitgerust met een aantal reparatie 
mechanismen. De verschillende mechanismen kunnen een bepaalde klasse van 
DNA beschadiging verwijderen. Gelukkig is er wel overlap tussen de verschillende 
reparatiesystemen en mocht de reparatie toch falen dan kunnen beschadigde cellen 
zichzelf opofferen en afsterven (apoptosis), hiermee wordt voorkomen dat de fout wordt 
doorgegeven of een tumor ontstaat. Één van die herstel mechanismen is Nucleotide 
Excisie Reparatie ook wel afgekort als NER. Dit mechanisme herstelt schades veroorzaakt 
door zonlicht en door stoffen uit uitlaatgassen en sigarettenrook. Voor de opsporing van 
de schades aan DNA gebruikt NER twee subroutes. Het Globaal Genoom NER (GG-NER), 
dit speurt het hele genoom (al het DNA in een cel) af op zoek naar beschadigingen, of het 
Transcriptie-gekoppeld NER (TC-NER) dat de schade herkent door het vastlopen van het 
transcriptieproces. Een team van meer dan 25 eiwitten helpt in beide gevallen met de 
herkenning en het wegknippen van de schade uit het DNA waarna de genetische code 
kan worden hersteld aan de hand van de intacte, andere DNA streng. Het hele proces 
van schadeherstel wordt extra gecompliceerd, als je bedenkt dat de instructie voor het 
opbouwen van de DNA-schadehersteleiwitten ook gegeven wordt door genen in het 
DNA. Iedereen kan zich voorstellen dat als de genen beschadigd worden die coderen 
voor één van die hersteleiwitten, de gevolgen dramatisch zijn en leiden tot een eruptie 
van ziekteverschijnselen. Het XPD eiwit is één van de componenten van het NER en dit 
proefschrift gaat over de gevolgen van verschillende mutaties en combinaties daarvan in 
het XPD eiwit.
In dit proefschrift hebben we naar verschillende mutaties in het XPD eiwit gekeken. 
Één van die mutaties is de G602D mutatie die zorgt voor xeroderma pigmentosum (XP), 
een ziekte met een sterk verhoogde kans op huidkanker gecombineerd met de versnelde 
veroudering van Cockayne syndroom (CS, samen XPCS). Daarnaast hebben we ook gekeken 
naar de mutatie R722W die lijdt tot trichothiodystrophy (TTD), een ziekte die veel lijkt 
op de versnelde veroudering van CS al hebben patiënten ook nog een schilferende huid 
en breekbare haren en nagels. Om deze ziektes goed te bestuderen zijn er muismodellen 
gegenereerd met dezelfde mutaties in hun DNA. De mutaties in de muis leidden tot 
vergelijkbare symptomen als in de patiënten. 
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Van elk gen in je lichaam krijg je een kopie van je vader en een kopie van je moeder. 
Deze twee kopieën van hetzelfde gen heten allelen. Als een allel niet bijdraagt aan het 
fenotype (de waarneembare eigenschap) wordt het recessief genoemd en als een allel 
als enige het fenotype bepaalt wordt het dominant genoemd. De meeste erfelijke 
aandoeningen zijn recessief, hetgeen betekent dat zowel het allel van je vader als dat 
van je moeder, gemuteerd moeten zijn. Wij hebben onderzoek gedaan naar muizen met 
op elk XPD allel een verschillende mutatie: Één allel had een TTD mutatie en de ander 
een XPCS mutatie. Deze muis noemen we een compound heterozygoot (oftewel CH). De 
CH muis, met gelijktijdige inactivatie van XPA, een ander belangrijk NER eiwit (ook wel 
CH|XPA genoemd), leeft een half jaar in vergelijking tot de 3 weken levende XPCS|XPA 
en TTD|XPA muizen. Bekend is dat veel van de NER deficiënte muimodellen een verlaagt 
groeihormoon (GH) en insuline gelijkende groeifactor-1 (IGF-1) niveau hebben die lijkt op 
het niveau van hele oude muizen. Dat is waarom wij in de levercellen van de XPCS|XPA en 
CH|XPA muis hebben gekeken naar verschillende boodschapper RNA (mRNA) niveaus van 
GH en IGF-1. We vonden daar een verlaging van de GH/IGF-1 as en een verhoging van de 
anti-oxidant reactie. Dit genexpressie patroon vind je ook terug in lang levende muizen of 
muizen die beperkt zijn in hun calorie inname en wordt adaptieve stress reactie genoemd. 
Deze stress reactie wordt waarschijnlijk aangespoord door ongerepareerde endogene 
(lichaamseigen) DNA schade en door de dieren gebruikt om reactieve metabolieten, zoals 
ROS en de extra DNA schade die daardoor ontstaat, te verlagen (Hoofdstukken 2 en 3). 
Ook in XPCS en TTD muizen zonder XPA inactivatie vinden we parameters die wijzen 
op calorie inname beperking, zoals lager lichaamsgewicht, hogere glucose tolerantie en 
hogere gevoeligheid voor insuline. In de CH dieren lijken deze parameters op die van 
‘normale’ (wildtype) muizen ten opzichte van de XPCS en TTD muizen. Dit duidt erop, dat 
ook hier de beide recessieve allelen elkaar complementeren en dus samen bereiken wat 
ze alleen niet kunnen. Deze complementatie vinden we niet terug in UV-gevoeligheid-, 
carcinogenese- en overlevingstudies in muizen en cellen. Dit leidde tot de conclusie dat 
beschadigingen in het DNA die ontstaan door UV straling of andere oorzaken niet de enige 
oorzaak kunnen zijn van het versneld verouderen van de muizen met een beschadigd 
NER (Hoofdstuk 6). 
Een andere vorm van schade die bijdraagt aan het versneld verouderen ontstaat door 
vrije zuurstof radicalen in het lichaam. Deze ontstaan als je lichaam het voedsel wat 
je eet omzet. Een snelle manier om veel ROS te laten ontstaan en de reactie van het 
lichaam op ROS en de bijbehorende acute stress in een orgaan te bestuderen is een nier 
ischemie reperfusie, oftewel een afklem experiment van de nier. In zo’n experiment 
wordt de bloedtoevoer naar een orgaan (in dit geval de nier) gestopt en daarna hersteld 
zoals dit ook gebeurt bij een hartinfarct of een beroerte. In Hoofdstuk 4 laten we zien dat 
dieren die beperkt worden in hun voedselinname vóór de chirurgische ingreep, door drie 
dagen vasten of 4 weken 70% van hun normale hoeveelheid voedsel in te nemen, veel 
beter bestand zijn tegen de acute oxidatieve stress die ontstaat in de nier na de ingreep. 
Omdat bekend is dat beschadigingen in NER in het lichaam dezelfde reactie oproepen als 
beperkte voedsel inname hebben we ook naar de oxidatieve stress gevoeligheid van CSA 
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en CSB (Cockayne syndroom A en B) muizen gekeken. CSA en CSB muizen hebben een 
orgaan-specifieke bescherming tegen de ontstane oxidatieve stress, waarschijnlijk door 
hun adaptieve stress reactie (Hoofdstuk 5). 
In het laatste hoofdstuk van dit proefschrift (Hoofdstuk 7) heb ik naar genactivatie 
gekeken die ontstaat door promoter demethylering (het weghalen van de methylgroep 
van cytosines, zodat het gen overgeschreven kan worden) via het GADD45a eiwit, met als 
doel te onderzoeken of NER eiwitten hiervoor van belang zijn en welke NER subroute er 
voor deze GADD45a afhankelijke demethylatie wordt gebruikt. We tonen aan dat TC-NER 
eiwitten belangrijk zijn voor de GADD45a afhankelijke promoter demethylatie en dat 
verschillende mutaties in hetzelfde gen (XPD) een andere uitwerking met betrekking tot 
demethylering hebben.
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Dankwoord
Eindelijk is het dan zo ver…. de koek is op, de pen is leeg en mijn proefschrift is af! Maar 
natuurlijk was dit proefschrift niet tot stand gekomen zonder de hulp van een heleboel 
mensen, die ik dan ook heel erg graag wil bedanken, ook al heb ik helemaal geen zin 
meer om te schrijven. 
Ik heb 5 jaar lang met heel veel plezier op de afdeling Genetica gewerkt en heb door 
mijn vele interne verhuizingen (van bench naar bench) naast veel verschillende collega’s 
gezeten en plezier met ze gehad. Allereerst wil ik mijn co-promoter en dagelijks begeleider 
Jay bedanken: Jay thank you for your support and guidance from day one I entered the              
lab. You are the best supervisor I can think of. You inspired and stimulated me in my 
scientific development, and I admire your tolerance even in the beginning when I had 
to disturb you for an explanation multiple times. You even stayed patience in the last 
months during our skype conversations, when I held you from your morning coffee. I will 
promise you I will never do that again. I also want to thank you, and of course Elisabeth 
for the great time I had in Boston. It was hard work, but I felt completely at home with 
you and the kids, thanks for everything!
Natuurlijk wil ik ook mijn promoter Jan Hoeijmakers bedanken voor de mogelijkheden 
die hij mij heeft geboden. Jan, je was altijd een bron van inspiratie en liet me vrij in het 
onderzoek dat ik wilde doen. Ook wil ik bij deze Bert en Wim bedanken, ik kon altijd 
jullie kantoortje binnen lopen voor een vraag of een gesprekje en kreeg dan meestal 
meteen wat goede tips mee. En natuurlijk ook de rest van de mensen in mijn commissie, 
dank jullie wel voor het lezen van mijn proefschrift!
Ook wil ik mijn dagelijkse (oud) collega’s bedanken: Karin, tja sinds je weg bent is 
het toch akelig stil in het lab niemand zingt meer mee met de radio. Inêz, Monica, Roel, 
Lieneke, Joris, Romana en alle andere (oud) lunch partners, het is heerlijk om tijdens de 
lunch eventjes niet over wetenschap te praten en stoom af te blazen, bedankt voor al 
de gezellige en grappige hoogdravende gesprekken die we hebben gevoerd boven onze 
borden en kopjes koffie. Ook wens ik Monica, Eugin en Karl heel veel succes bij hun 
aankomende promotie, hup jongens het einde is in zicht! Ik wil ook Ingrid en Renate 
bedanken die me zeker in het begin veel hebben geholpen met de muizen. Dan eventjes 
naar de andere kant, naar mijn twee reuze teddyberen Arjan en Nils het was heerlijk 
om eventjes onder het genot van een kopje thee of tijdens jullie hulp met één van mijn 
experimenten bij te kletsen of plezier te maken om de tijd te doden. Ook Chris en 
Wendy bedankt voor de gezelligheid op het lab en tijdens de Kleinwalsertal meetings. 
Wendy ik heb het altijd geweldig gevonden om met jou samen te werken en wens je veel 
geluk en succes in Gent. Ambra, thanks for all the (scientific) advice and the nice time 
in NY together with Arjan. Audrey we didn’t run as much as we wanted but it was really 
nice. Dan nog Joris en Jan de Wit, ik ben heel blij dat ik met jullie het kantoortje heb 
mogen delen, jullie stonden altijd klaar met goede tips, leuke discussies en gesprekken, 
dank jullie wel! Verder wil ik natuurlijk al mijn (oud) labgenoten van de 7e verdieping 
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bedanken voor de samenwerking en de gezelligheid. Ook de ondersteuning van de 
computermannen, dames van de keuken en de dierverzorgers was heel belangrijk. 
Secretaresses (Marike en Jasperina) hoe vaak heb ik wel niet aan jullie bureau gestaan 
met een vraag of probleem en het bijzondere was dat het altijd in no-time was opgelost, 
dank jullie wel. Ook wil ik de mensen van het RIVM bedanken voor de samenwerking 
en natuurlijk Harry voor de gezelligheid en weetjes over de beste kroegen en pistes op 
congressen.
Dan wil ik natuurlijk ook mijn vrienden bedanken. Als eerste mijn vrienden en 
vriendinnen die ik al jaren heb uit Oirschot, dank jullie wel voor jullie steun en natuurlijk 
ook voor de jarenlange vriendschap, ook al zie ik de meeste van jullie niet heel erg veel, 
onthoud een ding, jullie zijn speciaal voor me en ik hoop dat we nog heel lang vrienden 
blijven. Ook mijn vrienden en vriendinnen uit Utrecht die altijd in zijn voor een gezellig 
feestje, e-mail discussies, een etentje of gewoon een goed gesprek, thanks. En natuurlijk 
mijn studie vrienden en vrienden en vriendinnen in Amsterdam jullie zijn de laatste 
tijd erg belangrijk voor me geweest en het was heerlijk om even stoom af te blazen en 
tegen iemand aan te kletsen tijdens het schrijven van mijn proefschrift. Ook de lol en de 
goede gesprekken tijdens de vele etentjes, wandelingen, filmavondjes, avondjes stappen, 
picknicks (ooh, was het maar weer zo ver) en sportactiviteiten zijn me dierbaar.
Ilje mijn tijd in Rotterdam was een stuk saaier geweest zonder al onze DE café dates, 
succes nu met je eigen onderzoek.
En dan natuurlijk mijn lieve nimfo’s Elske en Sam. Elske het grappige is dat we tijdens 
onze studie niet super veel met elkaar op trokken, maar dat hebben we zeker ingehaald 
de laatste paar jaren en je bent een echte vriendin voor me gebleken. Het is heerlijk om 
tegen iemand aan te praten, die echt weet waar je het over hebt en dan ook nog eens 
met goed advies komt. Je bent een goede sparringpartner zowel in het dagelijks leven als 
tijdens het kickboxen. Het kost ons de laatste tijd wat moeite om ons te motiveren voor 
het kickboxen, maar dat is denk ik ook niet zo heel erg vreemd gezien onze workload. 
Ik wens je heel veel succes met jou promotie en natuurlijk met je nieuwe baan bij NWO. 
Sam, ik heb je leren kennen tijdens mijn eerste Kleinwalsertal meeting, waar we (soms 
tot grote irritatie van andere) heel veel plezier hebben gehad. Ook de tweede keer was 
weer een groot succes en sindsdien ben je een echt maatje van me geworden. Ik geniet 
van de van de lol en de goede gesprekken die we samen hebben en ik heb echt een super 
leuke tijd met je gehad in Breckenridge. We gaan zeker nog een keertje werken aan die 
snowboard techniek van je. Heel veel succes nog met het afronden van jou onderzoek de 
komende tijd. 
Ook wil ik mijn schoonfamilie heel erg bedanken. Wim en Annemarie dank je wel 
voor de goede gesprekken en de wijze raad, ik voel me altijd erg op mijn gemak bij jullie. 
Jeroen en Susanne dank je wel voor de gezelligheid bij de vele etentjes.
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Dan nog mijn lieve ouders, mijn zusje, twee broers en de schoonzussen. Pap en mam, 
wat ben ik ontzettend blij met jullie. Jullie hebben me altijd gesteund in elke keuze die 
ik maakte. Ook al zijn de dingen die ik doe voor jullie vaak een ver-van-je-bed-show en 
soms moeilijk te begrijpen, jullie blijven liefdevol en geïnteresseerd. Thuis komen in 
Oirschot voelt voor mij altijd warm en vertrouwd. Op een of andere manier vallen daar 
de zorgen van me af en kan ik de dingen bekijken vanuit een ander perspectief. Ook Joep, 
Claudia, Jop, Lena, Maarten, Erica, Suuz, Fien, Marloes en Janneke dank jullie wel voor al 
de onvoorwaardelijke liefde en steun die ik van jullie heb gehad.
En als laatste, lieve Mattijs ik zou niet eens weten hoe ik jou zou moeten bedanken, je 
bent echt mijn alles, het allerliefste vriendje en maatje dat ik mezelf zou kunnen wensen. 
Jij steunt me echt in alles wat ik doe en je hebt zo ontzettend veel geduld. Ik ben zo trots 
op dit boekje en zo blij dat jij hieraan hebt mee geholpen, wij zijn zo’n goed team! Ik 
verheug me nu al op onze wel verdiende vakantie.
Zucht!.....nou dat was nog best wel wat schrijfwerk zo’n dankwoord. Ik ben blij dat het 
nu eindelijk voorbij is, op naar de volgende uitdaging...
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